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 Abstract 
 
The effect of the addition of affinity and immobilisation tags on (i) the production (ii) 
the purification and (iii) the orientation-specific immobilisation onto activated 
surfaces of model proteins is reported in this study. Green Fluorescent Protein (GFP) 
was used as a model protein allowed for the ease of comparison of these effects due 
to its ability to be directly monitored and quantified by fluorescence. The 
immobilisation of GFP using several different methods has been investigated and 
compared. These included (i) direct chemical immobilisation by covalent methods 
taking advantage of the inherent reactivity of lysine and cysteine residues, (ii) the 
well-characterised biological specific recognition/immobilisation between biotin and 
streptavidin, (iii) the biological affinity tag of ‘Strep-TagII’ for a mutated streptavidin 
known as ‘Streptactin’ and (iv) a combination of both methods by biotin 
functionalising lysine and cysteine tagged proteins.  
Several activated surfaces have been studied for the immobilisation of these proteins, 
including 96-well plates, and monolithic columns. This works reports on the 
optimisation of the production and photo-activation of monolith capillary columns as 
potentially useful surfaces for the immobilisation of protein bio-ligands. The 
monitoring and quantification of the immobilisation of protein onto monolithic 
columns by the contactless conductivity detection (C4D) method also formed an 
important part of this study. Finally, initial work is reported here on the potential 
generation of a biologically active and novel biosensor for the online and direct 
quantification of free sialic acid in monolith capillary columns using both C4D and 
fluorescence detection.  
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Chapter 1: Introduction 
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1. Introduction 
The orientated immobilisation of proteins on any surface requires careful 
consideration. The inherent variety of factors which make up a properly folded and 
active protein is considerable. To immobilise a biomolecule without disrupting these 
factors and for it to remain active is a significant challenge. For this study a model 
protein (Green Fluorescent Protein) was chosen, which will enable the determination 
of the effect the addition of tags will have on protein immobilisation.  
1.1: Green Fluorescent Protein 
1.1.1: Introduction 
Green fluorescent protein (GFP) was first described in the early sixties when it was co-
purified with the aequorin protein from the jellyfish Aequorea victoria. (Osamu 
Shimomura et al., 1962) It took another twelve years before the close relationship 
between these two proteins was fully established. (Morise et al., 1974) In a hugely 
labour intensive process some 30,000 specimens of Aequorea victoria were processed, 
which enabled the purification, crystallisation and partial characterisation of the protein. 
This allowed the determination of the excitation and emission spectra of this unique 
protein for the first time. Initial excitation spectra were defined at 280nm, 400nm, and 
480nm. These spectra are broadly in line with the currently accepted spectra for wild-
type GFP (wtGFP) namely 280nm, 395nm and 475nm.  The emission spectrum of 
509nm corresponds exactly with the present day emission value given for wtGFP. (Yang 
et al., 1996) 
GFP has been widely used for at least 20 years as a protein tag or label because of its 
unique properties. It is a spontaneously fluorescent protein, requiring only correct 
protein folding to fluoresce. As outlined by (Morise et al., 1974) its role is to transduce 
the blue chemiluminescence of aequorin to green light. It is perfectly evolved to do this 
as one of its excitation peaks (475nm) is nearly identical to the emission peak of 
aequorin (470nm). The reason Aequorea victoria has evolved this complicated two-
protein system to produce green fluorescent light is not yet fully understood. Despite 
this seemingly inefficient mechanism this system seems to be widespread in the phylum 
Cnidaria. (Matz et al., 1999) 
To date, it remains unresolved as to exactly why these organisms fluoresce, or why 
green emission holds an advantage over the primary blue emitters. It has been proposed 
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that fluorescent proteins in coral are acting as a protective barrier against UV light from 
the sun. Salih and co-workers have shown that corals which are in  shallower waters 
have a greater diversity of fluorescent proteins than coral in deeper and darker waters 
(Salih et al., 2000) It is proposed that they may protect resident symbiotic organisms 
that produce energy by photosynthesis This may not fully explain the presence of 
fluorescent proteins in jellyfish but may give an important clue to the functions of these 
unique molecules.  
1.1.2: Structure of GFP 
 
In 1996 two papers were published which elucidated the crystal and molecular structure 
of GFP. Both groups described GFP as consisting of 238 amino acids, molecular weight 
of 30kDa and confirmed the protein as having two excitation spectra of 395nm and 
475nm and an emission spectra of 508nm. The protein folds in the shape of a cylinder, 
comprising 11 strands of β-sheet which protects a central α-helix (Ormo et al., 1996). 
These groups have also determined that the protein folds to a molecule which is 42Å 
long and 24Å in diameter.  This structure has been referred to as the “β-can”. (Figure 
1.1) 
 
Figure 1.1: Green Fluorescent Protein structure submitted to Protein Data bank by 
Ormo, M., Remington, S.J. (PDB I.D.: 1ema) 
 
Two β-can structures can combine to form a dimer structure (Yang et al., 1996). The 
structure uploaded to http://www.rcsb.org/pdb/home/home.do by this group shows the 
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outlined dimer structure under the PDB I.D. 1GFL. In the dimer structure the monomers 
are associated in a twisted head to tail orientation via hydrophilic contacts along with 
several hydrophobic contacts (Zacharias and Tsien 2006). In this dimer structure there is 
a 25Å separation between the two fluorophores of the GFP monomers (Youvan and 
Michel-Beyerle, 1996). To date, GFP is the only fluorescent protein known that is not an 
obligate homo-oligomer in its natural state.  
There are several residues which are reported to be involved in this dimerisation; the 
best studied are A206, L221 and F223. These residues have been changed both singly 
and in combination by site directed mutagenesis, mainly to positively charged residues 
such as A206K, L221K and F223R. These mutations have eliminated the formation of a 
dimer molecule. (Zacharias et al., 2002a) Of course oligomerisation is important when 
it comes to using GFP to monitor protein localisation, expression or fluorescent 
resonance energy transfer (FRET).  As dimerisation of GFP can have a seriously 
deleterious effect on all these processes, ((David A. Zacharias and Roger Y. Tsien, 
2005) recommend that at least one of the mutations outlined above should be used in all 
GFP expression constructs as they do not effect the function of the protein apart from 
the homo-affinity of GFP. This is achieved by mutating smaller neutral amino acids 
such as alanine to positively charged amino acid residues such as lysine or arginine. The 
inhibition of dimerisation by electrostatic interactions is vital as protein folding and 
protein-protein interactions are measured by fluorescence. Any additional fluorescence 
due to dimerisation can give an increased signal and false positives.  
The most vital component of the structure of GFP is the protection it affords the 
fluorophore forming residue, which is securely protected within the β-can structure. 
Yang and co-workers (1996) describe the cylindrical fold of GFP as “remarkable” and 
describe how the β-sheets are fitted to each other like the staves of a barrel and form a 
regular pattern of hydrogen bonds, which may account for the protein’s stability against 
denaturation. The α-helices then cap both ends of the protein and, as such, the 
chromophore forming residues are completely protected from the bulk solvent (Yang et 
al., 1996). The initial half of the polypeptide is made up of three anti-parallel strands, 
the central helix, followed by three further anti-parallel strands. The backbone then 
crosses the ‘bottom’ of the molecule, which forms the second half of the β-can structure 
in a five stranded ‘Greek Key’ motif. The ‘top’ of the molecule is capped by three short, 
helical segments, and by short, much distorted, helical segment caps at the bottom of the 
cylinder (Ormo et al., 1996). 
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GFP is used as a tag to monitor protein location by fluorescent microscopy. If GFP can 
be engineered to be more fluorescent it can potentially be used for localisation studies. 
It has been determined that the smallest possible domain in GFP required for 
fluorescence is amino-acids 7-229 (Li et al., 1997).  Consequently this means that only 
15 amino acid residues can be deleted from the wtGFP without losing fluorescence. N-
terminal deletions of the amino acids 2-8 completely remove fluorescence. By mutation 
it has been established that replacing the Glutamic acid at position 7 with other amino 
acids greatly reduces GFP fluorescence. Conversely at the C-terminus of the GFP 
protein mutation of residue 229 is tolerated as the protein will still fluoresce regardless 
of the amino acid residue present at that position. 
 
Figure 1.2:  Colour coded structure of GFP. Yellow = β-sheet, Red = α-helix, Green = 
Loop. Submitted to Protein Data bank by Ormo, M., Remington, S.J. (PDB I.D.: 1ema) 
 
The wild type Ile229 can be replaced with any other amino acid without a noticeable 
loss of fluorescence. Through a series of well defined mutations (Li et al., 1997) 
replaced the negatively charged glutamic acid residues at positions 6 and 7 with either a 
single or double mutation of a neutral amino acid (Alanine) or a positive amino acid. 
(Lysine) They found that if either residues were mutated the fluorescence of the wtGFP 
stayed the same. When both residues were changed to either neutral or positively 
charged amino acids the fluorescence was lost. They also mutated these residues to a 
negatively charged aspartic acid. This mutation also reduced the fluorescence of the 
protein by up to 70%. This led Li and his co-workers to suggest that glutamic acid 
residues at positions 6 and 7 are not only required for their negative charge but for 
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maintaining specific contacts within the wild type protein. The same group focused on 
mutating the Isoleucine residue at position 229. As Isoleucine has a hydrophobic 
character they mutated this residue to (i) another hydrophobic residue (Leucine), (ii) a 
positively charged residue (Lysine) and (iii) a negatively charged residue (Aspartic 
Acid). The relative fluorescence of these mutants displayed no significant difference 
from the wild type. This group also made deletions and insertions in the two largest 
loops of the protein. Both of these actions resulted in the complete abolition of 
fluorescence (Li et al., 1997). 
From these examples alone, it can be seen that GFP’s major function is the protection 
its tertiary structure gives to the chromophore forming residues. The protein is non-
fluorescent in its unfolded state, and has evolved to protect the chromophore from the 
surrounding solvent and produce an environment within the “β-can” to produce 
fluorescence. Hence, while this protein, once folded is extremely stable and resistant to 
denaturation agents, heat and extreme pH, any unfolding will lead to a loss of 
fluorescence. GFP has therefore been used successfully in folding studies, when fused 
downstream from a protein (Cabantous et al., 2008), and in solubility studies, where the 
respective strengths and weakness of Guanidine and Arginine were compared in relation 
to the solubilisation of insoluble particles (Tsumoto et al., 2003). 
1.1.3: The chromophore of GFP 
The structure of the GFP chromophore had been initially suggested by (Shimomura, 
1979). This was later confirmed by (Cody et al., 1993).  Later, (Prasher et al., 1992)  
managed to clone the wtGFP gene into E. coli,.  However they were not successful in 
creating fluorescent colonies. As it was not known at this stage if the chromophore 
required co-factors and it was assumed that bacterial cells did not have the required 
cellular machinery to produce this effect.  
Figure 1.3: Sequence alignment between original GFP clone, (Prasher et al., 1992) and 
GFPmut3 used in this study. 
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In 1994 (Chalfie et al., 1994) described for the first time that the eukaryotic GFP could 
be expressed in both prokaryotic and other eukaryotic systems to produce fluorescence 
without the need for specialised co-factors or ligands  
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Figure 1.4: The chromophore formation of eGFP mutant. (Reid and Flynn, 1997) 
 
In the 15 years since this paper was published there has been an explosion in the amount 
of reported work on this protein and the uses for its non-toxic auto-fluorescence. 
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fluorescence has now been reported in a wide variety of organisms from the simplest 
bacterial systems to mammals including pigs, rabbits and mice. Its use has 
revolutionised fluorescent microscopic imaging allowing us to visualise the inner 
workings of many different types of cells. The properties of this protein are reliant on a 
triple amino acid protected securely in the hydrophobic environment in the centre of the 
proteins ‘β-can’ structure (Yang et al., 1996). 
The amino acid sequence twists to bring the carboxyl carbon of Thr65 and the amino 
nitrogen of Gly67 into close proximity (Tsien, 1998). A nucleophilic reaction between 
these two atoms, followed by the loss of a water molecule results in the creation of an 
imidazolin-5-one heterocyclic ring system. (Figure 1.4) Fluorescence is then generated 
by oxidation of the imidazoline ring with Tyr66 and maturation of a fluorescent species. 
The green fluorescent protein fluorophore exists in two states. A protonated form, 
which is the predominant state, has an excitation maximum at 395nm, and a less 
prevalent, unprotonated form that absorbs 475nm. Despite the excitation wavelength, 
however, fluorescence emission has a maximum peak at 509nm.  
The internal environment and residues adjacent to these amino acids play a vitally 
important role in the formation of this fluorophore. One side of the chromophore faces a 
large cavity that occupies a volume of 135Å3.(Ormo et al., 1996) Four water molecules 
are located in this cavity, which form a chain of hydrogen bonds joining the side chains 
of Glu222 and Gln69. The cavity might also temporarily accommodate the O2 which 
dehydrogenates the α-β bond of Tyr66. (Ormo et al., 1996) There is also a complicated 
network of polar interactions between the protein structure and the chromophore. The 
amino acids His148, Thr203 and Ser205 all form hydrogen bonds with the phenolic 
hydroxyl. The carbonyl of the imidazolinone ring interacts with Arginine at position 96 
and Glutamine at position 94, and Glu222 forms a hydrogen bond with the side chain of 
Thr65.  An in-depth study of Arg96 indicated that the residue may be essential for the 
formation of the fluorophore by activating the S65 carbonyl for nucleophilic attack or 
by directly de-protonating the G67 backbone amide and may help catalyse the initial 
ring closure.(Wood et al., 2005) This study went on to indicate that R96 tunes the GFP 
spectral properties by stabilising the de-protonated form of the mature chromophore.  
The R96 steric properties may inhibit conformation of the Y66 side chain and pre-
organise the backbone of the chromophore-forming residues to align them for ring 
cyclisation. Also the R96 residue electrostatic interactions may favour the G67 nitrogen 
de-protonation and stabilise any intermediates in the cyclisation reaction. 
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1.1.4: Green Fluorescent Protein Mutations  
For a protein of such significance many mutations have been made to improve its 
performance. It will not be possible to outline all mutants, but Table 1.1 outlines the 
most common.  
 
Table 1.1: Selected Mutations and associated changes of properties for Green 
Fluorescent Protein 
 
Selected Mutations in GFP 
Mutation Effect Selected References 
Chromophore Mutations 
S65T, S65G, 
S65A 
Increase in fluorescence 
Slight Red Shift 
(Heim et al., 1994) 
Y66W, Y66H, 
Y66F 
All mutants ‘blue shift’  
to one extent or another  
depending on aromatic ring 
(Ormo et al., 1996, Palm et 
al., 1997, Cubitt et al., 1995)
Mutations effecting the Chromophore 
Q69M, Q69K Cause an 1nm to 2nm red 
shift (Griesbeck et al., 2001) 
T203F, T203H, 
T203Y 
Increase the excitation  
and emission spectra  
up to 20nm 
(Ormo et al., 1996) 
Folding Mutations 
Y145F Improves brightness (Heim and Tsien, 1996) 
M153T Improves folding at 37oC (Crameri et al., 1996) 
V163A 
Improves yield of  
correctly folded protein 
(Siemering et al., 1996) 
F64L Improves brightness (Patterson et al., 1997) 
F99S Improves folding at 37oC (Crameri et al., 1996) 
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1.2. Protein Immobilisation 
 
1.2.1 Introduction: 
 
The orientated immobilisation of proteins onto any surface often proves to be a difficult 
and complicated process. The large variety of components which make up a properly 
folded and active protein is considerable. This variety is derived from the twenty basic 
amino acids of which all proteins are composed, each containing its own unique 
chemical functional group, continuing to the quaternary structure of the correctly folded 
protein and finally to any post-translational modifications. All these factors play a vital 
role in the formation and function of a protein. For these reasons the chemical 
immobilisation of ‘active’ proteins has proven to be a challenging field.  
 
1.2.2 Immobilisation methods: 
 
The classical immobilisation of protein in a non-covalent, non-orientated manner has 
been used for many years. Common techniques such as passive absorption onto 
hydrophobic surfaces like nitrocellose membranes and polystyrene and electrostatic 
immobilisation onto polylysine surfaces are well characterised and studied. These 
immobilisation technique’s major advantages are that they do not require any additional 
coupling reagents or protein modification. They do have some significant disadvantages 
though: because they are not covalent interactions the immobilisations can be weak and 
reversible. The immobilisation of proteins onto hydrophobic surfaces can lead to 
conformational problems which could lead to denaturation. Finally, limited control over 
the immobilisation process often leads to steric hindrance problems. For these reasons 
these simple if effective methods do not have the required sensitively or refinement for 
the current requirements of this study.   
Large scale protein immobilisation techniques were focused on chemistries and 
methods which were borrowed from DNA microchips. (Macbeath et al., 1999) are 
recognised as the first published attempts at the formation of a large scale protein 
immobilisation experiment using a slide spotter normally used for DNA spotting.  In the 
reported experiment glass slides were functionalised with maleimide groups. Three 
molecules, biotin (recognised by streptavidin), a derivative of digoxigenin (recognised 
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by mouse monoclonal antibody DI-22) and a synthetic pipecolyl α-ketomaide 
(recognised by human immunophilin FKBP12) were immobilised on these slides by 
Michael addition. This reaction is characterised by the addition of a nucleophilic group 
across a double bond (Mather et al., 2006). The interaction between the bait and their 
determined probe was finally determined by Cy5-labelled antibodies.  
This experiment was soon followed by further attempts to immobilise large numbers of 
different proteins on solid surfaces without denaturating them. The use of a Schiff’s 
base reaction to covalently immobilise proteins involved the reaction between 
immobilised aldehydes with primary amines. (Macbeath and Schreiber, 2000)  Proteins 
may contain a variable number of lysine residues (which contain an amine moiety on 
their side chains) as well as the α-amine at their NH2-termini. This means proteins can 
immobilise in many different orientations. While this method may have little to no 
effect on the activity of a protein which has multiple active sites, an unfortunate 
covalent immobilisation event involving a lysine residue within the active site of a 
protein which only has a single site may destroy the activity of that protein due to steric 
hindrance. Ultimately this method of immobilisation did prove successful. Nearly 
11,000 distinct protein G spots were placed on a functionalised glass slide, with one 
reactive spot being picked out using Cy5 fluorescence (Macbeath and Schreiber, 2000).  
There have also been attempts to immobilise proteins on slides by non-covalent 
methods. (Khan et al., 2006) used a double histidine tag separated by 11 amino acids to 
increase the affinity and reduce a single tag’s rapid dissociation with great success. This 
method proved successful in both chip based assays and Surface Plasma Resonance 
(SPR) applications. A double histidine tag immobilisation method was also used to 
immobilise antibodies on slide surfaces, this time without the amino acid spacer 
sequence (Cornelia Steinhauer et al., 2006). The advantage of this method is that there 
is no need for protein pre-purification as purification and immobilisations steps can take 
place simultaneously. The addition of a histidine tag to either the N or C-terminal can 
result in a more orientated immobilisation event compared to relying on covalent 
immobilisation using inherent residues. Conversely these tags do display some 
disadvantages, namely the fact that the immobilisation is non-covalent, and as such 
protein leaching can occur.  
 
 
  
12 
1.2.3 Covalent Immobilisation Chemistries: 
 
When more stable protein immobilisations are required the use of covalent chemistry 
such as Michael addition and Schiff base chemistry is most widely prevalent. One of the 
major advantages of this highly stable method of immobilisation is that like passive 
absorption and electrostatic methods it may be performed without any additional 
modifications to the protein. This is most commonly achieved by taking advantage of 
the inherent lysine and cysteine residues within the proteins amino acid sequence both 
of which, have nucleophilic side chains. Lysine’s side chain has an amino functional 
group while cysteine’s has a thiol functional group. Both of these nucleophilic groups 
provide ideal chemical structure for several types of covalent immobilisation.   
 
Figure 1.5: Ester Reaction with amine residue of protein for immobilisation. NHS       
is N-hydroxysuccimide.  
 
As outlined in Figure 1.5, lysine residues are used to react with immobilised esters. The 
most commonly used of these esters is N-hydroxysuccimide (NHS) which forms a 
stable amide bond when reacted. Biomolecules to be immobilised by this method should 
be dissolved in a low ionic strength buffer before being passed over the functionalised 
surface. The efficiency of this reaction depends on several different factors such as pH, 
the amount of time given to the reaction, the protein concentration and the ionic strength 
of the buffer. (Rusmini et al., 2007)  A slight disadvantage of this method is that NHS 
esters are relatively unstable in aqueous buffers, and attachment of proteins in these 
conditions can compete with ester hydrolysis. The second major method of covalent 
immobilisation is using inherent cysteine residues within the proteins structure.  
O O O NH
N
O O
NH2
NHS Ester
Protein
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The thiol group of cysteine amino acids reacts by conjugate addition with α-β-
unsaturated carbonyls (maleimide is a perfect example of such a structure) to form a 
stable thioester bond.  
The amines of lysine can also react with maleimides but at physiological pH’s 
maleimide groups favour addition with thiols. The pH’s involved are well characterised, 
maleimide will react 1000 times more readily with the thiol group of cysteines at pH 
6.5-7.5 than with the amine group of lysines. This is due to the fact that amines are 
protonated at such pHs. (www.piercenet.com, Instructions for EZ-Link Maleimide-
PEG11-Biotin)   
NN
O O
SH
Maleimide
Protein
O O
S
 
Figure 1.6: Diagrammatic representation of thiol based immobilisation of proteins 
 
One of the major advantages of this method of covalent immobilisation is that cysteines 
are essential for the correct folding of many proteins tertiary structure. Cysteines are 
normally found in pairs within the proteins interior forming cystines though oxidation 
which stabilises the protein’s folding though a disulfide bond. As such free cysteines are 
not as common an amino acid residue in the majority of proteins compared to lysines. 
This means that if all exterior cysteines save one can be removed or a cysteine added 
where there were no inherent cysteine residues previously, covalent immobilisation by 
the reaction with maleimide can be presumed to be orientation specific. This 
methodology of course depends on the characteristics of each individual protein. This 
method of immobilisation has been most clearly demonstrated by the addition of a five 
cysteine tag to either the N or C-terminal of GFP and immobilised on maleimide 
functionalised surfaces. (Ichihara et al., 2006) 
Epoxide functionalised surfaces have also been used to immobilise proteins by their 
nucleophilic residues. As discussed previously, the most effective and well used 
nucleophilic residues are the amine groups of lysines and the thiols of cysteines. The 
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advantage of this method of immobilisation is that they are stable to hydrolysis at 
neutral pH which allows for relatively easy handling. Their disadvantage is  
 
Figure 1.7: Representation of the immobilisation of proteins using immobilised epoxide 
groups.  X = nitrogen or sulphur atoms 
 
that this reaction can result in slow reaction times and incomplete coupling. It has been 
shown that the immobilisation reaction proceeds at a faster rate if the biomolecule has 
already been immobilised hydrophobically on the epoxy surface. This may not always 
be an ideal immobilisation method. For example agarose which has been functionalised 
with epoxy residues has shown very little immobilisation at high and low ionic strength 
conditions. It is thought that this is due to the lack of a hydrophobic immobilisation 
step. Aldehyde groups may be used to immobilise proteins with exposed α-amine 
groups or lysine ε-amines. The amine group’s reaction with the aldehyde produces an 
imide with the surface functionalised aldehyde. This can then be reduced to form a 
secondary amine linkage (Wong et al., 2009), (Fig1.8). 
Figure 1.8: Graphic representation of the immobilisation of proteins on aldehyde 
functionalised surfaces. 
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All these methods suffer from certain disadvantages. They all rely on the covalent 
immobilisation of amino acids already present within the protein structure. As there is 
no way to determine exactly where these amino acids are within the protein, a 
potentially heterogeneously orientated population of immobilised proteins may be 
presented on a surface. Due to this fact many protein surfaces suffer from a high level of 
inactivity due to incorrectly orientated biomolecules. Secondly using amine or in some 
case carbonyl groups for immobilisation can disrupt the protein folding due to the loss 
of the electrostatic charges of these functional groups. Finally, all these methods depend 
on a high level of purity of the immobilised biomolecules. A major loss in sensitivity 
would occur if large amounts of impurities or containment proteins were immobilised 
instead of the target molecule. At a small scale this degree of purification does not form 
a major barrier. However, the unique properties of  scaled-up production of 
biomolecules often present a significant challenge.   
Several other methodologies for the immobilisation of biomolecules have been 
proposed. The most common of these is the ‘Staundinger reaction’, named after the 
German chemist who first described the reaction. The Staundinger ‘ligation’ method 
was first introduced in 2000 (Saxon and Bertozzi, 2000). It is known as a ligation rather 
than a reaction as the two reacting groups (an azide and a phosphine) are covalently 
attached to each other compared to the Staundinger reaction where the molecules are 
not covalently linked. The ligation is based on the functionality of the azide group (see 
Fig. 1.9). Azides are not present in living biological systems. They do not react with 
water, are resistant to oxidation and are mild electrophiles, they do not react with 
amines or any other biological nucleophiles and are stable at physiological 
temperatures. They are however susceptible to reduction by free thiols. Because of these 
qualities they have become used in many covalent immobilisation methods. The 
Staundinger ligation was first used to label cells and proteins. At room temperature and 
in the presence of water the coupling of an azide and a phosphine forms an amide bond. 
The first use of this method was published soon after. (Soellner et al., 2003) The ε-
amino of the first lysine of ribonuclease S’ (RNase S’) was replaced with an azido 
group. A glass slide, was treated with PEG, which had succimidyl ester termini for 
2hours followed by diphenylphosphinomethanethiol in dimethylformamide for 2hrs. 
This treatment resulted in a surface with a bound phosphinothioester. Immobilised 
RNase S’ was then tested in two ways. Firstly the ribonucleolytic activity was tested 
with a fluorescent substrate. Secondly, it was tested by using immunostaining. The 
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immunostaining was preformed with rabbit anti-RNaseA IgG, which was subsequently 
probed with an Alexa Fluor 488-conjugated secondary antibody.  Using both these 
methods it was determined that there was a 51% yield of successfully coupled protein, 
with 81% of the immobilised protein being active. This was compared to 
immobilisation of the PEG linker to amine functionalised slides, which had a similar 
percentage of the protein immobilised but the activity dropped to 6%. This clearly 
showed this immobilisation method had potential for protein immobilisation. One of the 
challenges is that to achieve site-specific immobilisation a method must be found to add 
an azide to the protein of interest, in the correct position. The most likely method to 
achieve this is enzymatically.   
 
 
Figure 1.9: Reaction scheme for a ‘Staundinger Reaction’. Where R’ may be a 
protein  
   
One of the first to suggest using Staudinger ligations for large scale protein microarray 
immobilisation was (Watzke et al., 2006). An azide group was placed on the C-terminus 
of a protein by expressed protein ligation (EPL). This method allows for a chemically 
synthesised C-terminal element to be fused to a recombinant N-terminal protein using 
intein protein splicing elements (Severinov and Muir, 1998). The ‘tagged’ protein was 
then immobilised onto a phosphine functionalised glass slide. The major drawback of 
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this method for protein immobilisation was the requirement for expressed protein to be 
modified prior to immobilisation. The following year (Kalia et al., 2007) used the same 
method to immobilise Bovine Pancreatic Ribonuclease onto a self-assembled gold 
monolayer rather than a glass slide. As the C-termini azide group is inert to any other 
biological functional groups present in the protein it was found that the protein was 
immobilised in a directed manner and it retained its activity.   
Another immobilisation method that has become relatively popular is known as “click 
chemistry”. This term was introduced in 2001 (Hartmuth C. Kolb et al., 2001). It was 
initially used to describe the construction of large complex chemical structures from 
smaller simpler structures, copying the methods nature uses. When “click chemistry” is 
referred to in the context of protein immobilisation, it refers to a 1,3-Dipolar 
cycloadditon. (Figure 1.10) This reaction was referred to in the above paper as the 
“cream of the crop” when it came to click chemistry. The initial definitions of these 
reactions were very specific i.e. they had to be modular, wide in scope, high yield, 
generate no toxic by-products which must be able to be purified by non-
chromatographic methods. As well as these tight controls, the process was required to 
take place under simple reaction conditions. They must be generated from easily 
available starting reagents, the reaction must take place in no solvent or a solvent that is 
non-toxic and the product must be easily purified. These strict criteria for the 1,3-
Dipolar cycloaddition has ensured that this is an effective method for the 
immobilisation of proteins onto solid surfaces.   
 
N N
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Azide Alkyne 1,2,3-triazole
 
 
Figure 1.10:  A reaction scheme for 1,3-Dipolar cylcoaddition, where R’ is a protein. 
 
As the addition of azides and alkynes to proteins is relatively easy and does not affect 
either protein structure, stability or function they may be used to effectively immobilise 
proteins with either an azide or alkyne functionalised surface. This reaction is 
irreversible and quantitative and made more efficient by the addition of Cu(I) species 
which catalyse the reaction (Wang et al., 2003).  
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Proof of concept of this method was provided when GFP was covalently immobilised 
by the addition of four amino acids on the C-terminal end of the protein sequence. The 
enzyme “protein farnesyltransferase” recognises this amino acid sequence only when 
present at the C-terminus of a protein and adds an azide functional group to the 
biomolecule of interest by protein prenylation. The protein was then covalently 
immobilised on agarose beads with an alkyne functional group (Duckworth et al., 
2006). 
A covalent method of protein immobilisation has also been investigated for use with 
monolithic columns. Monolithic columns have in recent years found use as a stationary 
phase in capillary electrophoresis. They are typically composed of a single piece of 
porous material rather than the more commonly used particulate stationary phase. 
Further information can be found in Section 1.4.  This immobilisation method was first 
introduced by (Tripp et al., 2000). Using porous monolith disks they functionalised the 
pores by filling the monolith with a reactive monomer (EDMA) and heating. This 
allows the monomer to be anchored to the pore surface by the radicals already present 
from the monolith production method. The monomer used in this case was 4,4-
dimethyl-2-vinyl-2-oxazolin-5-one (Vinyl Azlactone). They then passed amine  
 
Figure 1.11: Vinyl-azlactone protein immobilisation reaction.  
 
groups though this monolith disk and using gas chromatography determined that 50% of 
the groups were consumed within the first minute. This result held true over a range of 
solvents.   This process was called “Reactive Filtration” and was intended to remove 
unwanted products from chemical reactions. Other groups saw this as a method to 
covalently immobilise proteins using their inherent amine residues. Examples include 
the immobilisation of trypsin (Peterson et al., 2003),  Green Fluorescent Protein 
(Stachowiak et al., 2006), Horseradish Peroxidase, (Logan et al., 2007) and 
fluorescently labelled BSA. (Connolly et al., 2007) 
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1.3 Bio-affinity Immobilisation 
 
1.3.1: Introduction: 
One of the most well known and well studied methods of immobilising biomolecules is 
the use of the interaction between Avidin or Streptavidin and biotin.  This 
biorecognition event is not based on covalent interactions but is founded mainly on 
hydrogen bonding and hydrophobic interactions (Wilchek et al., 2006). Ultimately, this 
interaction is one of the strongest reported non-covalent biological interactions with an 
average dissociation constant of KD =10-15M.  
 
1.3.2: Structure and Biotin Binding: 
Avidin was originally isolated from egg white, while Streptavidin is secreted by 
Streptomyces avidinii. Streptavidin was first cloned in 1986 (Argarana et al., 1986) and 
expressed in 1989. (Sano and Cantor, 1990)  The more complex eukaryotic avidin was 
first sequenced in 1995. (Wallen et al., 1995) Amazingly, for these two proteins, one 
from a eukaryotic source the other from a prokaryotic both are structurally and 
functionally almost identical.  Despite structural similarities the amino acid sequences 
of both these proteins have only a 41% similarity while the identity percentage is 30% 
(Olli et al., 1999). They have similar secondary, tertiary and quaternary structures, 
which are resistant to high temperatures and extremes of pH. These proteins are also 
resistant to degradation by proteolytic enzymes.  Both Avidin and Streptavidin are 
composed of four identical monomeric subunits. Each of these monomers is composed 
of eight stranded anti-parallel β-barrels. The interaction of these monomers in the 
relation to the binding of biotin has been described as a “dimer of dimers”. The first 
monomeric subunit plays an important structural role in the binding of biotin by the 
fourth subunit and vice versa. 
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Figure 1.12: The structure of Biotin  
 
The same interaction occurs between monomeric subunits two and three (Laitinen et al., 
2006). Therefore each monomer in the dimer is required for the efficient binding of 
biotin by the corresponding subunit in the pair. The residue involved in this functional 
interplay is tryptophan in both cases but they are located in slightly different areas of 
both proteins. In avidin the Trp110 plays a vital role in the biotin binding pocket of the 
neighbouring subunit, while Trp120 plays a similar role in streptavidin.  The binding of 
biotin takes place at one end of each monomeric structure, so each fully folded 
quaternary streptavidin or avidin structure can bind up to four biotin molecules. It has 
been shown that the binding of a biotin molecule to a monomeric avidin or streptavidin 
has a dissociation constant of KD=10-7M, whereas the binding of biotin to a tetrameric 
protein restores the dissociation constant to its wild type value (KD =10-15M.) (Laitinen 
et al., 2006). This may indicate that the quaternary structure of the proteins plays a vital 
role in the extremely tight binding of the protein to its ligand.  
The crystal structure of streptavidin without bound biotin and a streptavidin biotin 
complex have been studied to try and determine the method by which biotin binds to the 
protein. The relatively high amounts of hydrophilic contact residues initially form 
hydrogen bonds with the biotin molecule. Secondly, there are several aromatic residues 
in the binding area, which provide a hydrophobic environment for the binding to take 
place (Weber et al., 1989). These interactions in themselves do not fully explain the 
unusually high affinity for biotin that this protein exhibits. There is evidence that that 
once the biotin has been bound initially to the protein, the conformation of several loops 
of the Avidin and Streptavidin proteins change, in such a way that may indicate a lid 
closing over the biotin, enclosing the biotin within the monomeric avidin/streptavidin 
structure (Gonzalez et al., 1997). As well as this, in the absence of the ligand five water 
molecules take the place of the biotin in the biotin binding pocket and take the shape 
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and hydrogen binding capacity of biotin. (Weber et al., 1989) The interface between the 
first and third monomeric subunits is maintained by three hydrophobic interactions and 
Van Der Waals in Avidin, while in Streptavidin polar amino acids play an important 
role. The interaction between the first and fourth monomers in both proteins is 
maintained by about two dozen hydrogen bonds. (Figure 1.13) Finally, as outlined 
previously the third monomer-monomer interaction in Avidin and Streptavidin is 
between the first and second monomer and third and fourth monomer. These 
interactions are maintained by tryptophan residues and play an important role in the 
binding of biotin (Laitinen et al., 2007).  
 
 
 
Figure 1.13: A: Molecular structure of Avidin. PDB accession code: 2avi, B: Molecular 
structure of Streptavidin, PDB accession code: 1mk5  
 
The tight binding between Biotin and Avidin/Streptavidin has been employed in a wide 
range of immobilisation protocols. It has been used to bind biotinylated liposomes to 
streptavdin functionalised agarose beads (Yang et al., 1998), glycoproteins to micro 
well plates, (Cordiano et al., 1995) viruses to sol gels (Riccardi Cdos et al., 2006) and 
to purify biotinylated proteins (Rybak et al., 2004). The search  for orientation specific 
immobilisation of proteins was also studied using this interaction. Using site directed 
mutagenesis all the inherent cysteines in streptavidin were removed and an additional 
tag with a single cysteine residue was added to the terminal of the protein. This tagged 
protein was then immobilised to maleimide functionalised surfaces by the previously 
A B 
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outlined thiol based immobilisation protocol. (Reznik et al., 2001)  These examples are 
only a small sample of the wide range of uses for this very important biological 
interaction.  
Due to the fact that this is such a well characterised interaction a number of companies 
have produced biotinylated products. The most prominent of these companies is Pierce 
Chemicals which provides a wide range of biotinylation molecules. These molecules 
take advantage of some of the covalent reactions outlined previously to add a biotin 
molecule to proteins, marketed under the EZ-Link® trademark. 
 
 
 
  
 
 
 
Figure 1.14: Biotin Spacer Linkers supplied by Pierce Chemical Limited. 
 
Further work has been carried out to broaden the scope of this interaction, including 
groundbreaking work on biological mimics of biotin outlined in Section 1.3.3 
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1.3.3: Streptactin and Strep-tagII: 
 
The initial work which led to the development of the ‘Strep tag’ was first outlined when 
a tag was engineered at the C-terminus of the VH domain of antibodies (Schmidt and 
Skerra, 1993). This tag allowed for the detection of an antibody by commonly used 
techniques such as Western Blots by a streptavidin-alkaline phosphatase conjugate. The 
‘Strep Tag’ is a nine amino acid sequence (Ala-Trp-Arg-His-Pro-Gln-Phe-Gly-Gly) 
which displays an affinity toward Streptavidin but not to Avidin and was initially only 
found to work reproducibly at the C-terminal of proteins. As well as being used for 
immobilisation this tag is used as an affinity tag to purify proteins produced as Strep-tag 
fusions in different expression systems. Because this tag does not have as strong an 
interaction with streptavidin as wild type biotin, it can be competitively eluted with 
biotin analogs such as desthiobiotin (Voss and Skerra, 1997).  
To determine exactly how this interaction works (Schmidt et al., 1996) undertook 
crystallisation studies of streptavidin with a bound Strep-Tag. They reported that the tag 
interacts with several residues of Streptavidin’s flexible loop, including residues 43, 45, 
51, 52 and 54. This flexible group has been studied extensively and is thought to be one 
of the major factors contributing to the high affinity for biotin these molecules possess. 
Once the ligand is bound, this loop changes confirmation to ‘close’ over the binding site 
and lock the ligand in place (Weber et al., 1989). This group continued to determine 
further Streptavidin residues which form hydrogen bonds to the Strep tag, namely 
residues 23, 37, 84, 88, 90 and 128. One of the most important of these interactions is 
how the C-terminal Gly-Gly moiety of the Strep-Tag interacts through a series of bonds 
to the protein through a salt bridge at Arganine residue 84. It is interesting to note that 
this is such a specific interaction that the Strep-Tag has been shown not to interact with 
the closely related Avidin. The mechanism of this interaction (relying largely on C-
terminal residues) sheds light on why this tag works only at the C-terminal end of 
proteins.   
In order to improve this tag the same group used a synthetic peptide spot assay to 
develop a second immobilisation tag which does not have a ‘C-terminal’ limitation. And 
succeeded in developing a second tag which they named as Strep-TagII (Schmidt et al., 
1996). This tag has the following sequence; (Asn-Trp-Ser-His-Pro-Gln-Phe-Glu-Lys) 
and showed a lower affinity for streptavidin (KD =13µM) than the original Strep tag but 
could be used at either the N or C-terminal end of fusion proteins. To overcome the 
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problem of lower affinity, streptavidin itself underwent several rounds of mutagenesis to 
increase the affinity for this new tag. The focus once again fell on the flexible loop of 
the protein. As outlined previously, this flexible loop plays a vital role in the binding 
both of the biotin molecule and the Strep-Tag amino acid sequence. By comparing the 
crystal structures of both streptavidin which has not bound to the Strep-TagII and 
streptavidin having bound to Strep-TagII, attention was drawn to residues 44-47 (Glu-
Ser-Ala-Val) of the flexible loop. (Voss and Skerra, 1997) The crystal structures show 
that in wild-type streptavidin the loop is “disordered” without the presence of a ligand, 
but once biotin is complexed to the binding site, the loop “closes” to protect this site. 
(Voss and Skerra, 1997) continued by mutating the residues from positions 44-47 in the 
protein. 
                  44 45  46  47 
Wild Type Streptavidin:  Glu Ser Ala Val 
Mut1     Val Thr Ala Arg 
Mut2     Ile Gly Ala Arg   
Table 1.2: Substitutions made to the flexible loop of Streptavidin (Voss and Skerra, 
1997) 
  
By immobilising the wild type and mutated streptavidin in a sandwich assay on a 
capture membrane the efficiency of binding was determined. Antibodies against 
streptavidin were first immobilised, followed by the streptavidin. This was then probed 
with a Strep-tagII labelled alkaline phosphatase. The mutations outlined were found to 
have a KD value for the Strep-TagII of ~1µM. This was a significantly tighter binding 
for the tag than the previously determined KD value with wt-Streptavidin of 13µM. A 
change in confirmation of the flexible loop was seen as the cause of this change in the 
dissociation co-efficient. Within the mutated streptavidin molecules the flexible loop 
had changed into an almost opposite orientation, which gives a larger peptide access to 
the active site. Oddly, the mutations do not interact with the Strep-TagII peptide in any 
way (Korndorfer and Skerra, 2002). It appears that these mutations stabilised the loop 
and removed the need for the protein to change confirmation (Voss and Skerra, 1997). 
While this system has a lower affinity for its ligand when compared to wt-streptavidin, 
it has a much higher affinity for the engineered Strep-TagII when compared to the wild-
type. This mutated protein has been available commercially as Strep-Tactin from IBA 
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( http://www.iba-go.com/). As the addition of an eight amino acid tag to a proteins N or 
C-terminus is a relatively easy task, this broadens the usefulness of this biological 
system.  
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1.4: Monolithic Columns 
 
The first modern rigid monoliths emerged at the start of the 1990’s. They were initially 
used as an alternative stationary phase for HPLC alongside the popular particulate 
stationary phase. They provided a good alternative to particulate based systems because 
a monoliths high porosity allows for low back-pressures which in turn allows 
separations to be run at high flow rates allowing for faster separations 
1.4.1 Introduction to Monolithic Columns: 
 
 
Figure 1.15: Structure of a Ethylene dimethacrylate monolithic column (Connolly et al., 
2007) 
 
Monoliths have been described by (Frantisek, 2006) as “a single large particle of porous 
material.”  Monoliths have their porous structure generated during their preparation. 
Their internal structure is defined by countless inter connected pores of different sizes. 
While their structurally rigidity is achieved by cross-linked monomers.  The creation of 
monolithic structures is defined by a liquid reaction creating a solid porous structure, 
through the cross-linking of monomers within the presence of a non-reactive solvent. As 
the initial reaction is ‘liquid’ it requires the use of a mold and therefore monolithic 
structures have been formed in a wide range of shapes and structures including rods, 
membranes, discs, fibres and columns. They have been constructed out of various 
materials, the most common are agarose monoliths, silca monoliths, Cryogels and 
GMA(Glycidyl methacrylate) or EDMA (Ethylene dimethacrylate) monoliths.(Rangan 
Mallik, 2006) Functionalised monoliths in many different forms are now commercially 
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available. BIA separations alone now provides nearly fifty distinct monolithic columns. 
(http://www.biaseparations.com) The significant increase in the popularity of 
monolith structures can be explained by this sheer variety, which allows for a wide 
range of separation and affinity chromatography techniques.  
  
 
1.4.2: Formation of monolithic columns: 
 
Monolithic columns are formed by radical polymerisation or co-polymerisation of 
monomers within a mould to generate the porous monolith structure. Normally, this is 
achieved by adding a reactive monomer, a cross-linking monomer, a porogen and an 
initiator to the mould.  Traditionally, the reaction was then started by heating the 
polymerisation mixture. More recently the use of photo-initiators and UV light as a 
method of forming monoliths has become popular (Yu et al., 2001). This has lead to an 
increased speed of monolith formation, and the ability to form monoliths at room 
temperature. A disadvantage of this technique is that one has to rely on UV transparent 
moulds, monomers and porogens (Lee et al., 2004). The use of UV light to generate 
monolithic structure also has an advantage in that it can be used to make focused 
monolithic “sections” within capillary columns. When using the original thermal-
initiator methods, a complete monolith column has to be generated. By using UV light 
and masking certain areas where one does not want monoliths to form, distinct sections 
of monolith can be formed within a column. 
One of the most vital aspects of monolith production is the control of pore size and pore 
formation. This parameter is mainly dictated by the porogen and the cross-linked 
monomer used in the formation reaction (Stulik et al., 2006). These investigators carried 
out an in-depth study on the effects on pore size and the amount of protein immobilised 
within a GMA/EDMA monolith (Homola et al., 1999). Under different polymerisation 
conditions the amount of protein immobilised was determined. These polymerisation 
conditions included varying the temperature of monolith initiation. It was found that in 
a range of temperatures between 55°C and 80°C the greatest amount of immobilised 
protein achieved was at 80°C. A change in the ratio between the structural monomer 
and the cross-linking monomer was also studied. As a decrease in the cross-linking 
monomer meant a corresponding decrease in the rigidity of the monolithic structure a 
cross-linking content of 16% v/v to the rest of the monolithic mixture was 
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recommended.  The final area of interest in this study was the concentration of porogen 
which would give the greatest surface area, but which would not have deleterious effect 
on the characteristic monolith low back pressures. For ultra-fast immunoextraction it 
was determined that a 60% (v/v) would be the optimum concentration of porogen. This 
produced a large enough surface area for protein immobilisation without causing a huge 
increase in the back pressure of the column (Jiang et al., 2005). The porogen to use is 
also an important consideration which has to be investigated and is considered one of 
the most important features of a monolithic preparation (Figure 1.16). For example (Lee 
et al., 2004) varied the ratios of two different porogens. The primary porogen used in 
these experiments was 1-decanol, with varying concentrations of cyclohexanol added. 
The pores formed when 1-decanol was the lone porogen were narrow and symmetrical 
with a maximum pore size of 2.2µm. When the ratio of porogen was changed to 2:1 1-
decanol to cyclohexanol the average pore size dropped to 0.66µm. These investigators 
went on to report that while the column with the smaller pores is more resistant to flow, 
both columns can withstand pressures of up to 25megapascals (MPa).  
 
Figure 1.16: The effect of porogen concentration on monolithic structure. Image 
from(Jiang et al., 2005). DoOH = Decanol. 
 
1.4.3.: Different types of monolith 
 
As previously mentioned monolithic structures can be composed of many functional 
monomers, each with different properties. The most commonly used, and the best 
researched are the following; 
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1.4.3.1: Glycidyl methacrylate (GMA) and Ethylene dimethacrylate (EDMA) 
monoliths: 
 
Methacrylate based monoliths have are most commonly used in affinity 
chromatography due to their inherent functional groups. Monoliths composed of these 
functional monomers and cross-linkers contain epoxy groups which can be used to 
immobilise ligands as outlined previously (Figure 1.7). An added benefit is the ease of 
use of these materials and the fact that by changing porogens, porogen concentrations 
and the cross-linker to monomer ratio the properties of these monoliths can be 
significantly changed (Rangan Mallik, 2006). 
  
1.4.3.2: Agarose Monoliths: 
 
Agarose has been used for many years as a method to separate biomolecules and its use 
as a monolith structure has been well documented (Walters, 2008). These monoliths are 
characterised by having large pores which are 20 to 200µm in diameter. The advantages 
of these monoliths are the low amounts of non-specific binding and their stability over a 
wide range of pH’s. They are inhibited by having a low inherent strength, large pores 
which limits amount of ligand immobilisation area and their susceptibility to high 
temperatures (Rangan Mallik, 2006). 
 
1.4.3.3: Silica Monoliths: 
 
Silica monoliths have become popular because of the use of silica particles in HPLC. 
They are characterised by having good mechanical strength but a major weakness is the 
complex preparation required and their tendency to shrink after they are formed 
(Rangan Mallik, 2006). The preparation of silica monolith columns consists of six 
separate steps. After acid and base catalysis the reactive alkoxysilanes polymerise. This 
reaction generates the gel. This gel then separates into two separate domains i.e. a solid 
and liquid phase. These phases continue to react with each other to give the final formed 
monolith structure in a process called ‘syneresis’. This syneresis reaction results in the 
shrinkage commonly associated with silca monoliths, but it also expels the liquid from 
the pores. These monoliths then have to be aged and dried. Finally, if these columns are 
to be used for affinity chromatography then the surfaces will have to be modified. The 
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pore size and structure of these monoliths are reliant on the thermodynamics and 
kinetics of the formation reaction. Therefore, the initial reaction mixture has to be very 
well defined (Rieux et al., 2005).     
 
Figure 1.17: Typical structure and pore morophology of a fused silca monolith. Picture 
from (Rangan Mallik, 2006) 
1.4.3.4: Cyrogels: 
 
These monoliths are defined by their large pore sizes more commonly known as 
marcopores. The most common way to produce these monoliths is by mixing of 
acrylamide, allyl glycidly ether, and N,N’-methylene bis-(acrylamide). TEMED and  
Figure 1.18: The structure and pore morophology of cyrogels: Illustration from (Rangan 
Mallik, 2006) 
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ammonium persulfate are used as initiators. The key to the formation of cyrogels as the 
name suggests is to perform the polymerisation at low temperatures, typically with the 
monomers dissolved in the aqueous phase below -10°C. The pores of the monolith are 
formed by the ice-crystals which are formed at this low temperature. Once the structure 
is formed the temperature is slowly increased to above freezing, allowing the ice to melt 
revealing the pores which are typically 10-100µm in diameter (Rangan Mallik, 2006). 
 
1.4.4.: Affinity Monolith Chromatography: 
 
Monolithic columns were first introduced as a new stationary phase in HPLC and 
Capillary Electrophoresis methods. More recently, many groups are using these 
structures as a stationary phase for affinity chromatography (Rangan Mallik, 2006). An 
important breakthrough in use of monoliths as a stationary phase is the control of 
surface chemistry of these surfaces by photografting. Many monolithic surfaces are 
hydrophobic when initially formed. This is not ideal for many proteins as many will be 
immobilised in a non-specific manner through hydrophobic interactions. A problem 
may also arise as many proteins with hydrophobic cores can be relatively easily 
denatured. The most common method to overcome this problem is to photograft a 
hydrophilic molecule onto the surface of the monolith. This provides a hydrophilic 
surface which can then be further modified to display reactive moieties for the covalent 
immobilisation of affinity ligands. (Stachowiak et al., 2006) have described that photo 
grafting of poly-(ethylene glycol) methacrylate (PEGMA) onto the monolithic surface 
reduced non-specific protein immobilisation in poly(butyl methacrylate-co-ethylene 
dimethacrylate) monolithic columns by as much as 98%. This group went on to 
immobilise protein in distinct zones along a capillary monolithic column using 
photografting techniques and the reactive monomer 2-vinyl-4,4-dimethylazlactone.  
A number of groups have made progress with immobilising ligands on monolithic 
surfaces. (Bedair and Oleschuk, 2006) have immobilised the lectin Concanavalin A onto 
glycidyl methacrylate/ethylene dimethacrylate monoliths using the Schiff base method. 
This was then used as a pre-concentrator on a nanoelectrospray emitter for the 
glycoprotein of Ribonuclease B before detection by mass spectrometry. (Ostryanina et 
al., 2002) immobilised protein and peptide ligands onto monolith supports known as 
Convective Interaction Media (CIM) discs (www.biaseperations.com) to fractionate 
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antibodies from the serum of rabbits. By using several CIM discs in series they were 
able to form a column which was highly selective. Peptide ligands have also been 
immobilised onto GMA monoliths for the study of interactions with plasminogen 
activators. These activators are highly important for the dissolving of blood clots and 
may play an important part in the treatment of heart disease (Vlakh et al., 2004). 
Other commonly used ligand for immobilisation on monolithic structures is Proteins A, 
G and L. These proteins have long been used in conventional immobilisation techniques 
and have made the transition to affinity chromatography monolithic columns. (Berruex 
et al., 2000) proposed the name High Performance Monolith Chromatography (HPMC) 
for the capture of polyclonal bovine IgG and a recombinant human antibody to CIM 
discs which had immobilised Protein A, G and L. (Gupalova et al., 2002) immobilised 
different forms of Protein G onto CIM discs to study their different binding 
characteristics to blood IgG’s and  blood serum albumin, while (Luo et al., 2002) used 
immobilised Protein A and L-histidine to purify IgG from blood serum. It was found 
that the immobilised Protein A monolith columns retained functionally for six months, a 
considerable lifespan for a biologically functionalised surface.  
Also of considerable interest is the transfer of immobilised metal affinity 
chromatography (IMAC) to monolithic supports. A successful example of this method 
was the creation of a Cryogel with a functionalised Cu2+ surface. As cryogel’s have 
large pore sizes due to their method of formation, E.coli cells could potentially be 
captured by these monolithic columns. This method was found to give an 80% recovery 
of E.coli cells when eluted with 10mM Imidazole or 20mM EDTA. (Arvidsson et al., 
2002) (Cheeks et al., 2009) then compared the purification of histidine tagged viral 
vectors by commercially available CIM discs and lab-made cryogels. They determined 
that the performance of CIM discs were superior in many ways to cyrogels especially in 
capture, concentration and elution capacity.  
As a potential method for affinity chromatography the use of monolithic columns has 
just begun to be explored. The benefit of using monolithic systems is that interactions 
between an immobilised ligand and an analyte can be relatively easily monitored. This 
becomes more evident when using macromolecules such as proteins, DNA or viruses 
where monoliths have an inherent higher capacity than traditional chromatographic 
supports (Peterka et al., 2006).  
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1.5: Capacitively Coupled Contactless Detection (C4D) 
 
1.5.1: Introduction to C4D:  
 
Absorbance at 280nm and fluorescence methods have long been used in capillary 
electrophoresis to detect peaks of eluted analytes. While these methods are ideal for a 
wide range of species they do have some limitations, the most important of which is the 
fact that not all analytes either absorb UV light or possess a fluorescent functionality.  
There is a continuing search for a non-invasive, easy to use detectors for these species. 
The focus of this search has been on electrochemical detection techniques, such as 
amperopmetry, potentionmetry and conductometry. Conductometry may be less 
sensitive than the other two methods but can be used for the broadest range of analytes 
(Guijt et al., 2004). Because of this conductivity detection in capillary electrophoresis 
has received a lot of attention over the past decade.  
 
1.5.2: Capacitively Coupled Contactless Conductivity Detection: 
 
Conductivity detectors were used as far back as the 1970’s. These methods involved 
contact conductivity detection, where the detectors were in direct contact with 
background electrolytes (BGEs). This is not an ideal situation as depending on the BGE 
reactions can occur with the electrodes of the detector. This leads to reduced 
reproducibility, loss of detection signal or electrode fouling.  
It was not until 1998 that further progress was made with this type of detection system. 
Two groups independently published a conductivity detection system for capillary 
electrophoresis.   (Fracassi Da Silva and Do Lago, 1998) and (Zemann et al., 1998) both 
used painted silver rings on a fused silca capillary to act as electrodes. Zemann and his 
colleagues went a step further and used stainless steel syringe needles to form 
electrodes. Both these systems, where the electrodes are not in direct contact with the 
solution to be measured, have become known as capacitively coupled contactless 
conductivity detection (C4D) systems. 
The use of the two syringe needles as electrodes for this system effectively “free” the 
detection of the conductivity within the capillary to any point. In this case as the needles 
were slightly larger than the capillary the detector cell was able to be moved to any 
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point on the capillary. The use of silver paint “locks” the detection to the area of the 
capillary between the two electrodes.  
In these initial papers the electrodes, which form cylindrical capacitors were separated 
by 1mm in (Fracassi Da Silva and Do Lago, 1998) and by 2mm in (Zemann et al., 
1998). It is within this detection window that the conductivity of the solution within the 
capillary is measured.  To do this an AC voltage is applied to one of the electrodes at 
constant amplitude. Applying an oscillation frequency causes a capacitive transition 
between the actuator electrode and the liquid inside the capillary. Passing through the 
gap between the electrodes, a second capacitive transition between the solution within 
the capillary and the pick-up electrode takes place (Figure 1.19). The generated electric 
current is indirectly proportional to the resistance or directly proportional to the 
conductance of the solution within the detector window(Scaronolínová et al., 2006). By 
using suitable electronics, the conductivity of the electrolyte in the detection gap can be 
determined.  
 
 
    
 
 
 
 
 
 
 
Figure 1.19: General Structure of C4D cell 
 
When different species in aqueous solution pass the detector, the conductivity of the 
solution is the only parameter which undergoes a change. Permittivity and permeability 
of aqueous solution are usually negligible and can be considered to remain constant for 
this case. Any changes in the detector window registered by the pick-up electrode are 
therefore related to changes in the conductivity of the solution in the cell, rather than the 
changes in any other parameter (Guijt et al., 2004).  
For modern detection cells the electrodes are kept at a constant distance within a 
grounded housing. The electrodes are usually separated by a thin metal sheet to reduce 
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cross capactivity and noise. When designing these detection cells parameters such as 
length of the electrodes as well as distance between them are important (Zemann, 2003).  
An alternating current (AC) is preferred over a direct current (DC) so as to minimise the 
polarisation of the electrodes. AC current also reduces the electrochemical reactions on 
the electrode surfaces, and to minimise interference of the DC current with the detection 
electronics.(Guijt et al., 2004) Taking all of these detection advances a commercially 
available conductivity detector was launched in 2004. This conductivity detector is 
marketed under the trade name “TraceDec”, and is available from Istech. 
(www.istech.at)  
 
 
 
.  
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1.6: A Sialic Acid Binding Protein: SiaP 
 
1.6.1: Introduction to Sialic Acid:  
 
Sialic acid is a generic term to describe a family of related nine-carbon sugars. These 
sugars are most commonly presented at the terminal positions via C2 to position 3 or 6 
of the previous sugar or to position eight of a previous sialic acid. The most abundant 
and best-studied sialic acid is N-Acetylneuraminic acid (Neu5Ac) as it is found most 
commonly in nature. (Severi et al., 2007) The special features of sialic acid are its 
amide group at carbon 5 and its carboxyl group at position 1.  
 
O
OH
OH
O
HO
HO
H
N
O
OH
OH
Neu5Ac
 
Figure 1.20: Structure of N-Acetylneuraminic Acid. (Neu5Ac)  
 
The importance of Sialic acids within biological systems cannot be understated. After 
nucleotides and proteins, carbohydrates have become known as the “third language of 
life” (Schauer, 2004).  Because these molecules are positioned at the terminus of the 
sugar structures which cover a cells’ surface they play a vital role in almost all 
biological events, most importantly intercellular adhesion and cell signalling, (Severi et 
al., 2007) As well as this many infectious microorganisms also recognise sialic acid as a 
cell adhesion point. The study of sialic acid has recieved great interest in the last 20 
years when its importance and structural diversity became fully known. Its importance 
in neuronal transmission, ion transport, reproduction, differentiation and protection are 
only now being understood. Its effect on disease states such as infections and 
inflammations, cancer and neurological, cardiovascular, endocrinological and 
autoimmune diseases as well as auto-immune and genetic disorders are even more wide-
spread and studied (Traving and Schauer, 1998).  
Within large scale bioreactors and biotechnology processes the production of correctly 
folded and formed glycoproteins is of vital importance. The sialylation of glycoproteins 
has such an effect on the structure and function it can lead to vast differences on the 
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safety and efficacy of the product (Geyer and Geyer, 2006). A rapid and efficient 
method to measure and determine the amount of sialylation of a glycoprotein product 
would therefore be of great use to the biotechnology industry. The growth of the 
biopharmaceutical industry relies on the production of new and novel compounds, and 
only now is the importance of correctly glycosylated products being realised. Combined 
with stricter controls by safety authorities the ability to quickly and correctly define the 
level of glycosylation within a biopharmaceutical product will lead to increased growth 
in the sector.    
 
1.6.2: Introduction to Haemophilus influenzae: 
The bacterium Haemophilus influenzae is a gram negative rod which was first isolated 
in 1892. It is a major cause of disease, such as septicaemia, meningitis, otitis and acute 
respiratory tract infections. (Severi et al., 2005) It was also the first organism to have its 
entire genome sequenced in 1995. (Fleischmann et al., 1995) It is an opportunistic 
pathogen and is adapted to infect and colonise humans. To protect itself from its host’s 
immune systems and to increase its pathogenicity the bacterium has developed a 
complicated layer of sugars presented on its surface. This lipopolysaccharide (LPS) has 
been shown to effectively “hide” the bacterium from the host immune system. (Severi et 
al., 2005) 
 
1.6.3: Sialic Acid use in Haemophilus influenzae: 
The LPS in H. influenzae is a highly complex structure and is vitally important for the 
virulence of the organism (Schweda et al., 2007). Despite this, in a clinical test of 24 
isolates which are thought to represent the genetic diversity of this bacterium, terminal 
sialic acid was found in the vast majority of samples (Bauer et al., 2001).  By knock out 
mutations it has been determined that if sialic acid is not present on the LPS of the 
bacterium its ability to survive in human serum is greatly reduced (Hood et al., 1999). 
As H. influenzae does not have the cellular machinery to produce sialic acid all 
molecules displayed within the LPS have been scavenged from the surrounding 
environment. It has also been shown that H. influenzae can use sialic acid as a rich 
source of both carbon and nitrogen for metabolism (Vimr et al., 2000). 
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Figure 1.21: Simplified representation of the sialic acid TRAP system in H. influenzae 
(Allen et al., 2005). 
 
Much work has been done to discover the transport system the bacterium uses to 
acquire ‘free’ sialic acid. A tripartite ATP-independent periplasmic transporter (TRAP) 
has been deduced to be the method by which H. influenzae acquires this vital sugar.  
(Severi et al., 2005, Allen et al., 2005) As outlined by (Allen et al., 2005) these TRAP 
transporters consist of three unique proteins, namely an extracellular solute receptor 
(ESR) and two distinct membrane proteins which transport the molecule of choice 
across the membrane.   Within H. influenzae these proteins are expressed from two 
genes, the ESR protein is expressed from gene HI0146 and is known as SiaP, while the 
membrane transport proteins are expressed from gene HI0147 and are known as SiaQM.  
 
1.6.4: Importance of SiaP within Haemophilus influenzae: 
The initial work on SiaP was first carried out in 2005, where the effect on the organism 
of knocking out both the HI0146 and HI0147 genes were determined. (Severi et al., 
2005) This study showed that the deletion of either of these genes removed the ability of 
H. influenzae to use sialic acid in either the decoration of its LPS or use it as a carbon or 
nitrogen source. Due to the fact that its LPS was not decorated with the hosts own sialic 
acid the ability of H. influenzae to survive within blood serum was found to be greatly 
reduced.  
Also shown in this landmark paper was the binding efficiency of SiaP for sialic acid. By 
over-expressing and purifying SiaP from E.coli cells the molecular mass of the protein 
was determined to be 34kDa. By measuring the change in the fluorescence of SiaP 
SiaP 
Outer Cell 
Membrane 
Inner Cell 
Membrane 
SiaQM  
Neu5Ac 
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before and after sialic acid binding it was shown that the Kd was 0.12µM. This is an 
extremely high affinity constant.  
A more in-depth study of the protein was released in 2006. (Muller et al., 2006) In this 
study the structure of SiaP was resolved to 1.7Å in an unbound form and to 2.2Å in a 
bound form. It was determined that SiaP has two α/β domains connected by three 
segments of the protein and separated by a large cleft. Domain I is composed of the 
residues 1-124 and 213-252, and contains a 5-stranded β-sheet, with which are packed 
with six α-helices. 
 
Figure 1.21: Structure of SiaP with bound Sialic Acid. PBD No: 3b50 (Johnston et 
al., 2008). 
 
Domain II is composed of residues 125-212 and 253-306 and has a 6-stranded β-sheet 
surrounded by 3 α-helices. The C-terminus of the molecule forms a pair of α-helices 
that folds along the base of the molecule and folds against both domains (Muller et al., 
2006). 
This protein folding pattern allows for a rotation of 25-31° around a hinge between the 
residues Thr127-Arg128, Ile211-Leu212 and Glu254-Lys255. This rotation only occurs 
when the sialic acid ligand is bound. Both domains effectively close around the bound 
ligand and this rotation is the cause of the highly specific interaction and tight binding 
between SiaP and sialic acid. The ligand binds within the cleft between the two domains 
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and its carboxylate group forms a salt bridge to Arg147 and a polar interaction Asn187 
(Muller et al., 2006). 
It is thought that the binding of sialic acid to SiaP is initiated by the interaction of the 
carboxylate group of the ligand and the conserved Arg47 residue in domain II of the 
protein. The full coordination of the carboxylate also includes an interaction with 
Arg127 which is within the hinge region and the formation of this interaction could be 
involved in triggering the hinge movement of the protein. Once the hinge movement has 
occurred the domain I interactions with the ligand can form, binding the ligand tightly 
(Muller et al., 2006). 
 
1.7: Outline of this Thesis: 
The study of orientation specific immobilisation of active proteins onto novel surfaces 
was one of the initial aims of this project. Green Fluorescent Protein was determined to 
be an ideal model protein candidate for initial tagging studies. It was hoped that by 
using the protein’s inherent fluorescence the optimum tagging strategy and a successful 
and reproducible method of immobilisation onto a number of functionalised surfaces 
could be explored.  Once initial tagging and orientation specific immobilisation 
parameters were elucidated, it was hoped to transfer these processes to a more 
biologically significant biomolecule.  
The position of Sialic acid on the terminal end of carbohydrates, present on 
glycoproteins makes it an ideal target for the biopharmaceutical industry. SiaP has a 
high binding efficiency for sialic acid. If this protein can be positioned in the correct 
orientation this will provide a valuable method for the rapid and accurate analysis of 
Sialic acid levels in biological systems and industrial processes.  By utilising monolithic 
columns and C4D it is hoped to establish a quick and un-complicated method to 
determine biological interactions. 
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2.1 Abbreviations: 
bp  Base pair 
BSA  Bovine Serum Albumin 
BUMA  Butyl methacrylate 
C4D  Capacitively Coupled Contactless Conductivity Detection 
DAP  2,2-Dimethoxy-2-Phenylacetophenone. 
dH20  Deionised water 
DMSO  Dimethyl sulphoxide 
DNA                  Deoxyribonucleic acid 
dNTP               Dexoyribonucleotide Triphosphate 
EDMA          Ethylene Glycol dimethacrylate 
EDTA  Ethylenediaminetetra acetic acid 
IMAC                Immobilised metal affinity chromatography 
IPTG  Isopropyl-β-D-thiogalactopyranoside 
LB  Luria Bertani 
MCS  Multiple cloning site 
MOPS  3-(N-Morpholino)propanesulfonic acid 
O.D.  Optical Density 
ORF  Open reading frame 
PAGE  Polyacrylamide gel electrophoresis 
PCR  Polymerase chain reaction 
PEEK  Polyetheretherketone 
PEGMA  Polyethylene Glycol Methacrylate 
PIPES  Piperazine-1,4-bis(2-ethanesulfonic acid) 
SDS  Sodium dodecyl sulphate 
TEMED  N,N,N,N’-tetramethyl ethylenediamine 
TFA  Trifluoroacetic Acid 
Tris  Tris (hydroxymethyl) amino acid 
UV  Ultraviolet light 
w/v  Weight per volume 
XGAL  5-bromo-4-chloro-3-indolyl-β-D-galactopyranoside 
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2.2 Bacterial Strains, Primer Sequences and Plasmids: 
 
The bacterial strains, primer sequences and plasmids used in this study are outlined in 
Tables 2.1, 2.2 and 2.3 respectively. 
 
Table 2.1: Bacterial Strains 
 
Strain Genotype Features Source 
Escherichia coli 
BL21 (DE3) F-, dcm ompT hsdSB(rB-mB)gal 
lon λ(DE3 [lacI lacUV5-T7  
gene l indl sam7 nin5])  
Protease deficient 
High transformation 
efficiency 
 Expression host 
 
Novagen 
XL10-Gold Tetr ∆(mcrA)183 ∆(mcrCB-
hsdSMR-mrr)173 
endA1 supE44 thi-1 recA1 
gyrA96 relA1 lac Hte  
[F’proAB lacIqZ ∆M15 Tn10 
(Tetr)Amy Camr] 
High transformation 
efficiency 
Expression host 
Stratagene 
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Table 2.2: Primer Sequences (Synthesised by Sigma-Aldrich, U.K.) 
Primer Name Primer Sequence 
 
Tm  
F. Primer  
UBspHIU-GFP 
 
5’ CCCCCUTCATGAUGTAAAGGAGAAGAACTTTTCACTGGA 3’ 66oC 
F. Primer  
UBamHIU-GFP 
 
5’ CCCCCCUGGATCCUATGAGTAAAGGAGAAGAACTTTTCACT GGA 3’ 
 
69oC 
F.Primer BamHI 
Lysine tag-GFP 
 
5’CCCCCCUGGATCCUAAGAAAAAGAAAAAGATGAGTAAAGGAGAAG 
AACTTTTCACTGGA 3’ 
70oC 
F. Primer BamHI 
Cysteine tag-GFP 
 
5’ CCCCCCUGGATCCUTGTTGCTGTTGCTGTTGCATGAGTAAAGGAG 
AAGAACTTTTCACTGGA 3’ 
74oC 
F. Primer UBamHI 
StrepII tag-GFP 
 
5’CCCCCCUGGATCCUTGGAGCCACCCGCAGTTCGAAAAAATGAGTAA 
AGGA GAAGAACTTTTCACTGGA 3’ 
76oC 
F. Primer 
Phosphorylation-GFP 
 
5’ P’TAGAAGCTTAATTAGCTGAGCTTG 3’ 66°C 
R. Primer  
UBglIIU-GFP 
 
5’CCCCCUAGATCTUTTTGTATAGTTCATCCATGCCATGTGTAATC 
CCA 3’ 
 
68oC 
R. Primer  
UHindIII U-GFP 
 
5’ CCCCCCUAAGCTTUCTATTTGTATAGTTCATCCATGCCATGTGT 3’ 
 
67oC 
R. Primer UHindIII 
Lysine tag-GFP 
 
5’CCCCCCUAAGCTTUCTACTTTTTCTTTTTCTTTTT GTATAGTTCATCC 
ATGCCATGTGT 3’ 
 
69oC 
R. Primer UHindIIIU 
Cysteine tag-GFP 
 
5’CCCCCCUAAGCTTUCTAGCAACAGCAACAGCAACATTTGTATAGTT 
CATCCATGCCATGTGT 3’ 
73oC 
R. Primer UHindIIIU 
StrepII tag -GFP 
 
5’CCCCCCUAAGCTTUCTATTTTTCGAACTGCGGGTGGCTCCATTT GT 
ATAGTTCATCCATGCCATGTGT 3’ 
 
75oC 
R.Primer 
Phosphorylation- 
cysteine residue-GFP 
5’ P’ACATTTGTATAGTTCATCCATGCC 3’ 66°C 
 
Restriction sites appear in bold and UunderlinedU. Inserted tags are in italics 
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Table 2.3: Plasmids generated in this study 
Plasmid 
 
Description Source 
pCR2.1 PCR Cloning Vector: AmpR, KmR, lacZα 
 
Invitrogen 
pQE30 AmpR,  Expression vector for N-terminally tagged 
(His)6 proteins, T5 promoter/lac operon 
 
Qiagen 
pQE60 AmpR, Expression vector for C-terminally tagged 
(His)6 proteins, T5 promoter/lac operon 
 
Qiagen 
pQE30-Xa  AmpR, Expression vector for N-terminally tagged 
 (His)6 and FXa Protease site, T5 promoter/lac operon 
 
Qiagen 
pUC18 Cloning vector: Plac, ampR, lacZα, ColE1 origin 
 
Amersham 
pRV Cloning vector in use in lab: AmpR , Ptac. 
 
 
Roman-Vaas  
(2005)  
pBK-
miniTn7gfp2 
Original source of GFP gene 
 
 
Koch, B(2001) 
pRV5 Derived Vector 
 
pVOS1 
 
pRV5 containing GFP, with a C-terminal histidine tag This Study 
pQE30 Derived Vectors 
 
pVOS2 pQE30 containing GFP 
 
This Study 
pVOS3 pQE30 containing GFP with a C-terminal lysine tag 
added by PCR 
 
This Study 
pVOS4 pQE30 containing GFP with a C-terminal cysteine tag  
added by PCR 
 
This Study 
pVOS5 pQE30 containing GFP with a C-terminal Strep-TagII  
added by PCR 
 
This Study 
pVOS12 pQE30 containing GFP with a C-terminal single 
cysteine residue added by PCR 
 
This Study 
pQE60 Derived Vectors 
 
 
pVOS9 pQE60 containing GFP with a N-terminal lysine tag  
added by PCR 
 
This Study 
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pVOS10 pQE60 containing GFP with a N-terminal cysteine tag  
added by PCR 
 
This Study 
pVOS11 
 
pQE60 containing GFP with a N-terminal Strep-tagII 
added by PCR 
 
This Study 
pQE30-Xa Derived Vectors 
 
pVOS2-Xa pQE30-Xa containing GFP  
 
This Study 
pVOS3-Xa pQE30-Xa containing GFP with a C-terminal lysine tag  
added by PCR 
 
This Study 
pVOS4-Xa pQE30-Xa containing GFP with a C-terminal cysteine 
tag added by PCR 
 
This Study 
pVOS5-Xa pQE30-Xa containing GFP with a C-terminal StrepII tag 
added by PCR 
 
This Study 
pVOS6-Xa pQE30-Xa containing GFP with a N-terminal lysine tag 
added by PCR 
 
This Study 
pVOS7-Xa pQE30-Xa containing GFP with a N-terminal cysteine 
tag added by PCR 
 
This Study 
pVOS8-Xa pQE30-Xa containing GFP with a N-terminal Strep-
tagII added by PCR 
 
This Study 
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2.3. Media: 
All chemicals and reagents were obtained from Sigma-Aldrich unless otherwise stated. 
Microbiological media were obtained from Cruinn Diagnostics Limited. Sterilisation 
was achieved by autoclaving at 121oC and 15lb/in2 for 20 minutes. 
 
Luria Bertani Broth (LB) 
Tryptone    10 g/L 
NaCl     10 g/L 
Yeast Extract    5 g/L 
 
The solution was adjusted to pH 7.0 with NaOH and sterilised by autoclaving. For solid 
LB agar, 15 g/L Technical Agar No.3 (Oxoid) was included.  
 
 
2.4: Solutions and Buffers: 
   
Tris-EDTA Buffer (TE Buffer) 
Tris-HCl   10 mM 
Na2-EDTA     1 mM 
pH    8.0 
 
50x Tris Acetate EDTA (TAE) Buffer 
 
  Tris    242 g/L 
  Glacial Acetic Acid  57.1ml/L 
  EDTA    100 ml/L (of 0.5 M stock) 
  pH    8.0 
The solution was diluted to 1X with dH20 before use.  
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Solutions for the 1-2-3 Method of Plasmid Preparation 
 
Solution 1:  
Glucose  50mM 
Na2-EDTA  10mM   
Tris-HCl  25mM  
 
Solution 2: 
NaOH   200mM 
SDS   1% (w/v) 
 
Solution 3: 
  Potassium Acetate 3M 
  pH   4.8 
To 60 ml of 5 M potassium acetate, 11.5ml of glacial acetic acid and 28.5ml of dH2O 
were added. The resulting solution was 3M with respect to potassium and 5M with 
respect to acetate. 
 
TB Buffer for Competent Cell Production 
PIPES   10mM 
CaCl2   15mM 
KCl   250mM 
pH   6.7 
The pH was adjusted with KOH and MnCl2 was then added to give a final concentration 
of 55mM. The solution was filter sterilised by passing through a 0.2µm filter and stored 
at 4°C. 
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DNA Gel Loading Dye (6x) 
  Bromophenol Blue 0.25% (w/v) 
  Xylene Cyanol 0.25% (w/v) 
  Ficoll (Type 400) 15% (w/v) 
 
This dye was made in dH2O and stored at room temperature following autoclaving. On a 
1% agarose gel, bromophenol blue and xylene cyanol migrate with the 300 bp and 4000 
bp fragments respectively.  
 
Lysis Buffer for Protein Purification 
  NaH2PO4  50mM 
  NaCl   300mM 
  Imidazole  10mM 
  pH   8.0 
 
Sample Buffer for SDS-PAGE 
  Glycerol  50%(v/v) 
  SDS   2% (w/v) 
  2-Mercaptoethanol 5% (v/v) 
  Bromophenol Blue 0.1% (w/v) 
  Tris-HCl, pH6.8 62.5mM 
 
For native PAGE, SDS and 2-mercaptoethanol were omitted and replaced with the 
equivalent volume of H2O. 
 
SDS-PAGE Running Buffer (5X) 
Tris-HCl  125mM 
Glycine  960mM 
SDS   0.5% (w/v) 
 
 For native PAGE, SDS was omitted.  
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Resin Binding Buffer 
Sodium Phosphate  20mM 
NaCl    500mM 
Imidazole   20-40mM 
pH    7.4 
  
The optimal imidazole concentration is protein dependent.  
 
Resin Elution Buffer 
Sodium Phosphate  20mM 
NaCl    500mM 
Imidazole   40-250mM 
pH    7.4 
 
The optimal imidazole concentration for elution is protein dependent.  
 
Stripping Buffer for IMAC Resins 
Sodium Phosphate  20mM 
NaCl    500mM 
EDTA    50mM 
pH    7.4 
 
Recharging Buffer for Nickel Resins 
NiSO4    100mM 
 
Coomassie Blue Stain (for 400mls) 
 
Coomassie Blue (R-250) 1g 
Methanol 160ml 
dH20 200ml 
Acetic Acid 40ml 
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Coomassie Blue De-Stain Solution (400mls) 
 
Methanol 160ml 
dH20 200ml 
Acetic Acid 40ml 
 
 
 
Phosphate Buffered Saline (PBS) 1X 
 
                        NaCl                                137m  
                        NaH2PO4  4.3mM 
               KCl  2.7mM 
              K2HPO4                           1.5mM 
              pH                                    7.4 
 
 For PBST, the detergent Tween-20 was added to a final concentration of 0.1%(v/V) 
 
 
1M HEPES (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid) Buffer 
 
               238.3g HEPES in 500mls dH20 
 
The pH was adjusted by the addition of NaOH and brought to 1L with dH20. This was 
sterilised by autoclaving.  
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Table 2.4: Antibiotics and other chemicals preparation and storage 
 
 
2.5 Enzymes 
All restriction endonucleases and T4 DNA ligase were obtained from New England Biolabs 
or Promega. REDTaq was obtained from Sigma-Aldrich. Phusion High-Fidelity DNA 
Polymerase was obtained from New England Biolabs. Enzymes were used with their 
relevant buffers according to the manufacturers instructions.  
 
2.6 Storing and culturing bacteria 
Strains were stored as glycerol stocks. A 0.75ml aliquot of a late log phase culture was 
added to 0.75ml of sterile 80% glycerol in a microfuge tube.  This was then mixed and 
stored at –20°C. A duplicate set of long-term stocks was stored at –80°C. Where hosts 
were harbouring plasmids, the appropriate antibiotics were added to the stock medium. 
Working stocks were stored on plates at 4°C. 
 
 Stock 
Concentration 
 
Storage 
Temperature 
Final 
Concentration 
Storage  
Buffer 
Ampicillin 
 
100mg/ml 
-20°C 100µg/ml Water 
Gentamicin 50mg/ml 
-20°C 10-20µg/ml Water 
Tetracycline 50mg/ml 
-20°C 10-20µg/ml 50% Ethanol 
Chloramphenicol 50mg/ml 
-20°C 20-30µg/ml 100% Ethanol 
Kanamycin 50mg/ml 
-20°C 20-30µg/ml Water 
Streptomycin 100mg/ml 
-20°C 50µg/ml Water 
IPTG 1M 
-20°C 1mM Water 
XGAL 50mg/ml 
-20°C 50µg/ml Di-Methyl 
Formide 
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2.7 Isolation and purification of DNA 
 
2.7.1 Isolation of plasmid DNA 
Two procedures for the isolation of plasmid DNA were employed. The 1-2-3 method was 
routinely used to yield high quality DNA. The Genelute plasmid miniprep Kit (Sigma) was 
used to prepare consistently pure and super coiled plasmid DNA, mostly for the purpose of 
DNA sequencing. 
 
2.7.2: Plasmid preparation by the 1-2-3 method: 
This method is adapted from a previously outlined procedure (Birnboim and Doly, 
1979) which utilises the selective alkaline denaturation of high molecular weight 
chromosomal DNA. Circular plasmid DNA remains double stranded. A 1.5ml volume 
of overnight bacterial culture was transferred to a microfuge tube and centrifuged at 
13,000rpm for 5 minutes to collect the cells. The supernatant was discarded and the cell 
pellet resuspended in 0.2ml of Solution 1 (Section 2.4). Alternatively, bacterial growth 
can be removed from an LB agar culture plate with a sterile loop and resuspended in 
0.2ml of Solution 1. The resuspension was left for 5 min at room temperature. 0.2ml of 
Solution 2 was added the tube was mixed by inversion and placed on ice for 5 min. 
0.2ml of Solution 3 was added the tube mixed by inversion and placed on ice for 10 
minutes. Chromosomal DNA was pelleted by centrifugation at 13,000rpm for 10 
minutes. The supernatant was transferred to a new microfuge tube with 0.4ml of phenol 
chloroform isoamylalcohol (25:24:1) and mixed by brief vortexing. After centrifugation 
at 13,000rpm for 5 minutes the mixture is separated into an upper aqueous and lower 
organic layer. The aqueous layer was removed to a new microfuge tube with an equal 
volume of isopropanol and mixed by inversion. The tube was left at room temperature 
for 5 minutes and then centrifuged at 13,000rpm for 20 minutes to pellet the plasmid 
DNA. The pellet was washed with 70% ethanol and then dried briefly in a SpeedVac 
(Savant) vacuum centrifuge. The plasmid DNA was resuspended in 50µl of TE buffer 
and 1µl of ribonuclease A was added to digest co-purified RNA. Plasmid DNA was 
stored at 4°C 
 
  
54 
2.7.3: Plasmid preparation using the GenElute plasmid miniprep kit 
This method was followed as outlined in the GenElute plasmid miniprep kit (Sigma 
Aldrich). Bacterial growth was taken off an LB agar culture plate with a sterile loop and 
resuspended in 200µl of the supplied resuspension solution. This sample was vortexed 
to thoroughly resuspend the cells. Cells were lysed by adding 200µl of the supplied lysis 
solution and the contents were mixed by gentle inversion until the mixture becomes 
clear. 350µl of the neutralisation/binding solution was added and mixed by inversion. 
The cell debris was pelleted by centrifugation at 13,000rpm for 10 minutes. A GenElute 
miniprep-binding column was inserted into a provided micro centrifuge tube. 500µl of 
column preparation solution was added to each miniprep column and centrifuged at 
13,000rpm for 1 minute. The flow through liquid was discarded. The cleared 
supernatent from the neutralisation step was added to the prepared miniprep column and 
centrifuged at 13,000rpm for 1 minute. The flow through was discarded. 750µl of wash 
solution was added to the column and centrifuged at 13,000rpm for 1 minute. The flow 
through was discarded and the column recentrifuged at 13,000rpm for five minutes to 
remove excess ethanol. The column was then transferred to a new collection tube and 
plasmid DNA eluted by adding 100µl elution buffer or TE buffer was to the column. 
The collection tube was centrifuged at 13,000rpm for 1 minute. This eluent was then 
used or stored at –20oC.  
 
2.8 Agarose gel electrophoresis for DNA characterisation 
DNA was analysed by running on agarose gels in a horizontal gel box. Agarose was 
added to 1X TAE buffer to the required concentration (typically 0.7% w/v) and 
dissolved by boiling. The solution was poured into plastic trays and allowed to set with 
a plastic comb fitted to generate sample wells. TAE buffer was used as the running 
buffer. Loading dye was incorporated into DNA samples to facilitate loading and to 
indicate DNA migration during electrophoresis. Mini-gels were run at 120 Volts for 20-
30 minutes or until the tracker dye had well separated. Gels were stained by immersing 
in a bath of ethidium bromide for 20min.  Gels were visualised on a UV transilluminator 
coupled with an image analyser to capture the image. On every gel 0.5µg of 1Kb Plus 
DNA Ladder (Invitrogen) was run as a molecular size marker.   
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2.9 Isolation of DNA 
 
2.9.1 Purification of DNA from PCR reaction 
200µl of TE Buffer was added to the PCR reaction. 200µl of phenol solution was added, 
vortexed and centrifuged at 13,000rpm for five minutes. The supernatant was removed 
and placed in a sterile micro-centrifuge tube. The volume of supernatant removed was 
measured and a volume of 3M sodium acetate equal to one tenth of this was added (e.g. 
300 µl supernatent; add 30µl sodium acetate) and vortexed. To this, twice the total 
volume of isopropanol was added, the solution was hand inverted and centrifuged at 
13,000rpm for thirty minutes. The isopropanol was carefully removed without 
disturbing the pellet and to this supernatent 100µl of 70% ethanol was added followed 
by centrifugation at 13,000rpm for five minutes. The ethanol supernatant was removed 
without disturbing the pellet. Open micro-centrifuge tubes were placed in a vacuum 
dryer for five minutes to remove any remaining ethanol. The pellet was resuspended in 
45µl of TE Buffer, for five to ten minutes. The plasmid DNA was then stored at 4°C for 
future use.  
2.9.2 Purification of DNA from agarose gel 
When pouring an agarose gel for use in DNA purification 1µl of SybrSafe (Invitrogen) 
was added to 30µl of agarose. This allows for the visualisation of the DNA without 
using UV light or staining with ethidium bromide, thereby increasing the efficiency of 
DNA purification.  The DNA was purified from agarose gels using HiYield™Gel/PCR 
DNA Extraction Kit. (RBC Bioscience) The kit was used according to the manufactures 
instructions. The gel slice was excised with a sterile scalpel, transferred into a sterile 
micro-centrifuge tube and weighed. 500µl of DF buffer (contained in HiYield™ kit) 
was added to up to 300mg of agarose gel and mixed by vortexing. The gel slice was 
then incubated at 50oC for 10-15 minutes until completely dissolved. During incubation 
the microfuge tube was inverted every 2-3minutes. A DF column was placed into a 
collection tube and up to 800µl from the incubation was transferred. This was 
centrifuged at 13,000rpm for 30seconds. The flow through was discarded and the DF 
column was replaced in the collection tube. 500µl of wash buffer was added to the DF 
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column and centrifuged at 13,000rpm for 30seconds. The flow through was once again 
discarded and the column replaced into the collection tube. The column was centrifuged 
for 5 minutes at 13,000rpm to remove any remaining buffer. The dried column was then 
transferred into a clean micro-centrifuge tube and 30µl of elution buffer or TE buffer 
was added to the centre of the column. After allowing to stand for five minutes, the 
column was centrifuged for two minutes at 13,000rpm to elute the purified DNA. This 
was then stored at 4oC.  
 
2.10: Preparation of high efficiency competent cells 
This method is based on a method developed by (Inoue et al., 1990). A 250ml flask 
containing 100ml of LB broth was inoculated from an overnight culture. This culture 
was incubated at 37°C, shaking at 220rpm, until an O.D.600nm of 0.5 was recorded. 
When the cells reached this Optical Density, they were transferred to an ice water bath 
to stop growth. The cooled broth was then transferred to two sterile centrifuge tubes and 
pelleted in a cooled Beckman J2-21 centrifuge for five minutes at 4,500rpm. The 
supernatant was then discarded and the pellet re-suspended in 80mls of TB buffer, 
which was then incubated on ice for 10 minutes. This suspension was then centrifuged 
as previously. The supernatant was discarded and 15mls of TB buffer was used to re-
suspend the pellet. DMSO was added slowly to give a final concentration of 7%. After 
incubation on ice for 10 minutes the cells were aliquotted into cooled microfuge tubes 
and flash frozen in liquid ethanol and stored at –80oC.  
 
2.11 Transformation of high efficiency competent cells 
Competent cells, prepared according to the procedures outlined in section 2.10 were 
allowed to thaw on ice.  A 200µl aliquot of cells was mixed gently with a 1-5µl 
DNA/ligation mixture and incubated on ice for 30 minutes. The cells were heat shocked 
at 42°C for 30seconds and then transferred back onto ice for 2minutes. Using aseptic 
technique, 800µl of LB broth was added. The cells were incubated at 37°C for 1hour. A 
100µl aliquot of the resulting transformation mixture was plated on an appropriate 
selective media and the plates were incubated at 37°C overnight. ` 
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2.12 Determining cell efficiency 
Competent cell efficiency is defined in terms of the number of colony forming units 
obtained per µg of transformed plasmid DNA. A 25ng/µl stock of pUC18 plasmid DNA 
was diluted to 250pg/µl, 25pg/µl and 2.5pg/µl. An aliquot of 2µl from each dilution was 
transformed as described above in section 2.11. The transformation efficiency was 
calculated from the number of colonies obtained, taking into account the dilution factor 
and the fraction of culture transferred to the spread plate.  
 
2.13 Polymerase chain reaction 
PCR reactions were carried out using a Hybrid PCR Express Thermocycler.  
 
Standard Phusion PCR Reaction Mixture: 
Templete DNA                                     1µl 
Primers                                                     0.5µl of each 
Buffer (5X)                                      4µl 
dNTPs (10mM each)                                  4µl 
dH2O                                       9µl 
Phusion Taq Polymerase (1:5 dilution)      1µl 
 
 
 
Standard PCR Program:  
 
                  Stage 1: Denaturation:                           98oC for 30seconds 
 
                  Stage 2: Denaturation:                           98oC for 10seconds 
                      Annealation:                             65oC for 30seconds 
                      Extension:                                 72oC for 90seconds 
 
         Stage3: Final Extension:                        77oC for 10minutes 
 
 
 
50 Cycles 
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2.14 DNA sequencing 
Recombinant clones and potential mutants were verified by DNA sequencing. Eurofins 
MWG Operon provided commercial sequencing services and samples were sent as 
soluble plasmid DNA in TE buffer.  
 
2.15 Over expression of proteins in E.coli 
100ml of LB broth was inoculated with 1ml of an overnight culture of E.coli that has 
been transformed with an expression plasmid. The appropriate selective antibiotics were 
included in the overnight culture to ensure that contaminating bacterial growth was 
inhibited. The culture was incubated at 37°C, and 220rpm, until an O.D.600 of 0.5 was 
reached. IPTG was added to a final concentration of 50µM to induce expression. The 
temperature was reduced to 30oC to aid protein production and was incubated overnight. 
The culture was centrifuged at 5,000rpm for 5minutes (Beckman JA-14 rotor) to pellet 
the cells. The supernatent was discarded and the pellets were resuspended in binding 
buffer and stored at 4oC. 
 
2.15.1 Preparation of cleared lysate 
The resuspended cells were lysed with a 3mm micro-tip sonicator (Sonics & Materials 
Inc.) using 2.5seconds, 40kHz pulses for 30 seconds. The cell debris was  removed by 
centrifugation at 4,000rpm for 20min at 4oC (Beckman JA-20 rotor). The cleared lysate 
was then passed through a 0.2µm filter and transferred to a fresh universal container and 
stored at 4oC. 
 
 
2.16 Immobilised Metal Affinity Chromatography (IMAC) 
Immobilised Metal Affinity Chromatography (IMAC) was used to purify recombinant 
proteins fused to a 6 residue Histidine tag.  This interaction is based on the coordinated 
binding of histidine residues to immobilised divalent cationic metal ions, such as nickel.  
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2.16.1: IMAC using Ni-NTA resin 
Histidine tagged proteins were purified by gravity flow over a Ni-NTA resin. A 1ml 
aliquot of Nickel Sepharose High Performance (GE Healthcare) was poured into a 0.7 x 
10cm column and allowed to settle. The column was washed with five column volumes 
of distilled water to remove the 20% ethanol storage buffer and equilibrated with five-
column volumes of binding buffer. The pre-treated lysate protein sample (Section 
2.15.2) was then applied to the column. Five column volumes of binding buffer (Section 
2.4) containing 10mM imidazole were applied to the column as a wash buffer. This was 
followed by passing five column volumes of binding buffer (Section 2.4) containing 
60mM imidazole to remove any containment proteins. His-tagged proteins were 
purified by passing five column volumes of elution buffer containing 250mM 
imidazole. Samples of each protein fraction were analysed by SDS-PAGE. (Section 
2.20) Protein concentration was determined by the BCA assay. (Section 2.18) 
 
2.17 Regenerating and cleaning of nickel resin 
The nickel resin was regenerated and cleaned as outlined in the GE Healthcare 
handbook. Briefly summarised the used resin was poured into a column and washed 
with 2 column volumes dH2O, followed by two column volumes of 50%(v/v) ethanol. 
The resin was then stripped with two column volumes of 100mM EDTA, pH8.0. 
Remaining impurities were removed with two column volumes of 200mM NaCl, 
followed by two column volumes of dH2O. Hydrophobically bound proteins and 
lipoproteins were removed by washing with ten column volumes of 30% isopropanol 
for 30 minutes, followed by ten column volumes with water. The resin was then 
recharged by adding two column volumes of 100mM NiSO4. The resin was washed 
again with two column volumes of dH2O, before transfer to a sterile universal, where it 
was stored in 20% ethanol.   
 
2.18: Protein quantification by BCA assay 
The bicinchonic acid (BCA) assay described by (Smith et al., 1985) was utilised to 
quantify total protein in the range of 20-2,000 µg/ml. All samples were diluted to within 
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the range of the assay and added in triplicate to 150µl of BCA reagent (Sigma), and 
incubated at 37°C for two hours. Absorbance was read at 570nm. A standard curve was 
generated using bovine serum albumin (BSA) as the reference protein. Protein 
concentration was determined from this standard curve.   
 
2.19 Sodium Dodecyl Sulfate Polyacrylamide Gel Electrophoresis (SDS-PAGE) 
Proteins were analysed by sodium dodecyl sulphate-polyacrylamide gel electrophoresis 
(SDS-PAGE) according to their size,  as outlined by  (Laemmli, 1970). 
 
2.19.1 Preparation of SDS gels 
12% separating gels and 4% stacking polyacrylamide gels were prepared as outlined in 
Table 2.5. Gels were poured in an ATTO vertical mini electrophoresis system (MSC). 
TEMED and APS were added directly before the gels were poured. The separating gel 
was poured first up to 2cm below the limit of the plates. The separating gel was layered 
with 200µl of isopropanol and left for to polymerise.    
 
Table 2.5:  Solution for the preparation of 12% SDS Gels 
Solution 
 
12% Separating Gel 4% Stacking Gel 
1.5M Tris-HCl, pH8.8 
 
1.625ml      / 
0.5M Tris-HCl, pH6.8 
 
     / 0.625ml 
dH20 
 
2.207ml 1.538ml 
Acrylamide/Bis-acrylamide 30%/0.8%(w/v) 
 
2.6ml 0.335ml 
10%(w/v) Ammonium Persulphate 
 
32.5µl 12.5µl 
20%(w/v) SDS 
 
32.5µl 12.5µl 
TEMED 
 
3.25µl 2.5µl 
 
After polymerisation, the isopropanol was removed by washing with distilled water and 
TEMED was added to the stacking gel, which was poured over the separating gel 
immediately. A comb was placed into the liquid stacking gel immediately to form 
sample wells in the polymerised gel.   
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2.19.2 Running of SDS-PAGE gels 
Once the gels were polymerised the comb and gasket were removed from the now solid 
gels and placed in an ATTO vertical gel box. The gels were fitted into the gel box at an 
angle to minimise the creation of air bubbles between the buffer and the bottom of the 
gels. The gels were then completely submerged with 1X Running Buffer (Section 2.4) 
and the wells washed using a Pasteur Pipette to remove any residual un-polymerised 
acrylamide. Prepared samples (section 2.20.3) were loaded into the gel by deposition 
into the gel wells. Typically, the gels were run at 60mA per two gels for 50min or until 
the dye front reached the end of the gel. The standards used in SDS-PAGE gels were 
purchased from either Sigma Aldrich or New England Biolabs (NEB) The banding 
patterns are outlined in Tables 2.7 and 2.8 respectively.  
 
 
2.19.3 Sample preparation for SDS-PAGE 
10µl of a protein sample was added to 10µl of SDS sample buffer (Section 2.4) in a 
microfuge tube. (Section 2.4). Samples were then boiled for five minutes and applied to 
wells  
 
2.19.4 SDS-PAGE gel staining 
SDS-PAGE gels were stained by two different methods. For quick analysis and staining 
gels were incubated in Coomassie Blue stain (Section 2.4) for 1hour with agitation. The 
gels were then de-stained with multiple washes of Coomassie Blue de-staining solution 
(Section 2.4) until proteins are visible as blue bands on a colourless background.  For a 
more sensitive analysis the Silver staining method was used as described by (Blum et 
al., 1987) , and outlined in Table 2.6  
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Table 2.6: Silver Stain method for SDS-PAGE Gels 
 
SDS-PAGE protein markers were purchased from NEB (www.neb.com) or Sigma-Aldrich 
(www.sigmaaldrich.com) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Figure 2.1:  NEB BroadRange Protein Marker 
Step Duration 
 
Reagent (total volume of each 100mls) 
Fixing 60minutes-Overnight 
 
30% Ethanol, 10% Acetic Acid 
 
Wash  15minutes 
 
20% Ethanol 
 
Wash  15minutes dH2O 
 
Sensitise  
 
1minute 
 
0.1% (w/v) Na2S2O3 
 
Rinse 2 x 20 seconds dH2O 
 
Silver Stain 
 
20minutes 0.1% AgNO3, 70µl of 37% (v/v) 
Formaldehyde stock 
 
Rinse  2 x 20 seconds dH2O 
 
Development Until bands appear 3% Na2CO3, 50µl of 37% Formaldehyde 
stock, 0.002% (w/v) Na2S2O3 
 
Stop 5minutes 50g/L Trizma Base, 2.5% Acetic Acid (v/v) 
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Figure 2.2: Sigma Wide Range Marker 
 
 
2.20 Immobilisation of tagged GFP on MaxiSorp white plates 
 
50µl of 5µg/ml Streptavidin was immobilised in each well of a NUNC MaxiSorp white 
plate and immobilised overnight at 4°C. The wells were blocked with 150µl of 2.5% 
BSA in PBS for one hour. The wells were then washed four times with PBS. 50µl of 
50mg/ml biotinylated protein was immobilised for an hour at room temperature. The 
plate was washed four times with PBST, followed by four washes of PBS. 100µl of PBS 
was added to each well and the fluorescence was read at an excitation wavelength of 
475nm and an emission wavelength of 509nm to determine the level of GFP 
immobilisation. 
 
 
2.21 Biotinylation of GFP 
When using a NHS-biotin linker it was vital that the protein was not dissolved in a 
buffer containing amine. When attempting to biotinylate a GFP with a maleimide-biotin 
Da 
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linker it was important that the buffer contained no sulfhydryls. A 5 to 20 fold molar 
excess of reagent to protein was used. The protein solutions contained at least a 
concentration of 2 mg/ml. The quantity in millimoles of reagent to achieve 20-fold 
molar excess was initially calculated.  
                   Umg proteinU    Ummol proteinU    U20mmol Biotin Reagent 
ml protein x  ml protein  x   mg protein    x       mmol protein     =   mmol Biotin Reagent   
 
The amount of the stock 250mM biotinylation reagent to add to the reaction was then 
calculated as outlined below. 
                                        U1,000,000µlU     U      L      U                
mmol Biotin Reagent    x       L        x        250mmol = µl Biotin Reagent stock solution  
 
For biotinylation using the NHS-biotin linker the reaction took place in an amine free 
buffer at pH 7.2-8.0. The required volume of the stock biotin reagent was added to the 
protein solution. The reaction was incubated on ice for two hours. An identical 
procedure was used for the biotinylation of GFP using Maleimide-biotin linker. The 
buffer conditions were different and took place in a sulfhydryl-free buffer at pH 6.5-7.5. 
Any remaining unreacted biotin reagent was removed by dialysis into PBS. 
 
2.22 Dialysis of biotinylated reagent 
Dialysis tubing was prepared by boiling in dH2O containing 2% (w/v) sodium carbonate 
for half an hour. The tubing was rinsed with dH2O and stored in 20% ethanol at 4°C 
until required. To perform dialysis the required length of dialysis tubing was washed 
with dH2O to remove any residual ethanol, one end was closed and the protein solution 
was placed within the dialysis tubing and sealed. This sample was placed in 500mls of 
PBS pH7.4 and agitated for three hours at room temperature. The dialysis tubing was 
removed and the PBS pH7.4 was replaced. The dialysis tubing was replaced within the 
PBS and agitated overnight at room temperature. The biotinylated protein solution was 
removed from the dialysis tubing and stored at 4°C for immobilisation on monolithic 
columns (Section 2.23) and NUNC MaxiSorp white plates (Section 2.20) 
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2.23 Preparation of Monolithic Columns  
Monolithic columns are most commonly used in High Performance Liquid 
Chromatography (HPLC). Monoliths differ from particle based columns as they are 
composed of a single piece porous material. This is discussed in Section 1.4.   
 
 
2.23.1 Vinylisation of 100µm I.D. U.V. transparent silca column 
The vinylisation method employed was based on a protocol described by (Ericson et al., 
1997) A section of transparent silica column was cut from the parent roll. The flow rate 
of the pump (Knauer Wellchrom K-120) was set to 10µl/min. The column was plumbed 
to a pump primed with acetone and rinsed for five minutes, then dried with nitrogen at 
room temperature for ten minutes. 0.2mol/L NaOH was pumped through the column at 
for thirty minutes, followed by washing with water for five minutes. 0.2mol/L HCl was 
passed through the column for five minutes and once more rinsed with water at for five 
minutes. This was followed by rinsing with acetone for five minutes. The cleaned 
column was dried with nitrogen for ten minutes. The capillary was then filled with a 
solution of 50% w/v of 3(trimethoxysilyl)propyl methacrylate in acetone until all air 
was expelled. The capillary was sealed at either end and immersed in a water bath at 
60˚C for twenty hours. The capillary was finally rinsed with acetone at 10µl/min for 
five minutes, dried with nitrogen and stored until required for further work.  
 
To fill a capillary with vinylisation reagents, a 433µl PEEK loop was filled with the 
reagents using a hand syringe. One end of the loop was connected to the pump and the 
other end to the capillary. In this way contamination of the pump with reactive reagents 
was avoided.  
 
 
 
 
 
 
 
 
 
 
  
66 
2.23.2 Creation of monolithic columns 
  
Monolithic columns were produced as outlined by (Lee et al., 2004)  
        W/V 
   EDMA: 0.1522ml  16%  
   BUMA: 0.2679ml  24% 
   Decanol: 0.7238ml  60% 
   DAP:  4mg   1% with respect to monomers 
 
Sections of 12cm column were cut from the vinylised UV transparent monolithic parent 
column (Section 2.22.1). DAP was added to a microfuge tube before the other 
components were added. The mixture was vortexed for 5-10 minutes and then 
centrifuged at 13,000rpm for ten minutes. The supernatant was degassed by bubbling 
nitrogen through the solution. The vinylised column was filled by capillary action and 
sealed at either end. The columns were placed in a Spectra Linker Crosslinker and 
irradiated three times with 9,999µJ/cm2 of UV light. The monolith was washed with 
methanol at 1µl per minute for thirty minutes. The columns were then stored until 
required.  
 
 
2.23.3 Benzophenone immobilisation on monolithic columns 
50mg of benzophenone was dissolved in 1ml of methanol, vortexed well and 
centrifuged for ten minutes. The supernatant was degassed with nitrogen for five 
minutes. The pump was primed with methanol, then using a 1ml syringe, PEEK tubing 
was filled with the degassed benzophenone in methanol. The monolithic column was 
attached to the PEEK tubing. Benzophenone solution was injected onto the column at 
1µl per minute so that the monolithic column was filled with benzophenone solution. 
The column was sealed at either end and irradiated three times with UV light (1 dose = 
9999x100µJ/ cm2). After UV irradiation the column was washed with methanol to 
remove any unreacted benzophenone. 
2.23.4 PEGMA immobilisation on monolithic columns 
Monoliths from the previous benzophenone immobilisation step were washed with 
water to remove any residual methanol. 36µl of PEGMA was added to 1ml of water, 
vortexed and de-gassed by bubbling nitrogen through the solution. PEEK tubing was 
40% 
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filled with PEGMA solution and attached to the flow splitter while the monolith was 
connected to the opposite end of the PEEK tubing.  The PEGMA solution was pumped 
through the monolith column at 1µl/min until the column was filled. The column was 
sealed at either end and irradiated three times with UV light (1 dose = 9999x100µJ/ 
cm2). After the UV doses, the columns were washed with water and stored.  
 
 
2.23.5 Vinyl-Azlactone photografting method 
 
Vinyl-Azlactone (4,4-dimethyl-2-vinylazlactone)   0.144ml 
  T-Butanol:      0.75ml 
  dH2O:       0.25ml 
  Benzophenone:     2.2mg 
 
Benzophenone was placed in a microfuge tube before the other components were added. 
Before addition T-butanol was gently warmed to 45°C in a water bath. The solution was 
vortexed to dissolve the benzophenone, then centrifuged for ten minutes at 13,000rpm 
to pellet any containments. The supernatant was transferred to a separate eppendorf and 
de-gassed with nitrogen. All PEEK tubing and connectors, which were in contact with 
vinyl azlactone, were washed with a solution of acetronitrile with 1% trifluoroacetic 
acid (TFA), to remove any contaminating proteins or amino acids. The pump was 
primed with methanol before three microtight sleeves (Sigma Aldrich) were placed on 
the pegalated column. PEEK tubing was filled with the Vinyl-Azlactone solution and 
connected to the flow splitter in the system. The monolith was plumed in and the vinyl-
azlactone was pumped through the column at 1µl/min until the monolith was full. The 
monolith was disconnected and sealed at either end. The micro-tight sleeves were 
positioned on the monolith such that there was a gap of 1cm between each sleeve. The 
column was placed in a light columnator and given three doses of UV light (1 dose = 
9999x100µJ/ cm2). The sleeves were then removed and the column plumed to the flow 
splitter and washed for twenty minutes at 1µl/min with methanol. The pump was then 
primed with water and the column washed at 1µl/min for half an hour. Finally the 
column was washed with 10mM HEPES buffer at pH 7.4.  Using a Trace-Dec detector 
the column was scanned at 1mm increments to produce a baseline conductivity scan.  
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2.23.6 Immobilisation of protein on monoliths 
A pump (Knauer Wellchrom K-120) was primed with 10mM HEPES, pH7.4 and 
monoliths with zones of grafted vinyl-azlactone were washed for half an hour. The C4D 
(capacitively coupled contactless conductivity detector) was placed on the column and 
the baseline reading was taken while 10mM HEPES pH7.4, was flowing through the 
column. PEEK tubing was filled with a 1mg/ml protein sample in 10mM HEPES 
pH7.4, and connected to the flow splitter, which was in turn connected to the monolith.  
The protein was pumped through the monolith column at 1µl/min for three hours. 1M 
ethanolamine pH7 was pumped over the column at 1µl/min for one hour to block any 
un-reacted vinyl-azlactone. The monolith was then removed from the PEEK tubing and 
washed overnight with 10mM HEPES. The trace-dec reading of the column was taken 
with the C4D detector and compared to the original baseline.    
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Chapter 3: Cloning, Purification and 
Immobilisation of tagged Green Fluorescent 
Protein 
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3.1 Cloning and Tagging of Green Fluorescent Protein 
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3.1.1: Overview: 
  
This section describes the addition of purification and immobilisation tags to a model 
protein; Green Fluorescent Protein (GFP). GFP was chosen as a model protein due to 
its inherent fluorescence, which can be utilised to monitor its expression, purification 
and immobilisation. A GFP mutant (GFPmut3) was used in this study, which was first 
described in 1996 (Cormack et al., 1996) and is notable for its more efficient folding in 
E.coli bacterial systems and increased fluorescence when compared to wild type. It 
will be referred to as GFP below. 
The tags which were to be added to GFP can be divided into two distinct groups. 
• Purification tag 
• Immobilisation tags 
The purification tag consisted of a six residue histidine sequence. This histidine tag will 
allow for the purification of the protein of interest by standard immobilised metal 
affinity chromatography (IMAC) protocols (Section 2.16). 
The immobilisation tags were further subdivided into two groups. 
• Immobilisation tags 
o Covalent Immobilisation Tags 
 Lysine Tag 
 Cysteine Tag 
o Bio-affinity Immobilisation Tag 
 Strep-TagII 
Lysine and cysteine residues were chosen as suitable amino acids for covalent 
immobilisation reactions due to their respective nucleophilic amine and thiol functional 
groups (Figures 1.5 and 1.6) A bio-affinity immobilisation tag was provided by Strep-
TagII (Section 1.3.3). This tag consists of an eight amino acid sequence which is a 
biological mimic of biotin. Immobilisation tags were added to GFP by the use of either 
the forward or reverse primers during PCR.  
To determine the effects of protein tagging on further downstream processes such as 
expression, purification and immobilisation, GFP was cloned into E.coli expression 
vectors, which placed the purification or immobilisation tags at either the N or C-
termini or in tandem at a single termini. The addition and position of the tags in 
relation to the level of protein expression within E.coli will be the focus of section 3.2. 
The immobilisation of tagged GFP on different surfaces and the effects the alternate 
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tags have on levels of immobilised protein will be outlined in section 3.3 and section 
3.4.  
 
3.1.2 Generation of C-terminal Histidine Tagged GFP Expression Vector 
GFP was initially cloned into an in house E.coli expression vector pRV (Figure 3.1.1), 
to facilitate its expression with a C-terminal histidine tag.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.1.1: pRV E.coli Expression Vector 
The pRV expression vector contains the following features. The multiple cloning site 
(MCS) is located before the (His)6 amino acid sequence (blue) which facilitates the C-
terminal tagging of a protein with the purification tag. Expression was under the 
control of the ptac promoter/lac operon (yellow). The bla gene that encodes beta-
lactamase confers the bacteria with ampicillin resistance (red).  
 
5’atg agt aaa gga gaa gaa ctt ttc act gga gtt gtc cca att ctt gtt gaa tta gat ggt gat gtt aat 
ggg cac aaa ttt tct gtc agt gga gag ggt gaa ggt gat gca aca tac gga aaa ctt acc ctt aaa ttt 
att tgc act act gga aaa cta cct gtt cca tgg cca aca ctt gtc act act ttc ggt tat ggt gtt caa tgc 
ttt gcg aga tac cca gat cat atg aaa cag cat gac ttt ttc aag agt gcc atg ccc gaa ggt tat gta 
cag gaa aga act ata ttt ttc aaa gat gac ggg aac tac aag aca cgt gct gaa gtc aag ttt gaa ggt 
gat acc ctt gtt aat aga atc gag tta aaa ggt att gat ttt aaa gaa gat gga aac att ctt gga cac 
aaa ttg gaa tac aac tat aac tca cac aat gta tac atc atg gca gac aaa caa aag aat gga atc aaa 
gtt aac ttc aaa att aga cac aac att gaa gat gga agc gtt caa cta gca gac cat tat caa caa aat 
act cca att ggc gat ggc cct gtc ctt tta cca gac aac cat tac ctg tcc aca caa tct gcc ctt tcg 
aaa gat ccc aac gaa aag aga gac cac atg gtc ctt ctt gag ttt gta aca gct gct ggg att aca cat  
ggc atg gat gaa cta tac aaa tag 3’ 
Figure 3.1.2: The DNA sequence of GFPmut3. The chromophore forming sequence is 
highlighted in green. Underlined sections are standard PCR Primer sites. Sequence 
highlighted in bold is an NcoI restriction site.  
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As illustrated in figure 3.1.1. DNA amplified by PCR can be cloned into the MCS of 
pRV as an NcoI-BglII fragment. However restriction analysis on GFPmut3 revealed an 
internal NcoI restriction site (figure 3.1.2), thus preventing this enzyme being utilised. 
However BspHI generates a compatible cohesive end, to NcoI.  GFP does not have an 
internal BspHI site and therefore this restriction enzyme could be used in a cloning 
strategy for the tagging of GFP. The primers illustrated in figure 3.1.3. were designed 
for the amplification by PCR of the GFP gene as a BspHI-BglII 717bp fragment from 
pBk-miniTn7gfp2 (Table 2.3). The restricted PCR product was ligated with the 
expression vector pRV (which was restricted with NcoI-BglII) to generate the 
expression vector pVOS1 (see figure 3.1.5) 
 
 
 
 
 
 
 
 
 
Figure 3.1.3: The forward and reverse primers used for the generation of an E.coli 
expression vector; pVOS1, which expresses a C-terminal Histidine tagged GFP. 
 
 
 
 
Figure 3.1.4: Schematic of the BspHI/BglII restricted GFP PCR product, amplified by 
forward and reverse primers illustrated in figure 3.1.3. and the schematic of the MCS 
of the pRV vector restricted by NcoI/BglII. The point of restriction is indicted by a 
black line.  
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Figure 3.1.5: Schematic of the vector pVOS1, an E.coli expression vector which will 
express a C-terminal histidine tagged GFP. GFP amplified by PCR as a BspHI-BglII 
fragment was ligated with the NcoI-BglII restricted pRV to generate pVOS1   
 
 
The ligation mix was used to transform XL10-Gold competent E.coli cells. (Section 
2.11) Following transformation, clones were initially screened by examining for 
fluorescence. Plasmid DNA was prepared from fluorescing colonies; vectors were 
verified by restriction analysis and subsequently by sequencing. Restriction analysis for 
pVOS1 is illustrated in figure 3.1.6. During the cloning procedure the vector borne 
NcoI site was destroyed by ligation with the BspHI restriction site. Hence restriction 
analysis was performed with EcoRI and BglII restriction enzymes.   
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Figure 3.1.6: DNA Agarose Gel displaying restriction analysis of pVOS1 confirming 
the insertion of GFP within the expression vector. Single digest reactions linearise the 
pVOS1, while a double digest with BglII and EcoRI excises the GFP DNA insert. The 
EcoRI restriction enzyme was used for restriction analysis as the ligation of NcoI and 
BspHI cohesive ends destroyed both restriction enzyme sites.   
 
The sequence confirmed pVOS1 vector was then used as the template vector for all 
future cloning reactions. Subsequent clones are formed by inserting GFP into the pQE-
30, pQE-30Xa and pQE-60 E.coli expression vectors available from Qiagen.  
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3.1.3: Generation of N-terminal Histidine Tagged GFP Expression Vector 
GFP was cloned into an E.coli expression vector pQE30 (available from Qiagen), to 
facilitate its expression with an N-terminal His tag.  
 
 
 
Figure 3.1.7: pQE30 (Qiagen) 
The expression vector pQE30 has the MCS located after the (His)6 amino acid 
sequence (blue) which facilitates the N-terminal tagging of a protein with the 
purification tag. Expression was under the control of the T5 promoter/lac operon 
(yellow). An ampicillin resistance gene is also present on the plasmid (red)  
 
The primers illustrated in figure 3.1.8. were designed for the amplification by PCR of 
the GFP gene as an BamHI /HindIII 717bp fragment. The restricted PCR product was 
ligated with the BamHI /HindIII restricted expression vector pQE30 to generate the 
expression vector pVOS2 (see figure 3.1.10) 
 
 
 
 
Figure 3.1.8: The forward and reverse primers used for the generation of an E.coli 
expression vector; pVOS2, which expresses an N-terminal Histidine tagged GFP. 
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Figure 3.1.9: Schematic of the BamHI /HindIII restricted GFP PCR product, amplified 
by forward and reverse primers illustrated in figure 3.1.8. and the schematic of the 
MCS of the pQE30 vector restricted by BamHI /HindIII. The point of restriction is 
indicted by a vertical black line.  
 
 
Figure 3.1.10: Illustration of the vector pVOS2. An E.coli expression vector which 
will express an N-terminal histidine tagged GFP. GFP was amplified by PCR as a 
BamHI /HindIII fragment and ligated with the BamHI /HindIII restricted pQE30 
vector, to generate pVOS2.   
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The ligation was transformed into XL10-Gold competent E.coli cells. Following 
transformation, clones were initially screened by examining for fluorescence. Plasmid 
DNA was prepared from fluorescing colonies; vectors were verified by restriction 
analysis and subsequently by sequencing. 
 
3.1.4: Generation of N-terminal Histidine Tagged GFP Expression Vector, with an 
N-terminal FXa protease site: 
GFP was cloned into an E.coli expression vector pQE30-Xa (available from Qiagen), 
to facilitate its expression with a N-terminal histidine tag and FXa protease site. The 
FXa protease site facilitates the removal of the histidine affinity tag after purification 
viva specific digestion by FactorXa protease. 
 
Figure 3.1.11: pQE30-Xa (Quigen) 
The expression vector pQE30-Xa has the MCS located after the (His)6 amino acid 
sequence (blue) which facilitates the N-terminal tagging of a protein with the 
purification tag. A FactorXa protease site is present after the Histidine tag but prior to 
the MCS. Expression was under the control of the T5 promoter/lac operon (yellow). 
An ampicillin resistance gene is also present on the plasmid (red)  
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The primers illustrated in figure 3.1.12. were designed for the amplification by PCR of 
the GFP gene as a BamHI /HindIII 717bp fragment. The restricted PCR product was 
ligated into the BamHI /HindIII restricted expression vector pQE30-Xa to generate the 
expression vector pVOS2-Xa (see figure 3.1.13) 
 
 
 
Figure 3.1.12: The forward and reverse primers used for the generation of an E.coli 
expression vector; pVOS2-Xa, which expresses an N-terminal Histidine tagged GFP. A 
FactorXa protease site is present after the Histidine tag but prior to the MCS. 
 
 
 
 
 
 
 
Figure 3.1.13: Schematic of the BamHI /HindIII restricted GFP PCR product, 
amplified by forward and reverse primers illustrated in figure 3.1.12. and the schematic 
of the MCS of the pQE30-Xa vector restricted by BamHI /HindIII. The point of 
restriction is indicted by a black line and break in the sequence.  
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 Figure 3.1.14: Illustration of vector pVOS2-Xa. An E.coli expression vector which 
 will express an N-terminal histidine tagged GFP. GFP amplified by PCR as a 
 BamHI /HindIII fragment was ligated with BamHI /HindIII restricted vector 
 pQE30-Xa, to generate pVOS2-Xa.   
 
 
The ligation was transformed into XL10-Gold competent E.coli cells. Following 
transformation, clones were initially screened by examining for fluorescence. Plasmid 
DNA was prepared from fluorescing colonies; vectors were verified by restriction 
analysis and subsequently by sequencing. 
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3.1.5: Generation of N-terminal Histidine Tagged GFP Expression Vectors, with 
a C-terminal immobilisation tag 
The cloning strategy for the addition of a C-terminal immobilisation tag to GFP was 
based on the cloning strategy employed for the creation of pVOS2 (see figure 3.1.9) 
For the PCR reaction the forward primer remained constant, however the reverse 
primer differed depending on the immobilisation tag added, illustrated by figure 
3.1.15. 
 
Figure 3.1.15: The forward and reverse primers used for the amplification of a  
C-terminal immobilisation tagged GFP and generation of expression vectors pVOS3, 
pVOS4 and pVOS5.   
 
The primers illustrated in figure 3.1.15. were designed for the amplification of the GFP 
gene as an BamHI /HindIII fragment by PCR. This PCR product was ligated into the 
BamHI /HindIII restricted expression vector pQE30 to generate the E.coli expression 
vectors pVOS3, pVOS4 and pVOS5 (see figure 3.1.16) 
 
Figure 3.1.16: Schematic of vectors pVOS3, pVOS4 and pVOS5. 
E.coli vectors for the expression of N-terminal purification tagged and C-terminal 
immobilisation tagged GFP. GFP was amplified by PCR using an identical forward primer and 
unique reverse primers. PCR products and the pQE-30 vector were restricted with BamHI-
HindIII and ligated.  
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Each ligation was transformed into XL10-Gold competent E.coli cells. Following 
transformation, clones were initially screened by examining for fluorescence. Plasmid 
DNA was prepared from fluorescing colonies; vectors were verified by restriction 
analysis and subsequently by sequencing. 
 
3.1.6: Generation of a Protease cleavable N-terminal Histidine Tagged GFP 
Expression Vectors, with a C-terminal immobilisation tag 
The cloning strategy for the addition of a C-terminal immobilisation tag  (6XLysine, 
6XCysteine or Strep-TagII) to GFP was based on the cloning strategy employed for 
the creation of pVOS2-Xa (see figure 3.1.13) The FXa protease site facilitates the 
removal of the histidine affinity tag after purification viva specific digestion by 
FactorXa protease. For the PCR reaction the forward primer remained constant, 
however the reverse primer differed depending on the immobilisation tag added, 
illustrated by figure 3.1.17. 
 
 
Figure 3.1.17: The forward and reverse primers used for the amplification of the  
C-terminal immobilisation tagged GFP and generation of expression vectors pVOS3-
Xa, pVOS4-Xa and pVOS5-Xa.   
 
 
The primers illustrated in figure 3.1.17. were designed for the amplification by PCR of 
the GFP gene as an BamHI /HindIII fragment. This PCR product was ligated into the 
BamHI /HindIII restricted expression vector pQE30-Xa to generate the E.coli 
expression vectors pVOS3-Xa, pVOS4-Xa and pVOS5-Xa (see figure 3.1.13) 
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Figure 3.1.18: Schematic of vectors; pVOS3-Xa, pVOS4-Xa and pVOS5-Xa 
E.coli vectors for the expression of N-terminal purification tagged and C-terminal 
immobilisation tagged GFP. A FactorXa protease site is present after the purification 
tag but prior to GFP. The GFP gene was amplified by PCR using an identical forward 
primer and unique reverse primers. PCR products and the pQE30-Xa vector were 
restricted with BamHI-HindIII and ligated.  
 
Each ligation was transformed into XL10-Gold competent E.coli cells. Following 
transformation, clones were initially screened by examining for fluorescence. Plasmid 
DNA was prepared from fluorescing colonies; vectors were verified by restriction 
analysis and subsequently by sequencing. 
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3.1.7: Generation of a Protease cleavable N-terminal Histidine Tagged GFP 
Expression Vectors, with a tandem N-terminal immobilisation tag 
The cloning strategy for the addition of an N-terminal immobilisation and 
purification tag to GFP was based on the cloning strategy employed for the creation 
of pVOS2-Xa (see figure 3.1.13) For the PCR reaction the reverse primer remained 
constant, however the forward primer differed depending on the immobilisation tag 
added, illustrated by figure 3.1.19. 
 
Figure 3.1.19: The forward and reverse primers used for the amplification of the  
N-terminal purification and immobilisation tagged GFP and generation of expression 
vectors pVOS6-Xa, pVOS7-Xa and pVOS8-Xa.   
 
The primers illustrated in figure 3.1.19. were designed for the amplification by PCR of 
the GFP gene as an BamHI /HindIII fragment. This PCR product was ligated into the 
BamHI /HindIII restricted expression vector pQE30-Xa to generate the E.coli 
expression vectors pVOS6-Xa, pVOS7-Xa and pVOS8-Xa (see figure 3.1.20) 
 
Figure 3.1.20: Schematic of vectors; pVOS6-Xa, pVOS7-Xa and pVOS8-Xa. 
E.coli vectors for the expression of N-terminal purification and immobilisation tagged 
GFP. A FactorXa protease site is present after the purification tag but prior to the 
immobilisation tag. GFP was amplified by PCR using unique forward primers and an 
identical reverse primer. PCR products and the pQE30-Xa vector were restricted with 
BamHI-HindIII and ligated.  
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Each ligation was transformed into XL10-Gold competent E.coli cells. Following 
transformation, clones were initially screened by examining for fluorescence. Plasmid 
DNA was prepared from fluorescing colonies; vectors were verified by restriction 
analysis and subsequently by sequencing. 
 
 
3.1.8: Generation of C-terminal purification tagged GFP expression vector, with 
an N-terminal immobilisation tag 
GFP was cloned into an E.coli expression vector pQE60 (available from Qiagen), to 
facilitate its expression with a C-terminal histidine tag. This cloning strategy differed 
from the original C-terminal tagging illustrated in section 3.1.2 as it is expressed 
from a T5 promoter/lac operon compared to a ptac promoter present in pRV.  For the 
PCR reaction the reverse primer remained constant, however the forward primer 
differed depending on the immobilisation tag added, illustrated by figure 3.1.22. 
 
 
 
Figure 3.1.21: pQE60 (Qiagen) 
The expression vector pQE60, contains the following features. The MCS is located 
before the (His)6 amino acid sequence, which facilitates the C-terminal tagging of a 
protein with the purification tag. Expression is under the control of the T5 
promoter/lac operon (yellow). The bla gene that encodes beta-lactamase confers the 
bacteria with ampicillin resistance (red)  
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Figure 3.1.22: Primers used for the amplification of N-terminal immobilisation and C-
terminal purification tagged GFP and the creation of E.coli expression vectors; pVOS9, 
pVOS10 and pVOS11.   
 
The primers illustrated in figure 3.1.22. were designed for the amplification by PCR of 
the GFP gene as an BamHI/BglII fragment. This PCR product was ligated into the 
BamHI / BglII restricted expression vector pQE60 to generate the E.coli expression 
vectors pVOS9, pVOS10 and pVOS11 (see figure 3.1.23) 
 
 
 
Figure 3.1.23: Schematic of the BamHI/BglII restricted GFP PCR product, amplified 
by the pVOS9 forward and reverse primers illustrated in figure 3.1.22. and the 
schematic of the MCS of the pQE60 vector restricted by BamHI/BglII. The point of 
restriction is indicted by a black line and break in the sequence. 
 
 
 
 
Histidine Tag 
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Figure 3.1.24:  Illustration of vector pVOS9. An E.coli expression vector which will 
express an N-terminal lysine tagged and C-terminal histidine tagged GFP. GFP was 
amplified by PCR as a BamHI /BglII fragment and ligated with the BamHI /BglII 
digested vector fragment of pQE60 to generate pVOS9  
 
The GFP expression vectors pVOS10 and pVOS11 were generated by using the 
relevant forward primer illustrated in figure 3.1.22. The cloning strategy was identical 
to that described in figure 3.1.23.   
 
 
Figure 3.1.25: Schematic of vectors; pVOS10 and pVOS11 
E.coli vectors for the expression of C-terminal purification and N-terminal 
immobilisation tagged GFP. GFP was amplified by PCR using unique forward primers 
and identical reverse primers. PCR products and the pQE60 vector were restricted with 
BamHI-BglII and ligated.  
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Each ligation was transformed into XL10-Gold competent E.coli cells. Following 
transformation, clones were initially screened by examining for fluorescence. Plasmid 
DNA was prepared from fluorescing colonies; vectors were verified by restriction 
analysis and subsequently by sequencing. 
 
3.1.9: Cloning of GFP with a single C-terminal cysteine residue: 
A single C-terminal cysteine residue was added to GFP by PCR amplification. It was 
found during protein expression and purification protocols (Section 3.2), that the 
expression of hexa-cysteine tagged GFP was problematic due to multimer formation, 
as noted by a large increase in the volume of high molecular weight bands present on 
SDS-PAGE gels. This was assumed to be caused by the addition of the cysteine 
immobilisation tag to the termini of GFP. This tagging protocol increased the instances 
of disulfide bond formation between multiple GFP proteins. The tagging of GFP with a 
single cysteine residue at the C-terminal of the GFP protein was developed to 
overcome this issue. Full vector PCR amplification using complementary 
phosphorylated primers carrying the desired additional residue was used for PCR 
amplification. The amplified plasmid, with the incorporated cysteine residue, is 
circularised by ligation which was facilitated by the use of phosphorylated primers. 
The high fidelity of Phusion Taq polymerase is of vital importance to this PCR cloning 
method as it facilitates full vector amplification. The primers used for this PCR 
amplification are illustrated in figure 3.1.26. 
 
 
   
 
 
 
 
 
Figure 3.1.26: Primers for the creation of pVOS12, an E.coli expression vector which 
places a single cysteine residue at the C-termini of the protein. The addition of 
phosphorylation groups at the 5’ of both the forward and reverse primers allows for the 
circularisation by ligation of PCR products.  
 
The expression vector pVOS2, which added a purification tag to the N-terminus of 
GFP, was used as the template DNA for PCR reactions. The completed PCR reaction 
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was run on an agarose gel to confirm the amplification of the PCR product. The 
linearised PCR product pVOS12 was excised from the agarose gel and was re-
circularised by ligation. The ligation was transformed into competent E.coli XL10-
Gold or BL21 cells.  
Following transformation, colonies were initially screened by examining for 
fluorescence. Plasmid DNA was prepared from fluorescing colonies; vectors were 
verified firstly by restriction analysis and subsequently by sequencing. Figure 3.1.27 
illustrates the cloning protocol for the creation of this E.coli expression vector which 
expresses GFP with an N-terminal purification tag, and a single C-terminal cysteine 
residue immobilisation tag.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.1.27: Cloning strategy for the creation of pVOS12 by full vector PCR 
amplification. This expression vector adds a single cysteine residue to the C-terminal 
of GFP. High fidelity Phusion Taq DNA polymerase allows for the complete vector 
amplification. 
Full Vector 
amplification with 
Phusion Taq (NEB) 
Ligation to re-circularise  
cysteine tagged expression 
vector 
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3.1.10: Summary 
A range of E.coli expression vectors have been successfully produced by a variety of 
cloning strategies.  These expression vectors were used to express GFP with a selection 
of different immobilisation tags. As outlined in the overview of this section, two 
covalent immobilisation tags and the bio-affinity immobilisation tag have been placed 
both N and C-terminally on the GFP protein. The six histidine amino acid purification 
tag has also been placed at both protein termini. Protein immobilisation and 
purification tags have also been placed in tandem at the N-terminus of GFP. Table 2.3 
outlines the expression vectors generated during this study and the tagged GFP protein 
expressed from these vectors.  
The wide range of composition and placement of immobilisation and purification tags 
allows for the study of the effect of such added tags on protein purification and 
immobilisation. The study of tagging effects will be outlined in more depth in future 
sections of this chapter.  
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3.2 Protein Expression and Purification 
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3.2.1 Overview: 
The study of protein expression within a bacterial system is a complex field.  Many 
factors affect the expression of proteins including the addition of purification and 
immobilisation tags, their location and the amino acid composition of these tags. A 
large range of tagged proteins was produced as outlined in Section 3.1., and studies 
were undertaken to determine the effects of these protein tags on protein expression 
levels. While incorporated tags can affect protein expression levels, external factors 
such as the bacterial strain, temperature of expression and induction and harvest have 
also been investigated to optimise protein production.  
       
3.2.2 Growth Conditions in XL10-Gold:   
Each of the sequenced clones were transformed in both XL10-Gold and BL21(DE3) E. 
coli strains. Initial expression work was performed with pVOS1 in XL10-Gold, to give 
an indication of expression. A 1ml aliquot from a 5ml overnight LB broth culture was 
used to inoculate two 100ml LB broths supplemented with ampicillin. After 
inoculation, both cultures were incubated at 30°C until an OD600 of 0.5 was reached. 
One of the two cultures was then induced by addition of IPTG to a final concentration 
of 50µM. The second 100ml culture remained uninduced. Both cultures were then 
incubated with shaking at 220rpm at 30°C. Immediately following induction with IPTG 
a 2ml sample was withdrawn from both cultures. This was noted as the time zero 
sample (T0). A 1ml aliquot was used to measure the optical density of the sample. The 
second 1ml aliquot was retained at -20°C for protein analysis by SDS-PAGE. 
Additional 2ml samples were taken every subsequent hour for five hours (designated 
T1 to T5) and a final sample withdrawn after overnight culturing (T-Ov). Each 
subsequent sample was processed in the same manner as the time zero sample. The 
samples retained for analysis by SDS-PAGE were lysed by sonication, and insoluble 
cell debris removed by centrifugation. Soluble fractions (prepared as described in 
section 2.19.3) from both the induced and uninduced samples at each time point were 
run on 12% SDS-PAGE. When GFP is run on SDS-PAGE small amounts of dimerised 
GFP were noted running at the 66.4kDa protein marker. The effect of temperature on 
protein expression within the XL10-Gold E.coli strain was studied.  
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Figure 3.2.1: Analysis of pVOS1 expression levels in E.coli strain; XL10-Gold at a range of 
temperatures. Gel A: Soluble fractions of VOS1 (GFP with a C-terminal His6 tag) expressed in 
XL10-Gold at 30oC. Gel B: Soluble fractions of VOS1 expressed in XL10-Gold at 37oC. Gel 
C: Soluble fractions of VOS1 grown in XL10-Gold at 37oC, induced and expressed at 30oC.  
Samples present in lanes across the three gels contain identical samples. (1) NEB Broad Range 
Protein Marker (Gel C: Sigma Wide Range Marker) (2) Time point 2 uninduced, (3) Time 
point 2 induced, (4) Time point 3 uninduced, (5) Time point 3 induced, (6) Time point 4 
uninduced, (7) Time point 4 induced, (8) Time point 5 uninduced, (9) Time point 5 induced, 
(10) Overnight uninduced, (11) Overnight induced. (12) Sigma Wide Range Protein Marker. 
Expressed overnight (24hrs) protein is highlighted by a red arrow. 
A 
B 
C 
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Figure 3.2.1 shows three 12% SDS-PAGE gels of protein expression levels at three 
separate temperatures from the E.coli XL10-Gold strain. Gel A outlines induced and 
uninduced T0 to T-Ov samples of VOS1 grown in XL10-Gold at 30°C. Gel B describes 
induced and uninduced T0 to T-Ov samples of VOS1 grown in XL10-Gold at 37°C. 
The final SDS-PAGE; Gel C, illustrates induced and uninduced T0 to T-Ov samples of 
VOS1 which were grown in XL10-Gold to induction at 37°C as outlined previously. 
Following induction, time zero samples were immediately taken and the cultures were 
incubated with shaking at 220rpm at 30°C.  
Early time point samples at all temperatures, show initial GFP concentrations in both 
induced and uninduced samples to be low. GFP concentrations increase over time to a 
maximum concentration in the overnight samples. The protein is expressed in both 
uninduced and induced samples at all temperature levels, but is expressed at a higher 
levels in the overnight induced cultures based on SDS-PAGE.  It was expected that 
temperature of expression would not have a significant effect, however the levels of 
protein expression within XL10-Gold, appear to be marginally greater at 30°C. The 
effect of the E.coli strain on protein expression was also studied, and is outlined in the 
next section.    
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3.2.3: Growth Conditions in BL21: 
The optimum over-expression of soluble proteins in bacterial systems as outlined in 
section 3.2.1 relies on several factors. One of the most important factors is the bacterial 
expression strain used. To study this effect GFP was over-expressed at different 
temperatures in the BL21 E.coli bacterial strain.. The effect of temperature on levels of 
protein expression in BL21 was studied. The over expression of VOS1 in BL21 was 
performed identically as described for the over expression of VOS1 in XL10-Gold. The 
soluble fractions of the uninduced and induced time samples were separated on 12% 
SDS-PAGE gels.  
     
 
 
 
 
 
. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.2.2: Analysis of pVOS1 expression levels in E.coli strain; BL21 at a range of 
temperatures. Gel A: Soluble fractions of VOS1 (GFP with a C-terminal His6 tag) 
expressed in BL21 at 30oC. Gel B: Soluble fractions of VOS1 grown in BL21 at 37oC, 
induced and expressed at 30oC. Samples present in lanes across the two gels contain 
identical samples. (1) NEB Broad Range Protein Marker, (2) Time point 2 uninduced, 
(3) Time point 2 induced, (4) Time point 3 uninduced, (5) Time point 3 induced, (6) 
Time point 4 uninduced, (7) Time point 4 induced, (8) Time point 5 uninduced, (9) 
Time point 5 induced, (10) Overnight uninduced, (11) Overnight (24hrs) induced, (12) 
NEB Broad Range Protein Marker. Expressed overnight protein is highlighted by a red 
arrow 
A 
B 
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The optimum temperature for expression of GFP within XL10-Gold proved to be 30°C. 
The overnight induced and uninduced VOS1 within BL21 at 30°C was not optimum for 
achieving large levels of expressed protein within soluble fractions. All protein 
concentration levels in the soluble fractions of BL21 viewed on 12% SDS-PAGE gels 
showed lower levels of expression than those within XL10-Gold. The difference in 
overnight expression levels of BL21 shows the greatest difference between the strains. 
The greater levels of protein expression visible in the XL10-Gold E.coli strain 
compared to the BL21 strain at all time points allowed for the use of the XL10-Gold 
strain in all future expression protocols. 
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3.2.4: Effect of protein tags on expression.  
To determine the effect of additional tags added to GFP on protein expression, VOS5 
(N-terminal His6, C-terminal Strep-TagII) was expressed in an identical manner as 
VOS1 in XL10-Gold and at a temperature of 30°C.  The soluble fraction retained was 
run on a 12% SDS-PAGE to determine relative amounts of expressed protein. VOS5 
was also expressed in XL10-Gold at 37°C to determine if the same temperature effect 
observed in the expression of VOS1 at different temperatures was present in a different 
GFP clone. 
 
 
 
 
 
 
 
Figure 3.2.3: Analysis of pVOS5 expression levels in E.coli strain; XL10-Gold at a range of 
temperatures. Gel A: Soluble fractions of VOS5 (N-terminal His6 tag, C-terminal Strep-TagII) 
expressed in XL10-Gold at 30oC. Gel B: Soluble fractions of VOS5 grown in XL10-Gold at 
37oC. Samples present in lanes across the two gels contain identical samples. (1) Gel A: Sigma 
Wide Range Protein Marker, Gel B: NEB Broad Range Protein Marker, (2) Time point 2 
uninduced, (3) Time point 2 induced, (4) Time point 3 uninduced, (5) Time point 3 induced, (6) 
Time point 4 uninduced, (7) Time point 4 induced, (8) Time point 5 uninduced, (9) Time point 
5 induced, (10) Overnight uninduced, (11) Overnight induced, (12) Sigma Wide Range Protein 
Marker. Expressed overnight protein is highlighted by a red arrow 
A 
B 
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From figure 3.2.3 it can be seen that the temperature of expression of VOS5 in XL10-
Gold was found to have a significant effect on GFP expression, with clearly better 
expression at 30°C than 37°C. This mirrors the expression levels seen of VOS1 at this 
temperature. Interestingly, when we examine expression at 37°C, GFP expression was 
best after overnight growth in the uninduced sample, however at 30°C the best 
expression was in the induced culture five hours after induction. Figure 3.2.3 illustrates 
that the addition of a tag to the C-terminus appears to have an effect on protein 
expression at 37°C.  
These studies on the temperature, has outlined the importance of temperature on protein 
expression levels. The most efficient temperature for GFP protein expression in XL10-
Gold was clearly shown to be at 30°C. The expression levels of C-terminal GFP tagged 
protein at 37°C (Figure 3.2.3), indicates that the addition, composition and location of 
protein tags can have an effect on the level of protein expression. To determine if this is 
the case in tagged GFP clones, all proteins were expressed and the soluble fraction ran 
on 12% SDS-PAGE gels. From the initial expression work performed in sections 3.2.2. 
and 3.2.3 optimum expression protocol was determined. Tagged GFP clones expressing 
in XL10-Gold were grown at 37°C with shaking at 220rpm to the induction point, 
immediately after induction the culture was incubated at 30°C with shaking at 220rpm. 
The cultures were then harvested after overnight incubation. This method allowed the 
cultures to reach an induction point quickly, yet produce greater levels of over-
expressed proteins.  
To study the effect the addition of protein immobilisation tags had on protein 
expression all tagged GFP proteins were over-expressed according to the conditions 
determined in this section. The soluble fractions were run on 12% SDS-PAGE gels 
(Section 2.19). Results are shown in Figures 3.2.4 to 3.2.7. 
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Figure 3.2.4: Expression levels of tagged GFPs; VOS2, VOS2Xa, VOS3 and VOS3Xa. 
(Lanes 1, 3, 5 & 7) NEB Broad Range Protein Marker, (2) Soluble fraction of VOS2 (N-
terminal His6 tag), (4) Soluble fraction of VOS2Xa (N-terminal His6 tag with FXa protease 
site), (6) Soluble fraction of VOS3 (N-terminal His6 tag, C-terminal Lysine6 tag), (8) Soluble 
fraction of VOS3Xa (N-terminal His6 tag and FXa protease site, C-terminal lysine6 tag) 
Overexpressed tagged GFP is highlighted by a red arrow.   
 
 
 
 
 
 
 
 
 
 
 
Figure 3.2.5: Expression levels of tagged GFPs; VOS4, VOS4Xa, VOS5, VOS5Xa (Lanes 1, 
3, 5 & 7) NEB Broad Range Protein Marker, (2) Soluble fraction of VOS4 (N-terminal His6 
tag, C-terminal cysteine6 tag), (4) Soluble fraction of VOS4Xa (N-terminal His6 tag with FXa 
protease site, C-terminal cysteine6 tag), (6) Soluble fraction of VOS5 (N-terminal His6 tag, C-
terminal Strep-TagII), (8) Soluble fraction of VOSXa (N-terminal His6 tag and FXa protease 
site, C-terminal Strep-TagII). Overexpressed tagged GFP is highlighted by a red arrow.   
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Figure 3.2.6: Expression levels of tagged GFPs; VOS6Xa, VOS7Xa, VOS8Xa and VOS12. 
(Lanes 1, 3, 5 & 7) NEB Broad Range Protein Marker, (2) Soluble fraction of VOS6Xa (N-
terminal His6 tag, FXa protease site and lysine6 tag), (4) Soluble fraction of VOS7Xa (N-
terminal His6 tag with FXa protease site and cysteine6 tag), (6) Soluble fraction of VOS8Xa (N-
terminal His6 tag, FXa protease site and Strep-TagII), (8) Soluble fraction of VOS12 (N-
terminal His6 tag, C-terminal single cysteine residue).  Overexpressed tagged GFP is 
highlighted by a red arrow.   
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.2.7: Expression levels of tagged GFPs; VOS9, VOS10 and VOS11. (Lanes 1, 3, 5) 
NEB Broad Range Protein Marker, (2) Soluble fraction of VOS9 (N-terminal lysine5 tag, C-
terminal His6 tag), (4) Soluble fraction of VOS10 (N-terminal cysteine6 tag, C-terminal His6 
tag), (6) Soluble fraction of VOS11 (N-terminal Strep-TagII and C-terminal His6 tag)  
Overexpressed tagged GFP is highlighted by a red arrow.   
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Figures 3.2.4 to 3.2.7 shows an important result, which validates the amount of protein 
expression optimisation undertook. The placement of the immobilisation tag has a vital 
effect on the levels of protein expression. It was found that the addition of an 
immobilisation tag directly downstream from the promoter region greatly reduced the 
level of protein expression (Figure 3.2.7). Protein expression levels illustrated in figure 
3.2.6 are high, these proteins are expressed with both purification and immobilisation 
tags at the N-terminus. The only difference between the clones expressed in figure 3.2.6 
and figure 3.2.7, is that the histidine tag is located directly downstream from the 
promoter region rather than the immobilisation tag. It may be that the presence of the 
immobilisation tag in such close proximity to the promoter region has a negative effect 
of DNA polymerase transcription levels leading to lower expression protein 
concentrations.      
The figures 3.2.4, 3.2.5 and 3.2.6 outline the expressed GFP protein levels within the 
soluble fraction. All of these GFP proteins have the histidine tag for protein purification 
at the N-terminal of the protein. There are some differences between these expressed 
proteins. The soluble fractions outlined in figures 3.2.4 and 3.2.5 are of expressed GFP, 
which present the histidine tag on the N-terminus and the immobilisation tags on the C-
terminus. The soluble fractions shown in figure 3.2.6 are of proteins which contain no 
tag on the C-terminus, but instead have all the added tags on the N-terminus 
downstream from the histidine tag. 
Figure 3.2.7 illustrates the soluble fractions produced from cultures which have the 
histidine tag present at the C-terminus of the expressed protein. The immobilisation 
tags were added to the N-terminus of these proteins. These immobilisation tags 
comprised of repeated lysine and cysteine residues or the Strep-TagII. The addition of 
immobilisation tags at the N-terminus of the protein results in a significant reduction in 
the quantities of protein expressed in XL10-Gold.  This was an important result, which 
outlines the significance of performing expression optimisation studies.   
 
 
 
 
 
 
 
 
 
 
  
102 
3.2.5 Purification Overview 
The incorporation of six histidine residues at either the N or C-terminal enables 
purification using IMAC columns, described in section 2.16.1. The optimisation of this 
purification is outlined in this section.     
 
3.2.6 Protein Purification Protocol Overview 
As outlined in Section 2.16.1, five column volumes of the soluble fraction of VOS1 
containing the over-expressed protein was applied to GE Healthcare nickel sepharose 
resin and a step wise gradient of increasing imidazole concentration was applied to 
determine the minimum imidazole concentration at which the GFP protein begins to 
elute from the resin.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.2.8: Initial imidazole gradient of VOS1 (C-terminal His6 tag) purification. Five 
column volumes of the soluble fraction were passed over the IMAC resin, seven column 
volumes of each imidazole concentration was passed over the resin and the elution fractions 
captured. These fractions were run on a 12% SDS-PAGE gel and stained by the silver stain 
method (Section 2.19.4). Purified GFP bands are highlighted by a red arrow.  
 
The imidazole gradient in Figure 3.2.8 shows GFP beginning to elute at 80mM 
imidazole. At both this concentration and at 100mM imidazole several higher 
molecular weight bands are visible. At 120mM imidazole, the larger bands have been 
eluted. It was decided to sacrifice some of the protein yield, which is eluted at 80mM to 
ensure the purity of the final product by removing the larger containment bands.  
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Figure 3.2.9: An optimised purification protocol for VOS1 (C-terminal His6 tag).  All GFP 
from the crude sample is captured by the resin as shown by the lack of a GFP band in the flow-
through lane. Purified GFP bands are highlighted by a red arrow. 
 
Figure 3.2.9 outlines the optimised purification protocol of the five column volumes of 
C-terminally histidine tagged GFP. From the flow-through lane it was seen that the 
IMAC resin completely captured the histidine tagged GFP. This column was washed 
with several column volumes of 80mM imidazole to ensure the thorough removal of 
any containment proteins. An elution buffer wash of 250mM was used to elute the 
VOS1 protein and as shown in figure 3.2.9, the protein was obtained in a highly 
purified form as assessed by SDS-PAGE. This optimised method was transferred to all 
other expressed GFP clones. It was found during continuing purification protocols that 
five columns volumes of all washes was sufficient for optimum purity of the expressed 
protein. From a 100ml of protein expression culture a typical yield of between 1 and 
2mg per ml of purified protein was produced. Protein concentration was determined by 
the BCA method. (Section 2.18) 
All protein expression clones were expressed as detailed in section 2.15, to determine 
the efficiency of protein production. Protein purification was carried out as outlined in 
section 2.16.1 and protein purification samples were run on 12% SDS-PAGE gels. 
These gels were stained by the silver staining method. (Section 2.19.4)      
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Figure 3.2.10: The purification of tagged GFPs; Gel A: VOS2 (N-terminal His6 tag), Gel B: 
VOS2Xa (N-terminal His6 tag with FXa protease site), Gel C: VOS3 (N-terminal His6 tag, C-
terminal Lysine6 tag) and Gel D: VOS3Xa (N-terminal His6 tag and FXa protease site, C-
terminal Lysine6 tag ) Lane 1: NEB Broad Range Protein Marker, Lane 2: Protein Soluble 
Fractions, Lane 3: Protein Flow Through, Lane 4: 80mM Imidazole Wash, Lane 5:  250mM 
Imidazole elution. Arrows are highlighting purified monomeric GFP. 
A B 
C D 
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Figure 3.2.11: The purification of tagged GFPs; Gel A: VOS4 (N-terminal His6 tag, C-terminal 
Cysteine6 tag), Gel B: VOS4Xa (N-terminal His6 tag and FXa protease site, C-terminal 
Cysteine6 tag), Gel C: VOS5 (N-terminal His6 tag, C-terminal Strep-TagII) and Gel D: 
VOS5Xa (N-terminal His6 tag and FXa protease site, C-terminal Strep-TagII) Lane 1: NEB 
Broad Range Protein Marker, Lane 2: Protein Soluble Fraction, Lane 3: Protein Flow 
Through, Lane 4:  80mM Imidazole Wash, Lane 5: 250mM Imidazole protein elution. Arrows 
are highlighting purified monomeric GFP. 
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Figure 3.2.12: The purification of tagged GFPs; Gel A: VOS6Xa (N-terminal His6 tag, 
FXa protease site and lysine6 tag), Gel B: VOS7Xa (N-terminal His6 tag. FXa protease 
site and cysteine6 tag), Gel C: VOS8Xa (N-terminal His6 tag, FXa protease site and 
Strep-TagII) and Gel D: VOS9 (N-terminal Lysine5 tag, C-terminal His6 tag)  Lane 1: 
NEB Broad Range Protein Marker, Lane 2: Protein Soluble Fraction, Lane 3: Protein 
Flow Through, Lane 4: 80mM Imidazole Wash, Lane 5: 250mM Imidazole elution. 
Arrows are highlighting purified monomeric GFP. 
 
 
 
 
 
C D 
A B 
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Figure 3.2.13: The purification of tagged GFPs; Gel A: VOS10 (N-terminal Cysteine6 tag and 
C-terminal His6 tag) and Gel B: VOS11 (N-terminal Strep-TagII and C-terminal His6 tag) Lane 
1: NEB Broad Range Protein Marker, Lane 2: Protein Soluble Fraction, Lane 3: Protein Flow 
Through, Lane 4: 80mM Imidazole Wash, Lane 5: 250mM Imidazole elution. Arrows are 
highlighting purified monomeric GFP. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.2.14: The purification of VOS12 (N-terminal His6 tag, Single C-terminal Cysteine residue) 
(1) NEB Broad Range Protein Marker, (2) VOS12 Soluble Fraction, (3) VOS12 Flow Through, (4) 
VOS12 80mM Imidazole Wash, (5) VOS12 250mM Imidazole elution. Arrow is highlighting 
purified monomeric GFP. 
  
 
 
A B 
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A gel band running just above the 27kDa protein marker band in the purification gels 
signifies the purification of the monomeric protein (Figures 3.2.10-3.2.14). The 
expression and purification of the majority of clones was successful using the methods 
outlined in Chapter 2. The expression and purification the N-terminal tagged GFPs, 
VOS9 (N-terminal Lysine5 tag, C-terminal His6 tag), VOS10 (N-terminal Cysteine6 tag 
and C-terminal His6 tag) and VOS11 (N-terminal Strep-TagII and C-terminal His6 tag)   
was considerably less efficient than other purifications. The immobilisation tags placed 
on the N-terminus as previously described had an effect on the volume of expressed 
protein (Figures 3.2.12 & 3.2.13). As levels of purified protein achieved by IMAC, 
directly relates to the concentration of expressed proteins the three described clones 
were not purified efficiently. Due to the reduced levels of purified protein produced, 
these proteins, were discarded from further studies.        
From the purification gels outlined of all the produced clones, it can be seen that certain 
clones have dimer bands in their purification lanes. While GFP can form dimers in 
solution it occurs rarely and is probably due to interactions between hydrophobic zones 
(Tsien, 1998). It was found during purification of clones which had added cysteine 
residues the presence of dimers was greatly increased. The presence of protein bands 
between 66.4kDa and 55.6kDa NEB protein markers in VOS4, VOS7Xa and VOS12 is 
indicative of the presence of a dimer. These dimers are formed by the oxidisation of 
cysteines to form cystines with other GFP molecules containing a cysteine tag. In an 
effort to reduce this effect, pVOS12 with a single C-terminal cysteine was constructed 
(Figure 3.1.14). GFP has only two inherent cysteine residues which are buried within 
the tertiary structure. By the addition of this single extra cysteine residue it was thought 
a single point for immobilisation reactions would be provided. This would reduce the 
volume of high molecular weight containment bands. The purification lane of VOS4 
within Figure 3.2.11 (Gel A, Lane 5) is indicative of the large molecular weight 
molecules generated by the addition of this cysteine tag. 
All purification gels outlined in this section were run in a reducing environment 
achieved by adding mercaptoethanol to the protein samples, the electrophoresis gel and 
the running buffer (Section 2.4). By removing SDS and 2-mercaptoethanol from the 
SDS-PAGE sample buffer as outlined in section 2.4, and boiling for five minutes the 
molecular weight of the expressed protein and the degree of aggregation can be 
revealed. (Figure 3.2.15) This gel outlines the banding pattern differences between 
samples of a cysteine tagged GFP clone in both reducing and non-reducing buffers. By 
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adding the reducing agent DTT to the protein sample in a gradient of increasing 
concentrations, an increase in the quantity of banding of monomeric protein and 
conversely a reduction the higher molecular weight bands can be seen as in figure 
3.2.16.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.2.15: The effect of a reducing agent on the protein banding of cysteine tagged GFP. 
(1) NEB Broad Range Marker, (2) VOS1 (C-terminal His6 tag) in reducing buffer, (3) VOS4 
(N-terminal His6 tag, C-terminal Cysteine6 tag) in reducing buffer, (4) VOS4 (N-terminal His6 
tag, C-terminal Cysteine6 tag)  in non-reducing buffer.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.2.16: The effect of a DTT Gradient on the banding pattern of cysteine tagged VOS12 
(N-terminal His6 tag, Single C-terminal Cysteine residue), (1) NEB Broad Range Marker, (2) 
VOS12 No DTT, (3) VOS12 10mM DTT, (4) VOS12 15mM DTT, (5) VOS12 20mM DTT, (6) 
VOS12 25mM DTT, (7) VOS12 30mM DTT, (8) VOS12 35mM DTT, (9) VOS12 40mM DTT, 
(10) VOS12 45mM DTT, (11) VOS12 50mM DTT  
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The addition of 50mM DTT highlighted in Figure 3.2.16 shows the reduction of the 
quantity of high molecular weight proteins. This compound is only required for 
cysteine tagged expressed proteins as all other clones do not form multimers. The 
purification of monomeric protein is required for efficient immobilisation. By reducing 
the number of cysteine residues available for immobilisation from a six residue tag, to a 
one residue tag, it was attempted to reduce the amount of high molecular weight 
aggregates.   
 
3.2.7: Summary 
The expression of GFP in E.coli cells was studied to determine the effect of 
temperature, cell strain, location, composition and type of tags, on the expression levels 
of GFP. Due to these studies it was clearly seen that the most efficient method for the 
production of large scale quantities of protein was at 30°C in XL10-Gold E.coli strain. 
The addition of specific tags resulted in a pronounced detrimental effect on protein 
expression. When immobilisation tags were added to the N-terminus of GFP 
immediately after the vectors promoter region, the levels of protein expression was 
significantly reduced. Therefore, these clones were deemed unsuitable for further study.      
The application of a single protein purification protocol to the range of tagged GFP 
proteins proved successful. Highly purified GFP was obtained by the silver staining 
method as judged by SDS-PAGE (See figures 3.2.10 to 3.2.14). The purification of 
GFP with an N-terminus immobilisation tag yielded low concentrations of protein due 
to poor expression levels. Higher molecule weight bands were visible on SDS gels for 
proteins which contained added cysteine residues. The optimisation of a reducing 
environment by the addition of DTT was successful.    
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3.3 Biotinylated GFP Immobilisation on NUNC MaxiSorp 
Plates 
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3.3.1. Overview 
The immobilisation of the tagged model protein GFP was the major focus of this study. 
The majority of covalent protein immobilisation methods rely on the side chain of  
amino acids. The most commonly used amino acids used for this purpose are lysine and 
cysteine. This is due to their nucleophilic R-groups, an amine moiety in the case of the 
lysine amino acid and a thiol moiety in the case of cysteine. Through cloning, 
additional lysine and cysteine residues have been added to the termini of GFP in an 
effort to increase the volume of immobilised and orientated proteins (Section 3.1). GFP 
was used as a model protein as its inherent fluorescence provided an easy and accurate 
method to measure quantities of immobilised protein.  The study of immobilisation 
surfaces is a vital process for the correct orientation and presentation of immobilised 
biomolecules. 
Pierce chemicals supply hetero-functional biotin linking reagents, which can be used to 
functionalise proteins with biotin (Figure 1.14). This process relies on the reactions that 
occur between an NHS moiety and the ε-amine within lysine amino acids and the 
maleimide group with the thiol moiety within cysteines. By the addition of additional 
lysine and cysteine residues to the N or C-termini of proteins, it is anticipated that the 
proportion of correctly orientated immobilised proteins can be increased. The addition 
of Strep-TagII to GFP does not require any additional modification for immobilisation, 
as this tag is already known for its specific reaction with streptactin, a mutated form of 
streptavidin. Streptavidin or streptactin were immobilised on NUNC MaxiSorp 96-well 
Plates and used to capture biotinylated lysine and cysteine tagged GFP as well as 
StrepII tagged GFP.  
 
3.3.2: Hetero-functional Biotin Linkers: 
Biotin linkers were purchased from Pierce Chemicals. (www.piercenet.com) Lysine 
residues are common on the surface of most proteins. Therefore the biotinylation of 
proteins can be achieved without the addition of additional lysine residues.  But the 
addition of a lysine tag increases the likelihood that the protein of interest will be 
immobilised in an orientated fashion.  
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Figure 3.3.1: Hetero-functional Linkers. The NHS functionality reacts with lysine amino acids 
within target proteins. Maleimide functionality reacts with cysteine amino acids. Biotin 
functionality is used for immobilisation by its interaction with strept(avidin)/tactin. Linkers 
purchased from Pierce Chemicals. (www.piercenet.com) 
 
Protein immobilisation protocols are often based on the thiol moiety of cysteine. Due to 
thiol side chain of cysteine, the amino acid is often found in pairs within the structure 
of proteins in its oxidised form, cystine. An exposed single cysteine residue or group of 
residues added by cloning methodology (Section 3.1), might allow for a more focused 
maleimide linker reaction, as those residues may be more sterically available. The 
natural fluorescence of GFP was exploited to examine the effect of adding additional 
lysine and cysteine residues on protein immobilisation.  
 
3.3.3 NUNC MaxiSorp 96-well Plates 
Initial studies were undertaken to determine whether white or black NUNC MaxiSorp 
96-well Plates should be used for this study. White and black MaxiSorp 96-well Plates 
are commonly used in fluorescence protocols, as they reduce the amount of background 
fluorescence.  Biotinylated GFP was immobilised in a 96-well plates as describe in 
Section 2.20. Fluorescence was read in a fluorescent plate reader.  
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Figure 3.3.2: Fluorescence values of VOS3 (N-terminal His6 tag, C-terminal Lysine6 tag) 
triplicate dilutions on black NUNC MaxiSorp 96-well plates. The PBS value is shown to 
highlight the background fluorescence for this study. PBS negative control values have not 
been subtracted from protein dilutions. Samples read in triplicate at an excitation wavelength of 
475nm and an emission wavelength of 509nm. 
 
Figure 3.3.3: Fluorescent results for VOS3 (N-terminal His6 tag, C-terminal Lysine6 tag) 
triplicate dilutions read on NUNC Maxisorp 96-well white plates. Negative control values 
(PBS) have been subtracted from data. Samples read in triplicate at an excitation wavelength of 
475nm and an emission wavelength of 509nm. The fluorescent readings of GFP follow the 
dilution curve. The scale of fluorescence readings on white plates are up to a 100 times greater 
than that of black plates as outlined in figure 3.3.2 
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From figures 3.3.2 and 3.3.3 it is apparent that white flat-bottom 96-well plates were 
the most reproducibly reliable immobilisation platform. Black plates from the same 
supplier showed large background fluorescence, which masked the fluorescent signal 
of the immobilised GFP. The signal achieved was over 100-fold greater for white 
plates when compared to 96-well plates.  Therefore NUNC white MaxiSorp 96-well 
plates were used in all subsequent work.  
 
3.3.4: Streptavidin and Streptactin Concentration Optimisation: 
In the experiment outlined in section 3.3.3, lysine tagged GFP was immobilised directly 
onto the plate. In subsequent studies streptavidin or streptactin was immobilised on 
white MaxiSorp plates to capture biotin labelled proteins. Tagged model protein GFP 
was biotinylated as outlined in Section 2.21. Studies were undertaken to determine the 
optimum concentration of streptavidin to immobilise to achieve the optimum 
fluorescent signal range.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.3.4: The effect of streptactin concentration on VOS5 (N-terminal His6 tag, C-terminal 
Strep-TagII) capture. Streptactin was immobilised on white MaxiSorp plates and used to 
capture VOS5. Samples were read in triplicate at an excitation wavelength of 475nm and an 
emission wavelength of 509nm. The optimum concentration of streptactin for the most efficient 
capture of Stre-TagII protein was determined to be 5µl/ml.  
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An increasing concentration of streptavidin was immobilised on white MaxiSorp plates 
to determine the optimum concentration to use in subsequent experiments. Figure 3.3.4 
shows that the optimum concentration of immobilised streptactin is in the range of 
4µg/ml to 10µg/ml.  Immobilisation time was also studied to test if this would have an 
effect on the amount of capture protein immobilised within the wells of the MaxiSorp 
96-well Plates.  
Streptavidin immobilisation times of one hour and overnight were chosen to determine 
if the length of immobilisation time had an effect on biotinylated protein capture. The 
figures 3.3.5 and 3.3.6 show that the length of time of immobilisation seems to have 
little to no effect on the quantity of capture protein immobilisation. All subsequent 
experiments were performed after strept(avidin)/tactin was immobilised for an hour at 
room temperature in MaxiSorp white plates. Like streptactin the optimum 
concentration of immobilised streptavidin was found to be 5µg/ml.   
 
 
 
Figure 3.3.5: A concentration gradient of streptavidin immobilised on NUNC white 96-well 
plate for an hour at room temperature. This was probed with biotinylated VOS12 (N-terminal 
His6 tag, C-terminal single cysteine residue).  Samples were read in triplicate at an excitation 
co-efficient of 475nm and an emission co-efficient of 509nm. The optimum concentration of 
streptavidin immobilised was 5µg/ml.   
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Figure 3.3.6: A concentration gradient of streptavidin immobilised on NUNC 96-well white 
plate overnight at room temperature. The streptavidin was probed with biotinylated VOS12 (N-
terminal His6 tag, C-terminal single cysteine residue) Samples were read in triplicate at an 
excitation wavelength of 475nm and an emission wavelength of 509nm. The optimum 
concentration of streptavidin after overnight immobilisation is 6µg/ml. 
 
3.3.5: Optimisation of Plate Reader Settings 
The importance of the excitation and emission wavelengths, at which fluorescent plates 
are read, is considerable. These settings are an unique property of the fluorescent 
molecule under investigation. GFP has a well defined emission peak of 509nm but has 
two excitation peaks, a major peak at 395nm, and a minor peak at 475nm. Therefore, to 
determine the correct excitation wavelength for measurement of GFP fluorescence, a 
range of excitation wavelengths were chosen. Biotinylated GFP was captured by 
immobilised streptavidin and the fluorescence measured at each excitation wavelength. 
The fluorescence reader used in this experiment allows for the control of the light used 
to probe the samples by adjustable slit widths. The effect of slit width size on the 
fluorescent reading was also studied.      
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Figure 3.3.7: Comparison of excitation wavelengths with an excitation slit of 10 and emission 
slit of 10. 5µg/ml of streptavidin was immobilised on white MaxiSorp 96 well plates for an 
hour at room temperature. Biotinylated VOS3 (N-terminal His6 tag, C-terminal lysine6 tag) was 
captured by the immobilised streptavidin. The plate was read in triplicate at an emission 
wavelength of 509nm and a variable excitation wavelength. (Ex=excitation wavelength, 
ExS=Excitation Slit width, EmS= Emission Slit width). The 475nm excitation wavelength gave 
the highest level of fluorescence signal.  
Figure 3.3.8: Comparison of excitation wavelengths with an excitation slit of 2.5 and an 
emission slit width of 10. 5µg/ml of streptavidin was immobilised on white MaxiSorp 96 well 
plates for an hour at room temperature. Biotinylated VOS3 (N-terminal His6 tag, C-terminal 
lysine6 tag) was captured by the immobilised streptavidin. The plate was read in triplicate at an 
emission wavelength of 509nm. (Ex=excitation wavelength, ExS=Excitation Slit width, EmS= 
Emission Slit width) For this slith width setting the 475nm excitation wavelength gave the 
highest fluorescent signal.  
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Figures 3.3.7 and 3.3.8 indicate that the most efficient excitation wavelength for the 
study of the efficiency of protein immobilisation was 475nm. This excitation 
wavelength was used in all subsequent protocols. An emission wavelength of 509nm 
was used in all studies. It was apparent that the excitation slit width had a major effect 
on sensitivity. The larger excitation slit width was found to have at least a two-fold 
increase in signal, across a wide range of excitation wavelengths. Unfortunately, it was 
found that reading certain fluorescent proteins at excitation wavelength of 475nm and 
slit width of 10, led to samples being off-scale. To remedy this all subsequent work was 
undertaken with a excitation slit width of 2.5 and emission slit width of 10. The 
emission wavelength was 475nm and an excitation wavelength of 509nm.   
 
 
3.3.6: Immobilisation of biotinylated GFP by Streptactin 
 
Table 3.3.1: Outline of biotinylated GFP proteins. Cysteine tagged GFP’s  (VOS4 and VOS12) 
were biotinylated with maleimide-biotin linker. Lysine tagged GFP (VOS3) was biotinylated 
with NHS-biotin linker. VOS2 was used as a control protein and was biotinylated with both the 
maleimide and NHS linker  
 
A section of biotinylated tagged GFPs were constructed (Section 2.21) and outlined in 
table 3.3.1. This set of tagged proteins was then captured on streptactin immobilised in 
the wells of 96 well plates.  Five GFP proteins were chosen as a sample range to study 
Tagged GFP 
 
Maleimide-Biotin tagged clone NHS-Biotin tagged clone 
 
 
VOS2 
 
 
VOS2ML 
 
VOS2NL 
VOS3 
 
N/A VOS3NL 
VOS4 
 
VOS4ML N/A 
VOS5 
 
N/A N/A 
VOS12 
 
VOS12ML N/A 
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protein immobilisation.  VOS2 was a control wild type GFP protein as it features only a 
histidine purification tag. VOS2 was tagged with both biotin linkers, to show baseline 
biotinylation levels. VOS3 (N-terminal His6 tag, C-terminal lysine6 tag) was tagged by 
the NHS-biotin linker. Similarly VOS4 (N-terminal His6 tag and C-terminal Cysteine6 
tag) and VOS12 (N-terminal His6 tag, C-terminal single cysteine residue) were 
biotinylated using the Maleimide-Biotin linker. Finally VOS5 was tagged with Strep-
tagII, which is recognised by streptactin. Biotinylated GFP was immobilised as outlined 
in Section 2.20 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.3.9: NHS-Biotin and Strep-tagII tagged GFP proteins captured by streptactin. 50µg/ml 
of each biotinylated GFP proteins, VOS2 (N-terminal His6 tag, no biotinylation), VOS2NL (N-
terminal His6 tag, biotinylated by NHS-biotin linker), VOS3NL (N-terminal His6 tag, C-
terminal Lysine6 tag, biotinylated by NHS-biotin linker) and VOS5 (N-terminal His6 tag, C-
terminal Strep-TagII) were captured by 5µg/ml immobilised streptactin. Fluorescence was read 
in triplicate on a white MaxiSorp 96-well plate at an excitation wavelength of 475nm and an 
emission wavelength of 509nm. 
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Figure 3.3.10: Maleimide-Biotin linked cysteine tagged GFP clones, captured by streptactin. 
50ug/ml of biotinylated GFP, VOS2 (N-terminal His6 tag, not biotinylated), VOS2ML (N-
terminal His6 tag, biotinylated with maleimide-biotin linker), VOS4 (N-terminal His6 tag, C-
terminal cysteine6 tag, biotinylated with maleimide-biotin linker), VOS12L (N-terminal His6 
tag, C-terminal single cysteine residue, biotinylated with maleimide-biotin linker), VOS5 (N-
terminal His6 tag, C-terminal Strep-TagII) were captured on 5µg/ml of immobilised streptactin. 
Fluorescence was measured in triplicate in a NUNC MaxiSorp white plate at an excitation 
wavelength of 475nm and an emission wavelength of 509nm.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.3.11: Comparison of NHS and Maleimide biotinylation tagging with Strep-TagII 
immobilisation on NUNC MaxiSorp white plates. 50ug/ml of biotinylated GFP proteins, VOS2 
(N-terminal His6 tag, no biotinylation), VOS2NL (N-terminal His6 tag, biotinylated by NHS-
biotin linker), VOS2ML (N-terminal His6 tag, biotinylated with maleimide-biotin linker), 
VOS3NL (N-terminal His6 tag, C-terminal Lysine6 tag, biotinylated by NHS-biotin linker), 
VOS4ML (N-terminal His6 tag, C-terminal cysteine6 tag, biotinylated with maleimide-biotin 
linker), VOS12ML (N-terminal His6 tag, C-terminal single cysteine residue, biotinylated with 
maleimide-biotin linker) and VOS5 (N-terminal His6 tag, C-terminal Strep-TagII) were 
captured by 5µg/ml immobilised streptactin and read in triplicate at excitation wavelength of 
475nm and emission wavelength of 509nm.    
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Figures 3.3.9 to 3.3.11 outline the effect of biotinylation reactions on the quantity of 
GFP immobilisation. The unbiotinylated wild type control VOS2 (N-terminal His6 tag) 
shows the least amount of fluorescence as would be expected. Surprisingly the highest 
fluorescent value achieved for all biotinylated clones was the NHS biotinylated VOS2 
(N-terminal His6 tag), which has no additional lysine tags. This was compared to the 
hexa-lysine tagged GFP clone (VOS3) (Figure 3.3.10). The lysine tagged GFP protein 
exhibited half the fluorescence of the wild type GFP in figure 3.3.11. The maleimide 
biotinylated wild type GFP, VOS2ML exhibited low immobilisation since unlike the 
NHS linker, the reactive residues are buried within the tertiary structure of the protein. 
The biotinylation of the other cysteine tagged GFPs with the maleimide linker were 
more successful. VOS4 (N-terminal His6 tag and C-terminal Cysteine6 tag) and VOS12 
(N-terminal His6 tag and C-terminal single cysteine residues) exhibited a ten times 
larger fluorescence reading than the biotinylated and non-biotinylated wild type (Figure 
3.3.10) The addition of six extra cysteine residues was more efficient than the addition 
of a single cysteine residue. VOS4 (N-terminal His6 tag and C-terminal Cysteine6 tag) 
exhibited four times more fluorescence than VOS12 (N-terminal His6 tag and C-
terminal single cysteine residues). It is possible that the VOS12 immobilisation was 
more orientated as there was only one cysteine residue available for biotinylation by the 
maleimide-biotin linker. 
Despite streptactin being developed as a highly efficient capture molecule for Strep-
TagII, the fluorescence values of VOS5 (N-terminal His6 tag and C-terminal Strep-
TagII) were lower than the values for biotinylated VOS3 or VOS4. The fluorescence 
value of immobilised VOS5 was half the value of immobilised biotinylated VOS4ML, 
but twice the fluorescence of VOS12, which had only a single cysteine residue 
available for biotinylation (Figure 3.3.10). The fluorescence of wild type and lysine 
tagged biotinylated GFP was seven times greater than VOS5 (Figure 3.3.9). The 
immobilisation of VOS5 can be considered to be more orientated, as the Strep-TagII is 
not inherent to the protein unlike lysine. Therefore, streptactin binds specifically in an 
orientated manner to the GFP.   
The next set of immobilisations were performed using streptavidin as the capture 
protein for biotinylated GFP. The same bank of biotinylated proteins were used as the 
probe molecules, outlined in section 3.3.7. and captured as outlined in Section 2.20.           
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3.3.7: Immobilisation of biotinylated GFP on Streptavidin 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.3.12: Immobilisation of wild type biotinylated GFP with NHS-biotin linker, VOS2 
(N-terminal His6 tag, Not biotinylated), VOS2NL (N-terminal His6 tag) and maleimide-biotin 
linker, VOS2ML, (N-terminal His6 tag) linkers. 50ug/ml of GFP was captured by 5µg/ml 
immobilised streptavidin. The white MaxiSorp 96-well plate was read in triplicate at an 
excitation wavelength of 475nm and an emission wavelength of 509nm.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.3.13: Triplicate readings of lysine tagged GFP, biotinylated with NHS-biotin linker, 
VOS2 (N-terminal His6 tag, Not biotinylated), VOS2NL (N-terminal His6 tag, biotinylated with 
NHS-biotin linker) and VOS3L, (N-terminal His6 tag, C-terminal lysine6 tag, biotinylated with 
NHS-biotin linker) linkers. 50ug/ml of GFP was captured by 5µg/ml immobilised streptavidin. 
The white MaxiSorp 96-well plate was read in triplicate at an excitation wavelength of 475nm 
and an emission wavelength of 509nm. The immobilisation of lysine tagged biotinylated GFP 
shows half the fluorescence value of the wild type biotinylated GFP values.  
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Biotinylated cysteine and lysine tagged GFP captured by 
immobilised strepavidin
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Figure 3.3.14: Triplicate readings of biotinylated cysteine tagged GFP. 50ug/ml of each 
biotinylated GFP, VOS2 (N-terminal His6 tag, Not biotinylated), VOS2ML, (N-terminal His6 
tag, biotinylated by the maleimide-biotin linker), VOS4ML (N-terminal His6 tag, C-terminal 
cysteine6 tag, biotinylated with maleimide-biotin linker), VOS12ML (N-terminal His6 tag, C-
terminal single cysteine residue, biotinylated with maleimide-biotin linker) were captured by 
5µg/ml of immobilised streptavidin. The NUNC MaxiSorp white 96-well plate was read in 
triplicate at an excitation wavelength of 475nm and an emission wavelength of 509nm.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.3.15: Cysteine and lysine tagged GFPs, biotinylated with Maleimide and NHS-biotin 
linkers. 50µg/ml of each biotinylated GFP; VOS2 (N-terminal His6 tag, no biotinylation), 
VOS2NL (N-terminal His6 tag, biotinylated by NHS-biotin linker), VOS2ML (N-terminal His6 
tag, biotinylated with maleimide-biotin linker), VOS3NL (N-terminal His6 tag, C-terminal 
Lysine6 tag, biotinylated by NHS-biotin linker), VOS4ML (N-terminal His6 tag, C-terminal 
cysteine6 tag, biotinylated with maleimide-biotin linker), VOS12ML (N-terminal His6 tag, C-
terminal single cysteine residue, biotinylated with maleimide-biotin linker) were captured by 
5µg/ml immobilised streptavidin. The NUNC MaxiSorp white 96-well plate was read in 
triplicate at an excitation wavelength of 475nm and an emission wavelength of 509nm.   
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Biotinylated GFP compared with Strep-tagII GFP immobilised on 
Streptavidin
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Figure 3.3.16: Combined triplicates of biotinylated immobilised GFP and Strep-TagII GFP. 
50ug/ml of biotinylated GFPs; VOS2 (N-terminal His6 tag), VOS2NL (N-terminal His6 tag, 
biotinylated with NHS-biotin linker), VOS2ML (N-terminal His6 tag, biotinylated with 
Maleimide-biotin linker), VOS3L (N-terminal His6 tag, C-terminal Lysine6 tag, biotinylated 
with NHS-biotin linker), VOS4L (N-terminal His6 tag, C-terminal Cysteine6 tag, biotinylated 
with Maleimide-biotin linker), VOS12L (N-terminal His6 tag, C-terminal single cysteine 
residue, biotinylated with Maleimide-biotin linker), VOS5 (N-terminal His6 tag, C-terminal 
Strep-TagII). were captured by 5µg/ml immobilised streptavidin. NUNC MaxiSorp white 96-
well plates were read in triplicate at excitation wavelength 475nm and emission wavelength 
509nm.  
 
Figures 3.3.12 to 3.3.16 outline the immobilisation of biotinylated GFPs captured by 
immobilised streptavidin on white MaxiSorp 96-well Plates. It was noted that the rate 
of immobilisation of biotinylated proteins on to streptactin was up to five times greater 
than the immobilisation on streptavidin. The immobilisation of the un-biotinylated 
VOS2 control showed the smallest amount of fluorescence. The biotinylated wild type 
protein which was biotinylated via maleimide-biotin linker showed the next highest 
fluorescence. As with streptactin immobilisation the rate of immobilisation of the wild 
type biotinylated GFP (VOS2NL) is double than that of the lysine tagged GFP 
(VOS3NL). The highest level of immobilisation was found with the cysteine tagged 
GFP (VOS4L) which was biotin linked via the maleimide-biotin linker. This was 
followed by the Strep-TagII GFP protein. It is important to note that the rate of 
immobilisation via the biotinylated single cysteine residue tag immobilisation shows a 
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higher level of fluorescence than the biotinylated wild type protein. This indicates that  
the addition of the single cysteine residue acts as a single point for biotinylation with a 
maleimide linker resulting in a higher level of immobilisation. This single cysteine 
residue is not available in wild type protein. The immobilisation of the biotinylated C-
terminal cysteine tagged protein (GFP4L) exhibits the highest fluorescence via capture 
with streptavidin.  
3.3.8 Summary 
The capture of biotinylated GFP via immobilised streptavidin and streptactin in 96 well 
plates proved successful. The immobilisation of biotinylated proteins on streptactin was 
ten times more efficient than immobilisation on streptavidin. When biotinylated GFP 
was immobilised on streptactin, the wild type NHS-biotinylated VOS2 demonstrated 
the highest level of immobilisation. The NHS-biotinylated lysine tagged GFP (VOS3) 
exhibited half the level of this wild type immobilisation. The level of protein 
fluorescence of lysine tagged biotinylated GFP is ten times greater than when compared 
to the fluorescence of cysteine tagged biotinylated GFP. This can be explained by the 
greater number of lysine residues in GFP available for biotinylation by the NHS-biotin 
linker. The addition of extra lysine residues for NHS biotinylation protocols, did not 
increase immobilisation levels on 96-well plates, as can be seen by the levels of 
immobilisation between the wild type biotinylated GFP (VOS2) and lysine tagged 
biotinylated GFP (VOS3). Streptactin captures double the amount of wild type 
biotinylated GFP than lysine tagged biotinylated GFP.   
The capture of maleimide-biotin linked cysteine tagged proteins by streptavidin or 
streptactin also proved successful. The tagging of the model protein GFP with six 
cysteine residues (VOS4) increased the level of immobilisation by up to six times 
compared to the wild type biotinylated GFP (VOS2) (Figure 3.3.10).  The tagging of 
GFP with a single cysteine residue (VOS12) doubled the level of immobilisation over 
the biotinylated wild type (VOS2). The scale of this protein immobilisation (VOS12) 
was six times less than the hexa-cysteine model protein (VOS4), indicating a distinct 
advantage of adding six cysteine residues to the GFP.   
The immobilisation of these tagged model proteins was next investigated on a unique 
immobilisation platform. The use of monolithic columns for protein immobilisation has 
only recently been reported (Logan et al., 2007). Section 3.4 outlines the initial work 
performed to immobilise GFP on to monolithic columns.     
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3.4: Orientation specific immobilisation of the model protein 
GFP within monolithic columns 
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3.4.1: Overview 
The use of monolithic columns for the immobilisation of proteins is a relatively recent 
development in protein technology (Rangan Mallik, 2006). The Vinyl-azlactone 
immobilisation method is one of the most commonly used and is summarised in figure 
1.11. and first described by Tripp et al. in 2000. The method for creating, 
functionalising and immobilising proteins within monolithic columns is outlined in 
detail in Section 2.23. A schematic simplified outline of this process is shown in Figure 
3.4.1.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.4.1: A summary of the protocol for the creation, immobilisation and conductivity 
reading of proteins within monolithic columns.   
 
The capture of proteins by zones of reactive vinyl-azlactone relies on the reaction 
outlined in Figure 1.11. The amine reactive moiety, on which this reaction is dependent, 
is present at the N-terminus of all proteins. Additionally amine moieties are present in 
the R-group of lysine amino acids. By incorporating extra lysine amine acids residues 
Step I: The creation of a hydrophilic 
monolith to reduce protein surface 
interactions by the immobilisation of 
PEGMA by UV methods. (Sections 
2.23.1, 2.23.1, 2.23.3 and 2.23.4) 
Step II: The monolith was filled with 
vinyl-azlactone. Sleeves were placed on 
the column to generate an 
‘immobilisation window’ and irradiated 
with UV light, creating a zone of 
immobilised vinyl-azlactone. (Section 
2.23.5) 
Step III:  Protein was passed over the 
column. This was followed by a wash 
of ethanolamine to block any un-
reacted vinyl-azlactone functionalities. 
(Section 2.23.6) 
Step IV: Following an overnight wash 
with biological buffer a conductivity 
scan using a C4D detector was 
performed. (Section 2.23.6) 
C4D Scan 
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in the form of a protein tag it was theorised that the levels of protein immobilisation 
could be increased. By placing this tag at the N or C-terminus it was also predicted that 
the immobilisation of proteins could be more orientation specific.     
The immobilisation of proteins on monolithic columns can be characterised by a 
number of benefits. The generation of reactive zones within teflon coated silica 
monolith columns is based on UV functionalisation. This allows for the generation of 
specific controllable areas of immobilised protein within the monolith. Secondly the 
size of monolithic columns facilitates the use of contactless conductivity detection for 
the study of protein immobilisation and interactions within the columns. The 
conductivity of the interior was detected and recorded by moving the conductivity 
detector millimetre by millimetre along the length monolith. Monolith size is beneficial, 
as the sample size required for efficient detection is reduced significantly.        
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.4.2: Six monolithic capillary columns prepared as outlined in Section 2.23. Monoliths 
were prepared from ethylene glycol dimethacrylate and butyl methacrylate reactive monomers.  
 
3.4.2: Achieving a standard baseline 
Initial attempts to immobilise the model protein GFP onto monolithic columns were 
hindered by the inability to produce an acceptable baseline conductivity reading. The 
immobilisation of vinyl-azlactone within monolithic columns as outlined in section 
2.23.5 requires the washing of the monolithic column with methanol and water. Any 
contaminating amino acids present in these washes will react with the zones of 
immobilised vinyl-azlactone. The conductivity scan of a monolithic column in figure 
3.4.3 shows two zones of contaminated immobilised vinyl-azlactone.  
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Figure 3.4.3: An example of a contaminated monolith baseline. When a monolith is 
being functionalised with vinyl-azlactone (Section 2.23.5), successive washes with 
methanol, water are required. If these washes are contaminated with proteins, peptides 
or amino acids, these contaminates will be captured by vinyl-azlactone as can be seen 
by an increase in the conductivity values for the two reactive zones.  
 
Initial experiments undertaken to immobilise the tagged model protein GFP on 
monolithic columns included the optimisation of the vinyl azlactone functionalisation 
step to reduce this type of contamination. This included use of ultra-pure filter sterilised 
water, the thorough washing of the Knauer Wellchrom K-120 pump with methanol to 
ensure the removal of any non-specific proteins and the sealing of the buffer reservoir 
to reduce external containments. These experiments proved successful and an efficient 
protocol for the creation of functionalised monolithic columns was established.   
3.4.3: The effect of protein tagging on immobilisation within monolithic columns  
As described in previous sections of this chapter (Chapter 3) the model protein GFP has 
been tagged with additional lysine residues in an effort to increase the quantity of 
correctly orientated immobilised protein on a range of surfaces including monoliths. 
For the immobilisation of GFP on monolithic columns, a steady and uncontaminated 
baseline was required as outlined in section 3.4.2. The conductivity baselines of all 
monolithic columns were measured after the functionalisation of two distinct zones of 
the monolithic column with vinyl azlactone. These baseline scans were performed with 
ultra-pure water flowing through the monolithic column and is outlined in figure 3.4.4.    
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Baseline scan for the immobilisation of lysine tagged GFP on 
monolithic columns
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Figure 3.4.4: The initial conductivity scan of a monolithic column for the 
immobilisation of a lysine tagged model protein GFP. The monolith has been 
functionalised in two discrete zones by the photografting immobilisation of vinyl-
azlactone. The baseline was achieved by moving the detector millimetre by millimetre 
and recording the conductivity, with water flowing through the column. 
 
To determine the effect of the addition of a lysine tag to the immobilisation of a model 
protein, an untagged GFP protein was first immobilised on the monolithic column (see 
figure 3.4.5).  
1mg/ml of the untagged GFP (VOS2-Xa) in ultra-pure water was passed over the 
column at 1µl/min for three hours. After the blocking of un-reacted vinyl-azlactone 
moieties with 1M ethanolamine the column was washed overnight with water. The 
conductivity scan of the monolithic column was then performed. Figure 3.4.5 shows the 
increase in the conductivity (compared to the baseline) of the two zones of immobilised 
protein. Protein immobilisation was cross-validated by placing the monolithic column 
on a Blue Light Transilluminator Dark Reader (Clare Chemical). This Transilluminator 
dark reader produces blue light, which excites the fluorophore of immobilised GFP 
causing it to fluoresce. 
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Figure 3.4.5: The conductivity scan of immobilised untagged GFP on monolithic 
columns. Two zones of the monolithic column were functionalised with vinyl-
azlactone. 1mg/ml of untagged GFP was immobilised by reaction with vinyl-azlactone 
and the conductivity measured. The two zones of increased conductivity show the 
immobilisation of untagged GFP. This immobilisation was confirmed by visualisation 
of immobilised GFP using the Blue Light Transilluminator Dark Reader (Clare 
Chemical)  
 
The zones of fluorescence coincided with the change in conductivity. The cross 
validation of conductivity and fluorescence methods clearly outline the immobilisation 
of untagged GFP by reaction with vinyl-azlactone. 
To determine the effect of adding lysine residues to GFP, the conductivity of 
immobilised lysine tagged GFP within a monolithic column was studied. A second 
monolithic column was produced under identical conditions and at the same time as the 
monolith used in figure 3.4.5 (Section 2.23.2) and therefore should have identical pore 
sizes and distribution. This can be assumed because the formation of monolithic 
structures is based on the concentration of porogen and cross-linking agent within the 
reaction (see Section 1.4.2).  Lysine tagged GFP (VOS3-Xa) was then immobilised as 
previously outlined for untagged GFP (VOS2-Xa) on this monolith.  
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Figure 3.4.6: The comparative conductivity scans of tagged (VOS3Xa) and untagged 
(VOS2Xa) GFP. These conductivity scans were performed with ultra-pure H2O flowing 
through the monolithic column at 1µl/min. The addition of six additional lysine 
residues to GFP increased the conductivity scan of the protein by almost three times.  
 
Figure 3.4.6 clearly demonstrates the effect of the addition of lysine amino acid 
residues to protein immobilisation within monolithic columns. The conductivity 
readings of lysine tagged GFP compared to the untagged GFP, increased by roughly 
three fold. To determine the increase in the conductivity caused by the additional lysine 
residues the Peak Explorer program (http://www.soft32.com/download_187555.html) 
was used. The Peak Explorer program was used to calculate the peak area of tagged and 
untagged proteins across a range of different unique monolithic columns. This enables 
the determination of the scale of change in conductivity and therefore immobilisation of 
proteins on different monolithic columns.    
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Figure 3.4.7: A representative screen capture from the Peak Explorer column. This 
program calculates the average area of the conductivity peaks of immobilised, tagged 
and untagged proteins. This allowed the comparison of the levels of immobilised 
proteins across different monolithic columns.   
 
The change in the conductivity of monolithic columns can be directly related to the 
degree of immobilisation. By using Peak Explorer the scale of immobilisation can be 
compared across two zones on a single monolithic column or zones across multiple 
columns.  The addition of six extra lysine residues increased the scale of 
immobilisation by over 400% for the first functionalised vinyl-azlactone zone as 
outlined in table 3.4.1. The increase in the scale of immobilisation in the second 
functionalised zone was over 200%. This difference in the percentage increase between 
the two zones was noted and may be explained by the first zone becoming fully 
saturated before the second zone. 
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Table 3.4.3: Percentage change in the peak areas generated by the immobilisation of 
tagged and un-tagged GFP within monolithic columns by vinyl-azlactone. 
 
 
 
3.4.4: Use of Biological Buffers as stable mobile phases 
Water does not provide a suitable environment for protein storage or use. This is 
primarily due to the many hydrophobic amino acids in proteins which may cause 
proteins to be denatured in such environments (Pace et al., 2004). Initial studies of 
protein immobilisation within monolithic columns used water as a mobile phase. It was 
fortunate that the protein being immobilised, GFP is relatively stable in aqueous 
environments. These initial immobilisation protocols were used unchanged from 
protocols developed to capture amino acids and chemical moieties within monoliths 
(Connolly et al., 2007).     
For future experiments which involve attempting to measure protein interactions by 
conductivity it was important to discover a biological buffer which possessed a low 
level of background conductivity. A buffer with a large conductivity value may mask a 
change in the conductivity reading when a protein immobilisation event occurs.  A 
range of common biological buffers were passed over a monolithic column and a 
conductivity scan performed to determine the buffer with the lowest background 
conductivity. Figure 3.4.8 demonstrates that the most commonly used biological buffers 
exhibit high conductivity values. The buffer which provided the lowest background 
conductivity scan proved to be the zwitterionic Good’s buffer HEPES pH7.4. This 
buffer was used in all future protein immobilisation experiments on monolithic 
columns.  
 Area of Immobilised Protein 
Zone 1 (mm2) 
Area of Immobilised Protein 
Zone 2 (mm) 
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                 136 % 
 
160 % 
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                  419 % 
 
                        234 % 
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Figure 3.4.8: Relative conductivity values of a selection of biological buffers within 
monolithic columns. For each conductivity scan the appropriate buffers was flown 
through the column and the conductivity at each millimetre measured. It was found that 
the most appropriate buffer to give a low background conductivity was 10mM HEPES. 
This biological buffer was used in all future experiments.  
 
3.4.5: Capture of biotinylated GFP on monolithic columns 
The capture of proteins by vinyl-azlactone on monolithic columns is based on the 
reaction with the lysine residues on the surface of the protein. This is not an orientated 
immobilisation, as lysine is a common amino acid present on the surface of proteins. To 
achieve orientated protein immobilisation GFP was tagged with the Strep-tagII (Section 
3.1) and was biotinylated with both the NHS and maleimide- biotin linkers (Section 
2.21). Tetrameric proteins; streptavidin and streptactin have a biotin binding site within 
each subunit as outlined in section 1.3. Therefore, regardless of the orientation of 
immobilisation for these proteins on the monolith, they can retain the ability to capture 
biotinylated proteins. Streptavidin was immobilised on the monolithic columns by 
reaction with photografted vinyl-azlactone. (Section 2.23.6) Figure 3.4.9 shows the 
monolithic column which was prepared as described in section 2.23 and a baseline 
conductivity scan performed with 10mM HEPES flowing through the column. 500mgs 
of streptavidin was immobilised in two vinyl-azlactone functionalised zones. After 
immobilisation of streptavidin, unreacted vinyl-azlactone was blocked by the washing 
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of the column with 1M ethanolamine in 10mM HEPES buffer at pH7.4 and a second 
conductivity scan was performed after an overnight wash with 10mM HEPES. This 
scan showed an increase in the conductivity where streptavidin has been immobilised 
by vinyl-azlactone.  
 
       
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
Figure 3.4.9: A conductivity scan showing the immobilisation of 500mM of 
streptavidin in 10mM HEPES by two vinyl-azlactone functionalised zones in a 
monolithic column. The baseline conductivity scan was performed with 10mM HEPES 
in the column. Apart from the conductivity of the immobilised zones the baseline 
remains low signifying localised immobilisation within the column.  
 
To confirm that un-biotinylated GFP would not be captured by the immobilised 
streptavidin, 200mM of VOS3 (N-terminal Histidine6 tag, C-terminal Lysine6 tag) in 
10mM HEPES, pH7.4 was passed over this column. With 10mM HEPES, p7.4 flowing 
through the column a conductivity scan was performed.  
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Figure 3.4.10: Conductivity change in the zones of immobilised streptavidin after 
passing un-biotinylated GFP through the column. The conductivity scan was performed 
after an overnight wash with 10mM HEPES, and with the same concentration of 
HEPES flowing through the column. There is a reduction of 50% in the conductivity of 
the zones after passing 200mM VOS3 through the column.  
 
When initially performing conductivity scans it was thought that an increase in 
conductivity would be the only response to an immobilisation or protein capture event 
within a monolithic column. Conductivity is a measure of the ability of the solution 
within the monolithic columns to conduct an electrical current. The capture or 
immobilisation of a protein can change this ability by its net charge. When the 
conductivity scan of VOS3 in figure 3.4.10 was performed, it was not realised that the 
immobilisation of a protein on streptavidin could also reduce the conductivity values. 
The 50% reduction in the conductivity of the monolith could not be explained at this 
point. When this VOS3 conductivity scan was taken, a reliable method of visualising 
fluorescent zones on monolithic columns had not yet been discovered. Therefore the 
ability to cross confirm the change in conductivity with fluorescence visualisation was 
not available. Because of these factors it was decided to pass biotinylated GFP over the 
monolithic column despite the reduction in conductivity. 
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200mgs of biotinylated VOS3 in 10mM HEPES at pH7.4 was passed over the column 
as described in section 2.23.6. The conductivity scan was performed after washing 
overnight with 10mM HEPES. 
    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.4.11: The conductivity change within a monolithic column after passing 
biotinylated GFP over two zones of immobilised streptavidin. There is an increase in 
the conductivity from the un-biotinylated GFP conductivity. The conductivity is still a 
third less than the initial streptavidin conductivity values. An efficient method of 
obtaining a fluorescent picture for this conductivity scan was achieved. It became 
apparent that the capture of proteins on monolithic columns could cause the 
conductivity to decrease as well as increase. The fluorescence visible was a 
combination of the initial un-biotinylated VOS3 protein and the biotinylated VOS3 
protein.   
 
The conductivity scans shown in figure 3.4.11 clearly demonstrate the change in the 
conductivity by passing biotinylated GFP over the immobilised streptavidin. The 
biotinylated GFP conductivity scan increased by a third over the un-biotinylated 
conductivity values. This biotinylated GFP conductivity scan is a third smaller than the 
initial streptavidin conductivity values.  The development of a method to easily 
visualise fluorescent zones on monolithic columns using a Blue Light Transilluminator 
Dark Reader, enables the confirmation of the capture of GFP on immobilised 
streptavidin. The fluorescent zones visible in the monolithic columns comprise of a 
combination of the un-biotinylated and biotinylated GFP proteins. It was possible that 
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the un-biotinylated GFP was interacting with immobilised streptavidin by protein-
protein interaction. The streptavidin is capturing the biotinylated GFP as shown by the 
increase in the conductivity. It is noted that the intensity of fluorescence in the first 
zone of immobilised protein decreases from left to right. The conductivity values of the 
same zone increase from left to right. This result may indicate that the greater the 
amount of GFP immobilised on monolithic columns the lower the conductivity. This 
novel result was relatively un-expected, as an increase in conductivity relative to an 
increase in protein immobilisation was initially expected. It also supports the previously 
described observation that as proteins pass along the monolith from left to right, they 
will saturate the first reaction zone of the column before saturating the second zone.  
In order to assess whether the immobilisation of un-biotinylated GFP on streptavidin 
functionalised zones within monolithic columns is due to protein-protein interactions, a 
second monolithic column was produced with two zones of immobilised streptavidin. 
This second monolith was prepared at the same time as the monolith outlined in figures 
3.4.9, 3.4.10 and 3.4.11. Immobilised streptavidin zones were generated as previously 
described. 0.2mgs un-biotinylated GFP (VOS3) in 10mM HEPES buffer was passed 
over this column and after an overnight wash by HEPES buffer a conductivity scan was 
performed.  
Figure 3.4.12 shows an identical conductivity profile for the streptavidin and un-
biotinylated GFP immobilisation as figure 3.4.10. The scale of streptavidin conductivity 
indicates an equal amount of protein immobilised by the covalent reaction with vinyl-
azlactone on both columns. As in figure 3.4.10 after passing un-biotinylated GFP over 
the monolithic column containing immobilised streptavidin the conductivity values 
were reduced by 50%. The monolith column was placed on a blue light transilluminator 
dark reader and the presence of two distinct zones of fluorescence confirmed protein 
immobilisation. These results indicate that the un-biotinylated GFP protein is 
interacting and being captured by the immobilised zones of streptavidin.   
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Figure 3.4.12: The baseline, streptavidin and un-biotinylated conductivity scans within 
a monolithic column. Confirming the results shown in figure 3.4.10, passing un-
biotinylated GFP over a monolith column with two zones of immobilised streptavidin 
reduces the conductivity by 50% in both reactive zones. To confirm this reduction in 
conductivity is caused by the presence of GFP, the monolith was visualised under blue 
light and two fluorescent zones were present.   
  
 
To determine whether GFP was interacting with streptavidin by protein-protein 
interactions, the column was washed for 48hours with 1M NaCl in 10mM HEPES. 
High salt concentrations should disrupt any protein-protein interactions. Measurements 
of the conductivity of monolithic columns which contain highly ionic molecules were 
difficult. To reduce the conductivity values and enable them to be read by the 
conductivity detector the monolith was washed by 10mM HEPES at pH7.4.  
Figure 3.4.13 shows the conductivity scan of the column after washing for 48hrs with 
1M NaCl. Sodium Chloride is a highly conductive molecule and after washing the 
column for 8hrs with 10mM HEPES the conductivity baseline was three times higher 
than the original baseline. In an attempt to bring this baseline back down to original 
levels the monolith was continuously washed with 10mM HEPES overnight. The 
column was also viewed on the blue light transilluminator dark reader to determine if 
any immobilised GFP was present. The intensity of fluorescence visible on the 
monolithic column was greatly reduced by the wash with sodium chloride. A reduced 
amount of fluorescence indicates that not all GFP was removed from the column. This 
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result clearly demonstrates that washing monolithic columns with high salt 
concentrations to reduce protein-protein interactions was not completely successful. A 
conductivity scan of monolithic columns which contained solutions with high salt 
concentrations proved difficult to obtain. The continuous washing of the column with 
10mM HEPES buffer failed to reduce the conductivity values to the original baseline 
after a 48hr wash. This indicates that salt can be retained and detected within the pores 
of the monolithic columns for at least two days after passing the solution over the 
column. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Figure 3.4.13: The conductivity scan of a monolithic containing covalently 
immobilised streptavidin and a un-biotinylated GFP washed for 48hrs with 1M NaCl 
and a further 8 hours with 10mM HEPES to equilibrate. The equilibration process is 
important as even after an 8 hour step the baseline is three times higher than the 
original baseline. The conductivity of the functionalised zones is still higher than the 
original streptavidin immobilisation. This is due to the highly conductive salt NaCl still 
being retained by the column.  
 
The conductivity scan shown in figure 3.4.14 was the achieved after 48hours of 
consistent washing with 10mM HEPES. This conductivity could not be reduced by 
further washing with HEPES. The monolithic column was washed for a week and the 
conductivity scan illustrated in Figure 3.4.14 was the lowest conductivity achieved. 
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Figure 3.4.14: The conductivity of monolith after a further overnight wash with 10mM 
HEPES at 1µl/min. The conductivity was reduced by 10mV from the conductivity of 
the wash with 1M NaCl, but still not had been reduced to the conductivity of 
streptavidin. After washing with 10mM HEPES for 48hrs the column conductivity 
could not be reduced further.  
 
The continued use of this column was no longer possible as any further conductivity 
scans and changes in peak area, could not be compared to the original streptavidin 
conductivity scan. Also one could not attempt to measure the capture of biotinylated 
GFP by immobilised streptavidin within monolithic columns, as the change in 
conductivity could be due to protein-protein interactions or the bio-affinity reaction 
between streptavidin and biotin. Unfortunately due to time constraints further study of 
this potential protein-protein effect within monolithic columns was not possible.  
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3.4.6: Summary  
Preliminary results shown in this section clearly demonstrate that conductivity can be 
used to determine the degree of protein immobilisation or interactions within 
monolithic columns. As the model protein GFP fluoresces under blue light, 
conductivity and fluorescence can be used to cross-confirm protein immobilisation.  
Using both these non-evasive protein detection methods the addition of six extra lysine 
residues was shown to increase the amount of protein immobilisation within monolithic 
columns by over 400% in an orientation specific manner. The immobilisation of 
streptavidin and its capture of biotinylated proteins within monolithic columns were 
also studied by conductivity. The capture of biotinylated proteins by streptavidin 
proved to have issues, due to un-biotinylated protein being immobilised within the 
functionalised zones. This immobilisation was theorised to be due to protein-protein 
interactions. The reduction of protein-protein interactions between streptavidin and un-
biotinylated GFP by washing columns with high concentrations of salt proved to be 
relatively successful. Unfortunately, a 1M sodium chloride wash could not totally 
remove the protein-protein interaction. This phenomenon was shown by fluorescence as 
the reduction could not be confirmed by conductivity measurement due to the high 
conductivity of salt, which masked any change. The removal of salt from the 
monolithic column by continued washing with 10mM HEPES proved difficult. The 
conductivity of the column was only reduced by 10mV after two days of consistent 
washing.  
The use of GFP as a model protein for optimising immobilisation of proteins within 
monolithic columns proved particularly useful for initial studies due to its inherent 
fluorescence. The immobilisation of the vast majority of proteins can only be detected 
by conductivity.        
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Chapter 4: Model System; The capture of sialic 
acid by immobilised SiaP within monolithic 
columns and detection by C4D 
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4.1 Overview 
Sialic acids generally occupy the terminal position(s) in glycan chains (Varki., 1999). 
Sialic acid therefore has a wide range of functions within biological systems and has 
only recently received the attention this important molecule deserves.  Their main 
function relates to cellular and molecular recognition. Sialic acids are antigenic 
determinants of blood groups and as such enable the immune system to distinguish 
between self and non-self structures according to their sialic acid pattern. They also 
serve as ligands for lectins and antibodies and therefore play an important regulatory 
role in many physiological processes (Traving and Schauer, 1998). 
Sialic acid has also become increasingly interesting to the biopharmaceutical industry, 
because of its unique features. Sialylated biopharmaceuticals have exhibited an 
increased activity and stability in vivo (Fernandes and Gregoriadis, 2001). Therefore, a 
growing number of glycosylated pharmaceutical products are being studied with regard 
to their sialylation and its effects. Furthermore, an accurate estimation of the sialic acid 
level of a glycoprotein based drug as well as the determination of its sialylation pattern 
would allow for a more efficient production.   
As outlined in the introduction (Section 1.6.2) the pathogen Haemophilus influenzae is 
exclusively adapted to infect humans. It evades the innate immune response of the host 
by sialylation of its lipoligosaccharides with the hosts own sialic acids and thus appears 
as-self for the hosts defence system (Mandrell et al., 1992). Surprisingly then, although 
sialic acid is crucial for the pathogens survival within the host, Haemophilus influenzae 
is unable to synthesis sialic acid. It therefore requires an exogenous source of sialic acid 
(Bouchet et al., 2003). It was found that sialic acid acquisition is mediated via a 
tripartite ATP-independent periplasmic (TRAP) transporter (Muller et al., 2006). The 
extracytoplasmic solute receptor of this TRAP system is known as SiaP. As this protein 
has evolved to capture sialic acid, it was theorised that the SiaP protein could be used 
for sialic acid capture and detection (Severi et al., 2005). 
The SiaP proteins C-terminus is located on exactly the opposite side of the protein from 
the sialic acid binding site. C-terminal tagged SiaP protein was donated for this study 
by Jakub Szczepaniak who worked in our laboratory. A histidine tag was added to the 
C-termini of this SiaP along with an eight residue spacer sequence to aid protein 
purification. Downstream from this purification tag six lysine residues were added for 
orientation-specific protein immobilisation (Szczepaniak J., 2009).  
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Figure 4.1: A graphic representation of the SiaP protein used in this study which was 
provided by Jakub Szczepaniak. This figure shows a SiaP molecule in the ‘closed’ 
position with a bound sialic acid molecule.  The tags added to C-termini are shown in a 
coloured graphic. Eight amino acid spacer residues were added to aid protein 
purification. Six histidine residues were added for protein purification and six lysine 
residues were added to increase the amount of orientated-specific protein 
immobilisation.   
 
4.2 Immobilisation of SiaP on monolithic columns.  
Using the experience gained from the immobilisation of GFP on monoliths (Chapter 3), 
C-terminal lysine tagged SiaP was immobilised on monolithic columns. Two 
functionalised zones of vinyl-azlactone were generated by irradiation with UV light 
(section 2.23). A baseline conductivity scan was performed after washing with 10mM 
HEPES. A concentration of 200mM SiaP was passed over the column. In a change to 
the GFP monolith immobilisation protocol, the column was washed with 10mM NaOH 
in 10mM HEPES after SiaP immobilisation. Our laboratory had found that that our 
purified recombinant SiaP contained some bound sialic acid and that this could be 
removed with a 10mM NaoH wash (Szczepaniak J., 2009). Therefore this wash was 
applied to the monolith immobilisation protocol to ensure that the immobilised SiaP 
was free of bound sialic acid.  After further washing to remove NaOH from within the 
monolith with 10mM HEPES a second conductivity scan was performed.  
 
 
 
  
148 
 
Figure 4.2: The conductivity scan of two zones of immobilised SiaP. After protein 
immobilisation the monolithic column was washed with 10mM NaOH in 10mM 
HEPES to remove any bound sialic acid. Two clear increases in the conductivity 
indicate a focused immobilisation of SiaP on the monolithic column.  
 
The addition of six lysine residues to the C-termini of SiaP was expected to increase the 
level of immobilised protein based on the results discussed in chapter 3. It was also 
expected that the immobilisation was more orientation specific with the lysine residues 
at the C-termini. It was an important factor as SiaP requires steric space to capture 
sialic acid, changing from an ‘open’ confirmation to a ‘closed’ (Johnston et al., 2008). 
Tagging the protein at the N-terminus would remove the proteins ability to capture 
sialic acid.  
 
4.3: The detection of Sialic Acid capture within monolithic columns by 
conductivity 
Initial experiments were performed to determine if the capture of sialic acid by SiaP 
immobilised on monolithic columns could be detected by conductivity measurements. 
A 5mM concentration of sialic acid was initially passed over the monolith column 
functionalised with immobilised SiaP. Surface plasmon resonance results achieved by 
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our laboratory indicated that the capture of 5mM sialic acid by SiaP can be detected 
(Szczepaniak J., 2009).  
 
     
 
 
 
 
 
 
 
 
 
  
 
 
Figure 4.3: A conductivity scan of a monolithic column after passing 5mM sialic acid 
over two zones of immobilised SiaP. An increase in conductivity may indicate the 
capture of sialic acid. Sialic acid in 10mM HEPES was passed over the column for 30 
minutes. This was followed by a wash with 10mM HEPES for fifteen minutes before a 
conductivity scan was performed.    
 
 
 
A sample of 5mM sialic acid in 10mM HEPES was passed over the SiaP functionalised 
monolith for half an hour. This column was then washed for fifteen minutes with 
10mM HEPES to remove any free sialic acid and a conductivity scan performed. An 
increase in conductivity of approximately 40% was observed as illustrated in figure 4.3. 
This column was continually washed with 10mM HEPES and a conductivity scan was 
performed after 90 minutes to observe the effect on conductivity within the monolithic 
column. 
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Conductivity after washing with 10mM HEPES for 90 minutes after 
5mM Sialic acid conductivity scan
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Figure 4.4: The change in conductivity after washing the monolithic column with 
10mM HEPES for 90 minutes after capture of 5mM Sialic acid by immobilised SiaP. 
The conductivity of the first zone of immobilised SiaP reduced by approximately 20%. 
The second zone of immobilised protein retained the same conductivity profile.   
 
As can be seen in figure 4.4 the conductivity profile of the first zone of immobilised 
SiaP was reduced by approximately 20%. This change is contrasted by the stability of 
conductivity in the second zone of immobilised protein. It was theorised that as HEPES 
flows through the monolith, it reaches and therefore washes sialic acid from the first 
zone of immobilised SiaP. The free sialic acid is then captured by the second zone of 
SiaP, which causes it to maintain its conductivity profile. This monolith column was 
washed continuously for the rest of the day and a conductivity scan performed every 
hour to measure changes in conductivity. The conductivity scan illustrated in figure 4.4 
clearly demonstrates a reduction in conductivity in the first zone of immobilised 
protein. It is not until the conductivity of the first zone has been reduced to the original 
SiaP immobilisation conductivity that the conductivity of the second zone begins to 
decline (Figure 4.5).    
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Conductivity after washing with 10mM HEPES for 5 hours after 
5mM Sialic acid conductivity scan
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Figure 4.5: The change in conductivity after washing a SiaP functionalised monolith 
which had captured 5mM sialic acid for 5 hours with 10mM HEPES. The conductivity 
of the first immobilised zone of SiaP was reduced to the original immobilised SiaP 
conductivity. The second zone of immobilised SiaP was reduced by approximately 
20%. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.6: The change in conductivity after washing a SiaP functionalised monolith 
which had captured 5mM sialic acid, overnight with 10mM HEPES. The conductivity 
of both immobilised zones of SiaP has been reduced to the original immobilised SiaP 
conductivity.  
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The reduction of conductivity to the original SiaP values illustrated in figure 4.5 
demonstrated the effect of overnight washing of the column. Before this experiment 
was performed it was thought that a wash of 10mM NaOH would be required to 
remove captured sialic acid from immobilised SiaP, as had been required for surface 
plasmon resonance (Szczepaniak J., 2009). The results outlined for the capture of 5mM 
Sialic acid by immobilised SiaP indicate that this restoration step may not be necessary. 
A period of extended washing may recharge the immobilised SiaP monolith. This 
would provide a distinct advantage over the surface plasmon resonance method of 
interaction detection. The conductivity of the immobilised zones of SiaP after 5mM 
sialic acid removal was used as the baseline for the application of 2.5mM sialic acid. 
This concentration of sialic acid was chosen to try and determine the detection limit of 
this detection method.  
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Figure 4.7: The conductivity change of the monolith after the application of 2.5mM to 
the zones of immobilised SiaP. There is an approximate 10% increase in the level of 
conductivity in the first functionalised zone. The change in conductivity of the second 
SiaP functionalised zones was approximately 5%   
  
153 
 
As can be seen in figure 4.7 the conductivity of the monolithic column after the 
application of 2.5mM Sialic acid displayed a lower change in conductivity compared to 
5mM sialic acid. The reduced conductivity change in the second functionalised zone 
was thought to be due to the majority of the sialic acid being captured by the first zone 
of immobilised SiaP. After 45 minutes of washing with 10mM HEPES the conductivity 
scan both conductivity peaks were reduced to the background SiaP conductivity profile. 
This column continued to be washed with 10mM HEPES overnight and a final 
conductivity scan was performed. The conductivity scan produced by this overnight 
scan remained the same as the original SiaP conductivity. A second 5mM application of 
sialic acid was passed over the monolithic column this was to determine if the capture 
of sialic acid was reproducible. The application and washing times were kept consistent 
with the previous time 5mM sialic acid was applied to the column.    
 
 
Figure 4.8: The conductivity scan for the repeat application of 5mM Sialic acid to a 
monolith with SiaP functionalised zones. The increase in the conductivity of both zones 
of immobilised SiaP was approximately 40%. This increase in conductivity mirrors the 
increase which was observed the first time 5mM Sialic acid was applied to the 
monolith.   
 
The conductivity scan illustrated in figure 4.8 closely mirrors the conductivity profiles 
achieved in figure 4.3. This indicates that the conductivity detection method is a 
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reproducible method to determine interactions within monolithic columns. The 
monolith was once again washed with 10mM over the course of the day and 
conductivity scans performed at time intervals mirroring the time intervals outlined for 
the first application of sialic acid to the column.  
 
Figure 4.9: Conductivity scans of repeat application of 5mM Sialic acid to SiaP 
functionalised monolithic column. Conductivity scans were performed at set intervals 
and following overnight wash with 10mM HEPES. The conductivity scan profiles 
closely mirror those illustrated in figure 4.6.   
 
The conductivity scans outlined in figure 4.9 closely mirror the conductivity scans 
outlined in figure 4.6. The reproducibility of the conductivity method for detecting 
SiaP-sialic acid interaction on monolithic columns was further studied by calculating 
the change in the peak areas of both SiaP immobilised zones after passing 5mM Sialic 
acid over the column. The peak area change as the column is washed with 10mM 
HEPES was also noted and compared between the two columns; the initial 5mM sialic 
acid application and the repeat application.   Figure 4.9 illustrates the change in both 
peak areas for both monolithic columns after 15minutes, 90 minutes and overnight 
washes with 10mM HEPES. The peak areas in the first and second SiaP zones of 
immobilisation for both applications of sialic acid after a 15minute wash show an area 
increase of between 25 to 40%. After washing for 90 minutes the peak area of the first 
zone of immobilisation for both columns had reduced dramatically to approximately a 
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10% increase in peak area. The second zone of SiaP immobilisation though retained the 
increase in peak area after washing for 90 minutes, as observed after washing for 15 
minutes. These changes were thought to be due to sialic acid being removed by 
washing from the first zone of immobilised SiaP, but being recaptured by the second 
immobilised zone. This in turn caused it to exhibit a peak area change of 30% over the 
peak generated by SiaP immobilisation alone. After overnight washing with 10mM 
HEPES all peak areas, from the original and repeat application of sialic acid to the SiaP 
functionalised monolith showed a peak area change of approximately 1%. Indicating 
that sialic acid has been removed from immobilised SiaP protein within a monolithic 
column.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.10: The difference in peak areas between the original monolithic capture of 
5mM Sialic acid and the repeat application. The peak areas between both monoliths and 
the two functionalised zones on both monoliths show similarities. The peak area for 
both zones after each 5mM sialic acid capture after 15minutes of washing with 10mM 
HEPES show an increase in peak areas of between 25 and 40%. After 90 minutes of 
washing the initial zone in both monoliths was greatly reduced. The second 
functionalised zones on each monolith retained the increase in the peak area. After an 
overnight wash with 10mM HEPES all functionalised zones over the two columns 
reduced the change in peak area to less than 5%.  
 
As the repeat application of 5mM sialic acid appeared reproducible it was deemed that 
the immobilised SiaP protein was not affected by the continuous washing with buffer. 
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The reduced change in the conductivity reading for 2.5mM sialic acid application was 
due to the lower amounts of sialic acid being captured by immobilised SiaP.  
In order to determine if an increased conductivity signal could be achieved by 
increasing the concentration of sialic acid applied to the monolithic column. 7.5mM 
and 10mM Sialic acid concentrations were applied to the same monolithic column and 
conductivity scans performed after identical wash times as those outlined for the 
application of 5mM Sialic acid.   
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Figure 4.11: The change in conductivity after the application of 7.5mM Sialic acid to 
a SiaP functionalised monolithic column. There was an approximate 10% increase in 
conductivity in the first zone of immobilised SiaP. There was no change in the 
conductivity of the second immobilised SiaP zone. 
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Figure 4.12: The change in conductivity after the application of 10mM Sialic acid to a 
SiaP functionalised monolithic column. There was an approximate 20% increase in the 
conductivity values of both immobilised SiaP zones. The conductivity was reduced to 
the conductivity of the SiaP immobilisation after continuous washing with 10mM 
HEPES.  
 
As can be seen in figures 4.11 and 4.12 the application of different concentrations of 
sialic acid to the monolith column did result in a change in conductivity. However, the 
increase in conductivity did not appear to be concentration specific. The addition of 
7.5mM Sialic acid to the SiaP functionalised monolith elicited a change in conductivity 
in only the first zone of immobilised protein. This conductivity change outlined in 
figure 4.11 was an increase of 10%. This was a reduced conductivity change when 
compared to the addition of 5mM sialic acid. The lack of change of the conductivity in 
the second protein zone , could not be readily explained , but does indicates that no 
sialic acid was captured by the functionalised zone. Once again, as observed in the 
washing protocols with 5mM sialic acid, the conductivity may be reduced to the 
observed SiaP conductivity with continuous washing with 10mM HEPES buffer. The 
application of 10mM sialic acid to the SiaP functionalised monolith produced an 
increase in conductivity of 20% over the ‘background’ SiaP conductivity reading. 
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Figure 4.12 illustrates that the conductivity could be reduced to the original SiaP 
reading with washing by 10mM HEPES.  
The difference in conductivity readings between the application of 7.5mM sialic acid 
and 10mM sialic acid to the monolithic column was a concern. The increase in sialic 
acid concentration did not produce a corresponding increase in the conductivity. The 
overall reduction of conductivity by washing with buffer was seen as an indication that 
SiaP may not be capturing the free sugar within the monolith. To determine if this was 
the case an un-related sugar was applied to the functionalised monolith.  
     
4.4: Effect of Glucose on conductivity 
To determine if the change in conductivity was due to the specific interaction between 
sialic acid and SiaP, an unrelated sugar molecule (glucose) was applied to the SiaP 
functionalised monolith. A solution of 5mM Glucose was applied to the monolithic 
column for thirty minutes. After washing with 10mM HEPES for fifteen minutes a 
conductivity scan was performed. As illustrated in figure 4.13, there was an increase in 
conductivity of 20% in the two zones of immobilised SiaP within the monolith. This 
increase in conductivity could be reduced by continuous washing with 10mM HEPES 
which mirrored all previous sialic acid applications. This result indicated that the 
increase in the conductivity seen with sialic acid may not be due to a specific 
interaction between the free sialic acid and the immobilised SiaP protein. It was 
theorised that the observed increase in conductivity in all previous sialic acid 
applications were due to non-specific interactions between the sialic acid and protein.  
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Conductivity change in zones of immobilised SiaP after 5mM glucose 
application
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 Figure 4.13: The change in conductivity after the application of 5mM glucose to the 
monolithic column. There was a 20% increase in both SiaP immobilised zones after the 
addition of glucose. The conductivity scan was performed after set periods of time and 
the change in conductivity observed. The conductivity had reduced to the original SiaP 
conductivity after an overnight wash of 10mM HEPES buffer.   
 
 
4.5: Summary 
The preliminary results outlined in this section provide an insight into the future work 
required for the successful creation of a novel free sialic acid detector. The conductivity 
measurement allowed for the determination of the extent of capture of the SiaP protein 
within two distinct functionalised zones within a monolithic column. The effect on 
conductivity of the addition of differing concentrations of free sialic acid was then 
studied. An increase in conductivity signified that there was a capture of free sugar by 
immobilised protein. The increase in conductivity was significantly less for 2.5mM 
sialic acid than for 5mM sialic acid, indicating a potentially accurate method to 
measure concentrations of free sugar. The similarity of the changes in the areas of 
conductivity peaks for two separately applied samples of 5mM Sialic acid indicated a 
method which had reasonable levels of reproducibility.  
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When higher concentrations of sialic acid were applied to the monolithic column the 
increases in conductivity did not match the increase in sialic acid concentration. The 
conductivity scan for both 7.5mM and 10mM sialic acid applications to the monolithic 
column showed a lower increase in conductivity than the 5mM application. Also of 
concern was the fact that the conductivity of the sialic acid applications could be 
relatively easily reduced to the SiaP conductivity levels by washing with buffer. The 
affinity between SiaP and sialic acid is known to be high with a Kd of 28nM (Johnston 
et al., 2008), and a more stringent wash protocol was initially thought to be required. 
To examine if the bindings observed were sugar specific free glucose was applied to the 
monolithic column and conductivity scans performed. The conductivity scan profile 
achieved for glucose was identical to the scans achieved for the sialic acid application. 
This indicated that the conductivity profiles of the various concentrations of sialic acid 
was not due to the specific capture of free sialic acid by immobilised SiaP, but rather a 
non-specific interaction between the free sugars and the immobilised protein. 
This novel method of free sialic acid detection is in a very early stage of development 
but initial experiments have shown that an interaction between immobilised SiaP 
protein and a free sugar may be detected by conductivity. It is expected that with 
further optimisation of protein immobilisation within monoliths coupled with the 
determination of optimum buffer conditions that an efficient, simple to use, fast and 
sensitive free sialic acid detector could be developed.      
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Chapter 5: Discussion and Conclusions 
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5.1: General Discussion 
The aim of this work was (i) the production of a range of specifically tagged model 
proteins and (ii) to study their effects on protein expression, purification and ultimate 
immobilisation. It was expected that by studying the variation of the placement and 
composition of immobilisation tags a more orientation specific immobilisation could 
be achieved. The experience gained from the tagging and immobilisation of the 
model protein Green Fluorescent Protein (GFP) was transferred to immobilisation 
protocols for the specific bio-ligand protein SiaP. In nature this protein captures free 
sialic acid (Severi et al., 2005). As well as defining an efficient tagging protocol for 
protein immobilisation, the generation and study of a novel immobilisation activated 
surface and associated detection method was of vital importance. Monolithic columns 
have already been described for trypsin immobilisation (Peterson et al., 2003). 
Monolithic formation took place in a nanoelectrospray needle which was plumbed to 
a mass spectrometer to detect immobilised trypsin activity. Myoglobin digested by 
the immobilised trypsin within a monolith was found to give a 80% coverage by mass 
spectrometry (Peterson et al., 2003). It has also been reported that the activity of 
immobilised trypsin is not affected by organic solvents (Slysz and Schriemer, 2003). 
Trypsin activity is not representative of most proteins as it is particularly solvent 
resistant (Klibanov, 1997). Therefore, the activity of any protein immobilised within 
monolithic columns can be solvent dependent, and will require optimisation for each 
unique biomolecule.  
Achieving qualitative and quantitative information of immobilised protein on 
monolithic surfaces enclosed within a capillary column presents a challenge. One of 
the most common techniques used for these measurements is surface plasmon 
resonance (Homola et al., 1999). This detection technique however can only measure 
amounts of proteins immobilised on flat planar surfaces and is not applicable to 
protein immobilisation within monolithic columns. Therefore, a novel detection 
method was required. Following work previously reported from this group (Connolly 
et al., 2007) the ability of C4D detection to measure an immobilisation and interaction 
event within monolithic columns was studied and assessed.  
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5.2 Cloning and Tagging of Green Fluorescent Protein 
The GFP utilised in this study was a mutated version of the wild type, namely, 
GFPmut3. This protein was originally generated by selection for increased 
fluorescence by FACS (Fluorescence-activated cell sorting) (Cormack et al., 1996). 
This mutant is significant for its increased fluorescence observed in the FACS 
system, but more importantly it exhibits an increased folding efficiency in E.coli 
bacteria. This ensures that any irregularities in expression were due to the addition of 
purification and immobilisation tags.   
The pQE-30 and pQE-60 expression vectors were utilised for the cloning of GFP with 
an N or C terminal histidine tags. Both cloning vectors contained six histidine 
residues, either upstream or downstream of the multiple cloning site, facilitating the 
translation of a purification tag to the protein of interest. The addition of a second tag 
by PCR allowed for a highly controllable tagging system, which in turn enabled the 
generation of a large set of diversely tagged proteins.  
Three specific immobilisation tags were added to GFP, which can be split into two 
distinct groups. The first group, containing a six residue lysine or cysteine tag, relies 
on covalent chemistry for immobilisation (see Section 1.2.3) (Ichihara et al., 2006, 
Wong et al., 2009), (Xu and Lam, 2004). The second group contained, a Strep-TagII 
which is an eight amino acid tag developed as a biological mimic for biotin (Schmidt 
et al., 1996). This tag allows proteins to be immobilised by the well characterised 
reaction between streptavidin or streptactin and biotin (Weber et al., 1989).   
During the course of this study, it was discovered that the addition of six cysteine 
residues to GFP resulted in the formation of large protein multimers. This was due to 
the formation of disulfide bonds which were generated by the oxidation reaction 
between cysteine residues of the tag. Therefore, GFP was tagged with a single C-
terminal cysteine amino acid to remove the majority of reactive cysteine residues 
from the tag. This tagging approach has already been described. The addition of a 
single cysteine residue to GFP in place of six residues was found to significantly 
reduce the formation of high molecular weight multimers. This allowed for a more 
accurate measurement of the amount of protein immobilised on activated surfaces. 
The protein expression levels of a number of diversely tagged GFP proteins were then 
further investigated.  
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5.3 Protein expression and purification 
E.coli is one of the most commonly used hosts of recombinant protein expression 
(Baneyx, 1999). It facilities protein expression by its relative simplicity, rapid high 
density growth rate on inexpensive substrates and well characterised genetics which 
allow for large scale protein production. The optimal E.coli strain and temperature 
conditions for the over-expression of GFP from pVOS1 was investigated.  XL10-
Gold is a commonly used E.coli strain that contains the lacIq allele. This genotype 
results in a high expression level of the LacI repressor protein, which in turn strongly 
represses the activity of the Ptac promoter in the absence of IPTG. BL21 is a 
commonly used expression strain that is OmpT and Ion protease deficient, which 
should allow for higher recovery of recombinant proteins (Sørensen and Mortensen, 
2005). 
The GFP expression vector pVOS1 was transformed into the above E.coli strains. The 
optimal expression temperature and harvest time for both of these strains was 
investigated. The temperature ranges chosen for the study of protein expression was 
30°C, 37°C and a combination of both temperatures. This combination involved 
growth to the point of induction at 37°C, following induction by IPTG expression, 
carried out at 30°C. The importance of the optimisation of protein expression within 
E.coli has previously been outlined (Georgiou and Valax, 1996). Cultures were 
allowed to incubate for a defined period, sampling two millilitres routinely at hourly 
intervals. 
SDS-PAGE was utilised to determine an optimum temperature for protein expression 
(Laemmli, 1970). Control samples were taken from an uninduced culture and run 
alongside the induced samples to compare protein expression levels. The expression 
of tagged GFP from the XL10-Gold E.coli strain exhibited high levels of expression 
at all temperatures after overnight incubation (see Figure 3.2.1).   XL10-Gold was 
found to be a leaky expresser due to the presence of GFP in the overnight un-induced 
sample (see Figure 3.2.1, Lane 10). However, GFP is a non-toxic protein and 
therefore should not have an effect on cell growth. The folding of GFP in E.coli 
systems is so well defined it is commonly used as a fusion protein to measure the 
expression and folding of troublesome proteins (Cha et al., 2000).  The highest yield 
of expressed protein was found after overnight expression at 37°C/30°C. GFP was 
discovered and initially purified from the jellyfish Aequorea Victoria (Tsien, 1998) 
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and evolved to be expressed at the lower temperatures found in a maritime 
environment. Incubation at 37°C allows for rapid high density growth to the point of 
induction, while protein expression at 30°C mimics natural expression conditions for 
GFP.   
The greatest yield of over expressed protein in BL21 was found to be present five 
hours after induction at each temperature. The levels of overnight expression in BL21 
were significantly reduced when compared to the five hour sample. During the course 
of this study GFP was found to be present in the media after overnight expression 
from BL21. This indicates GFP is released from the cells but further studies are 
required to investigate this effect which could be due to cell lysis or protein export 
from the cell. The level of expressed protein in BL21 appeared to be less than the 
levels of expressed protein in XL10-Gold by visualisation of SDS-PAGE analysis.  
Due to this finding all future proteins were expressed overnight at 37°C/30°C from 
XL10-Gold.  During the course of the study all expressed protein was purified from 
the soluble fraction, with insoluble fractions exhibiting little fluorescence. 
The established optimal protein expression protocol for pVOS1 was used for the 
expression for all subsequent GFP clones (see Figures 3.2.4 to 3.2.7). GFP was over 
expressed from twelve clones successful. Three clones (pVOS9, pVOS10 and 
pVOS11) showed a distinct reduction in the levels of protein expression over the 
average expression levels exhibited by the other over-expressing clones. These three 
clones were tagged at their N-termini with a protein immobilisation tag and at their C-
termini with a histidine tag. This result correlates with results achieved previously 
(Ichihara et al., 2006). This group studied the effect of tagging on the expression of 
eGFP (enhanced Green Fluorescent Protein). When a five residue cysteine tag was 
added to the N-terminal the levels of protein expression fell when compared to eGFP 
which was cysteine tagged at the C-terminus. Interestingly, a second group added a 
hexa-arginine to the N-termini of GFP and reported no effect in protein expression 
levels (Nock et al., 1997). 
Therefore, it was concluded that the addition of poly-lysine/cysteine tag or a Strep-
TagII to the N-termini of this protein severely affected the levels of expressed protein 
within the soluble fraction (see Figure 3.2.7). The fusion of these three tags, in 
particular the lysine and cysteine with six repeat residues, directly downstream from 
the promoter region of the vector, may have affected the initial transcription process, 
and lead to the reduction in overall protein expression. When both the purification 
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and immobilisation tags were placed at the N-termini the level of protein expression 
was not affected.  As illustrated in figure 3.2.6 the placement of the protein 
purification tag immediately downstream from the promoter region did not effect 
protein expression.  This result indicates that the specific location of the 
immobilisation tag was the cause of the observed reduction in expression levels.  
 
Figure 5.1: Graphical representation of tagged GFP and the tags effect on protein 
expression levels 
 
The result illustrated in figure 5.1 justified the work undertaken to produce a number 
of differently tagged proteins and to study their effects on protein expression. The 
three clones (pVOS9, pVOS10 & pVOS11) were then deemed unsuitable for future 
work.  
Once the optimal conditions of recombinant protein expression were evaluated a 
purification strategy was investigated to maximise the recovery of recombinant 
protein from the soluble cell extract while maintaining a high level of purity.  The 
expression plasmid pVOS1 was used to establish an optimal protein purification 
protocol.  Expression of GFP with this plasmid included an addition of six histidine 
residues to the C-terminus to the expressed protein. IMAC purification strategies 
were employed for the purification of the expressed protein utilising nickel sepharose 
resin coupled with step wise elution with imidazole (Porath et al., 1975, Nilsson et 
N-termini  
N-termini 
N-termini 
C-termini 
C-termini 
C-temini 
  
167 
al., 1997). The imidazole gradient (see figure 3.2.8) found that histidine tagged GFP 
remained bound to the resin at concentrations of imidazole up to 80mM.  After 
several column volumes of washing with 80mM imidazole an elution buffer wash of 
250mM imidazole was found to elute histidine tagged protein from the nickel resin 
column (see figure 3.2.9). This optimal protein purification protocol was successfully 
applied to the remaining clones (see Figures 3.2.10 to 3.2.14). The exception to this 
purification method was the clones which were not over-expressed in the soluble 
fraction (see Figure 3.2.12, Gel D and Figure 3.2.13). 
Samples of hexa-cysteine tagged purified proteins, when examined on SDS-PAGE 
gels, were found to contain high molecular weight contaminant bands. To investigate 
if these high molecular weight bands were due to possible disulfide bond formation 
between cysteine residues, proteins were examined on SDS-PAGE gels in a non-
reducing environment.  Figure 3.2.16 showed that a DTT concentration of 50mM 
greatly reduced the amount of high molecular weight protein bands visible in the 
SDS-PAGE gel (Cleland, 2002). This indicates that the larger protein bands were 
multimeric GFP products produced by the oxidisation of cysteines between 
immobilisation tags to form cystine residues. This finding led to the creation of an 
additional clone for the expression of GFP with a single cysteine residue on the C-
terminus. SDS-PAGE analysis of expressed GFP purified from this clone reveals 
dimer formation. By limiting the number of cysteine residues within the 
immobilisation tag to one, the formation of large multimers is significantly reduced. 
Dimer formation persists due to the single cysteine residue being available for 
oxidation by a second identically tagged protein.  
 
5.4 Biotinylated GFP immobilisation onto 96 well plates        
Biotinylated GFP was captured on 96 well NUNC MaxiSorp plates by immobilised 
streptavidin or its mutant streptactin. This mutant streptactin has been reported to 
have a higher affinity for the Step-TagII (Voss and Skerra, 1997). The capture and 
immobilisation of GFP which has been tagged with Strep-TagII can be directly 
monitored by fluorescence (as outlined in section 3.3). The GFP proteins which were 
tagged with the covalent immobilisation tags (hexa-lysine and cysteine) require 
further modification to be captured by streptavidin/tactin. Both cysteine and lysine 
tagged GFPs were tagged with heterofunctional biolinkers based on the respective 
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chemistries of their added immobilisation tags (see Figure 3.3.1) (Wong et al., 2009).  
The lysine tagged protein was biotinylated with a linker which contained a NHS 
reactive moiety, while the cysteine tagged protein was biotinylated with a linker 
which contained a maleimide moiety as discussed in section 3.3.2. In this way, the 
effectiveness of the addition of these immobilisation tags can be directly related to the 
amount of biotinylated GFP captured by immobilised streptavidin or streptactin.  
Optimum immobilisation and excitation and emission wavelength conditions were 
initially determined. Both wavelength values were identical to the values originally 
described in the creation of the GFPmut3 mutant (Cormack et al., 1996). It was found 
that the highest fluorescence values achieved were after immobilisation of 5µg/ml 
streptavidin/tactin for an hour at room temperature before probing with 50µg/ml of 
biotinylated GFP.  The capture of biotinylated GFP by immobilised streptactin was 
found to be five-fold greater than that bound by streptavidin (see Figure 3.3.9). This 
was mirrored across all tagged proteins whether they were biotinylated with the NHS-
biotin linker, the maleimide-biotin linker or the Strep-TagII. The significant increase 
in the levels of protein capture may be attributed to the changes in the binding 
pockets between streptavidin and its mutant streptactin (Korndorfer and Skerra, 
2002). It was theorised by our group that the mutated flexible loop of the streptactin 
protein outlined in the previous report, allows for greater availability of the binding 
site for the biotin moiety.  
The level of fluorescence seen with the immobilisation of the GFP tagged with Strep-
TagII was significantly lower than the proteins which were biotinylated with the 
biotinylation linkers. The immobilisation of the tetrameric streptavidin and streptactin 
proteins can theoretically bind up to four biotinylated proteins (Diamandis and 
Christopoulos, 1991). The linker used for the biotinylation of both the cysteine and 
lysine tag acts as a spacer between the biotin moiety and GFP. As the added Strep-
TagII is in close proximity to the point of capture of GFP by a subunit of the 
multimeric streptavidin/tactin it may obstruct binding at other subunits. Due to time 
constraints a GFP protein which contained a linker separating the GFP and Strep-
TagII could not be generated. This protein would establish whether steric hindrance 
played a role in the amount of biotinylated protein captured by immobilised 
streptavidin or streptactin.  
The levels of captured biotinylated tagged proteins demonstrated unexpected result. 
The biotinylated GFP which contained no additional lysine residues showed up to a 
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33% higher level of capture/immobilisation when compared to the biotinylated GFP 
which contained the added lysine tag. This effect was found when the protein was 
captured by either streptavidin or streptactin indicating it is capture molecule 
independent.  
When comparing the fluorescence levels of cysteine tagged biotinylated GFP there 
was a 500% increased capture by the biotinylated GFP with a six residue cysteine tag 
when compared to the GFP with a single cysteine residue at the C-terminus and an 
1100% increase when compared to the untagged GFP protein which was biotinylated 
with the same linker.  Wild type GFP contains two cysteine residues within the amino 
acid sequence and both are buried within the structure of the protein (Tsien, 1998).  
These cysteine residues are not available for the biotinylation reaction. Wild type 
GFP was not biotinylated with the maleimide linker and therefore was not found to be 
captured by immobilised streptavidin/tactin.    
 
5.5 Orientation specific immobilisation of the model protein GFP within 
monolithic columns 
 
The immobilisation of proteins within a monolithic column is a relatively recent 
development (Rangan Mallik, 2006). There are examples of the use of immobilised 
proteins within monolithic column for protein mapping (Frantisek, 2006). Similarily 
the use of conductivity for detection within capillary electrophoresis is a commonly 
used method (Zemann, 2003). To date, there has not been an attempt to detect protein 
immobilsation or interactions within monolithic columns using this conductivity 
method.  
The use of GFP for this experiment allowed for cross-confirmation of protein 
immobilisaiton within the monolithic column by both fluorescence and conductivity.  
Significant optimisation was carried out in this work to develop protocols which 
allowed for the reproducible and controllable creation of monoliths. The 
immobilisation of proteins within the monolithic columns also required a significant 
degree of optimisation to account for possible non-specific changes in conductivity.  
Experiments were performed to determine if the addition of six extra lysine residues 
to the C-terminus increased the amount of protein specifically immobilsed within the 
monolith. The level of protein immobilisation was determined by the change in the 
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conductivity due to a change in the monoliths abilty to conduct a current. The ability  
to conduct a current is altered by a proteins net charge. The addition of six extra 
lysine residues to a GFP protein causes a 200% increase in the conductivity where the 
protein is immobilised in the of the functionalised zones within a monolith (see figure 
3.4.6). Therefore in all subsequent experiments proteins were tagged with additional 
lysine residues for immobilisation within monolithic columns. The method of 
immobilisation used for the capture of lysine tagged GFP within monolithic columns 
made use of the inherent or added lysine residues. The increase in the conductivity of 
lysine tagged GFP in comparsion to non-tagged GFP suggests that the majority of the 
immobilised protein is orientation specific. 
However, due to the presence of inherent lysine residues, all immobilised protein may 
not be specifically orientated. Therefore, in an attempt to achieve a more reliable 
orientation specific protein immobilisation, biotinylated GFP was captured by 
immobilised streptavidin. As previously outlined the tetrameric protein, strepavidin 
was immobilised by its inherent lysines within two zones of vinyl-azlactone 
functionalised monolithic column (see Section 3.4.5). Initial studies indicated that the 
optimium buffer used for the capture of biotinylated proteins by immobilised 
streptavidin was the low conductivity HEPES buffer. The low conductivity of this 
buffer was vital as it would not mask any changes in conductivity within the 
functionalised zones. Biotinylated and un-biotinylated GFP proteins were passed over 
streptavidin functionalised zones of the monolithic column. When GFP was passed 
through the column, the conductivity values of the two functional zones increased for 
both biotinylated or un-biotinylated proteins by approximately 66%. The capture of 
both forms of tagged GFPs by immobilised streptavidin was confirmed by 
fluorescence measurement. The capture of un-biotinylated GFP indicated that the 
interaction between streptavidin and GFP was not due to biotinylation. This was 
theorised to be due to protein protein interactions (Jones and Thornton, 1996).  To 
confirm this theory, 1M NaCl solution was passed over the column in an attempt to 
disrupt the interaction (Phizicky and Fields, 1995). The high salt conconcentration 
wash reduced the level of fluorescence which could be visulised within the 
monolithic column but did not remove it completely. The conductivity of the washed 
column however increased due to the high conductivity of the salt. After two days of 
continious washing with 10mM HEPES the conductivity was reduced by 12.5%  (see 
Figure 3.4.14). 
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These results indicate that it is possible to measure protein immobilisation in 
monolithic columns by measuring changes in conductivity. Furthermore , the addition 
of a six residue lysine tag was found to increase protein immobilisation within 
monolithic columns, most likely, in an orientation specific manner. Finally to achieve 
an orientated immobilisation of biotinylated proteins with monolithic column requires 
further optimisation as there are non-specific protein-protein interactions involved. 
  
5.6  Model System; The capture of sialic acid by immobilised SiaP within 
monolithic columns and detection by C4D  
Utilising optimised protocols a protein with a high affinity for free sialic acid (SiaP) 
was immobilised within vinyl-azlactone functionalised zones of a monolithic column. 
The change in conductivity of the SiaP functionalised zones with the addition of 
5mM sialic acid was measured. The conductivity of the column increased in both 
immobilised protein zones by approximately 33% (see Figure 4.3). Hourly 
conductivity scans were performed during continous washing of the monolith with 
10mM HEPES. The conductivity of the immobilised SiaP zones were found to 
ultimately reduce over time by 33% to the original SiaP  conductivity baseline. 
Reproducability of the system was confirmed by re-application of 5mM sialic acid to 
this column. The resulting change in conductivity mirrored previous 5mM sialic acid 
conductivity readings. This indicates that measureing changes in conductivity of 
immobilised SiaP is potentially a possible method for the determination of free sialic 
acid concentration.   
Continuous washing with buffer reduced the conductivity of the first zone to the SiaP 
conductivity baseline prior to the reduction of the conductivity in the second zone. It 
was theorised that the free sialic acid removed from the first zone by washing is 
recaptured by the second zone of immobilised SiaP. A concentration of 2.5mM sialic 
acid was applied to the column to determine the detection limit of this method. When 
half the concentration of free sialic acid (5mM to 2.5mM) was appied to the monolith, 
a fifty percent reduction in the conductivity change was observed (see Figure 4.7). 
However, when 7.5mM and 10mM of sialic acid was applied to this column the 
change in conductivity did not mirror corresponding increase in sialic acid 
concentration (see Figures 4.11 and 4.12).   
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It was theorised that the capture of sialic acid was not a specific capture by SiaP but 
rather a non-specific interaction. In an attempt to determine whether this binding was 
sugar-specific, glucose was applied to the column. This application of glucose was 
found to increase the level of conductivity within the two zones of immobilsed SiaP 
(see Figure 4.13) indicating that the changes in the conductivity found with sialic 
acid, may not be due to specific capture of sialic acid by the immobilised SiaP. 
Further study is required to determine if this ‘system’ can specifically measure the 
level of free sialic acid in solution.   
 
 
5.7 Conclusions and Future Work   
This study has described results that clearly show the effects of adding different 
affinity and immobilisation tags to protein expression, purification and 
immobilisation.   
The potential use of conductivity detection to determine the capture of biotinylated 
protein to streptavidin has been confirmed. This detection method cannot however 
distinguish between protein to protein interactions and biotin-streptavidin 
interactions. More experimentation will be required to optimise the capture of 
biotinylated proteins by immobilised streptavidin within monolithic columns. These 
experiments should include changing the buffering conditions to favour biotin-
streptavidin reactions while inhibiting protein to protein interactions. The 
optimisation of this immobilisation method will allow for the development of an 
extremely novel functionalised surface, which will allow for the immobilisation of 
orientation specific proteins.  
The protein SiaP, exhibits a high affinity for free sialic acid (Severi et al., 2005). 
Preliminary results indicate that the capture of sialic acid by immobilised SiaP within 
monolithic columns can be detected by a change in conductivity. The change in 
conductivity observed may not be due to the capture of sialic acid by SiaP but may be 
due to non-specific sugar-protein interactions. Further experiments should be 
performed to determine how to reduce the level of these non-specific interactions 
while increase binding of sialic acid by SiaP. The optimisation of this protocol is also 
required, such as the determination of the detection limits, sample application times 
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and regeneration of the immobilised SiaP ‘surface’. The development of a rapid and 
reliable free sialic acid monitor would generate an extremely novel on-line detector.  
The correct degree of sialylation of glycoproteins can significantly improve their 
activity, immunogenetic characteristics and blood retention time (Byrne et al., 2007). 
The development of a method which can measure the concentration of free sialic acid 
during the cell culture process would prove an important development in the 
optimisation of the biopharmaceutical processes.     
The level of protein immobilisation within monolithic columns has to be compared to 
levels of protein immobilisation on other surfaces such as glass slides, resins, and 
nitrocellulose.   As previously outlined the immobilisation of proteins on such 
surfaces can be achieved by many different methods, most commonly through 
absorption, covalent immobilisation or bio-affinity methods (Wong et al., 2009). 
A disadvantage of using monolithic columns is this surface cannot match the quantity 
of unique proteins immobilised on commonly used surfaces such as glass slides, due 
to current methods of monolithic column functionalisation. For example over 10,000 
unique proteins have been immobilised on functionalised glass slides. (Macbeath and 
Schreiber, 2000). 
One of the major challenges for this conductivity detection method is to increase its 
sensitivity. Biosensors which have been generated with immobilised proteins exhibit 
impressive detection limits. A biosensor for the detection of PSA (prostate-specific 
antigen) has been generated which can detect levels of 0.2 to 60ng/ml from a 
background of human serum albumin (Wu et al., 2001). Even more impressively 
40ρg/ml of B-type natriuretic peptide, which is a biomarker for heart failure, has been 
detected by a biosensor (Mizutani, 2008). These detection limits compare extremely 
well when compared to the 2.5mM limit of sialic acid detection which has been 
currently achieved by the conductivity method. Though detection limit comparisons 
between the different biosensors are not entirely accurate due to the different surfaces 
used in biosensor creation.  
Monoliths which were developed originally for liquid chromatography (Svec and 
Frechet, 1992), have in recent times achieved notice as potential surfaces for 
biosensors (Logan et al., 2007, Frantisek, 2006, Peterson et al., 2003). To date no 
‘on-column’ detection method has been outlined, with all monoliths being attached to 
MALDI-MS or MALDI-TOF to determine reactions which have taken place with the 
column (Peterson et al., 2002). It has been found that the levels of bio-molecules 
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immobilised with monolithic columns have been difficult to quantify. Normal 
procedures involve destroying the monolith and performing standard protein 
quantification assays on the destroyed column. The development of a protein 
detection method for monolithic columns therefore is a timely and necessary method 
and conductivity has already been described to detect immobilised protein within 
monoliths (Connolly et al., 2007). 
Finally the well characterised advantages of monolithic columns such as low sample 
volumes and high throughput coupled with a sensitive and easy to use detection 
method such as C4D would allow for the creation of extremely novel bio-surfaces. If 
the few remaining scientific limitations can be over-come a new vista of protein 
immobilisation surfaces and detection will become visible.  
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